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Abstract 
This Thesis describes an investigation into the use of a continuous 
hydrothermal reactor for the synthesis of nanomaterials with potential use in 
three different biomedical applications ± bone scaffolds, fluorescent biomarkers 
and MRI contrast agents. 
 
In Chapter 1, an introduction to nanotechnology is given, followed by a brief 
account of the most prominent routes of nanomaterial synthesis. This includes a 
literature review of the key publications to date, which use different reactor 
designs for the continuous hydrothermal synthesis of nanoparticles. This Chapter 
also describes some problems associated with nanomaterial synthesis, along 
with the aims and motivations of this PhD. 
 
Chapter 2 details the principles behind the main characterisation techniques 
which are used in the work throughout this Thesis. Some advantages and 
limitations of each technique are given. 
 
Chapter 3 reports the synthesis of three different morphologies of 
hydroxyapatite. Attempts to introduce a drug and cations into the structure of 
hydroxyapatite are also detailed. Finally, cell proliferation and bone nodules 
assays showed that hydroxyapatite synthesised via this route exhibits no 
cytotoxic effect on mouse embryonic stem cells. 
 
The synthesis of ZnS is the focus of Chapter 4, with the production of uncoated 
particles along with the implementation of three different stabilisers. The 
addition of 3-Mercaptopropionic acid was shown to decrease cluster size, shift 
the isoelectric point of particles, and alter their photoluminescent properties. 
 
In Chapter 5, the synthesis of Fe2O3, Fe3O4, Gd(OH)3 and Co3O4 are described. 
The structural properties of these materials are analysed, as well as their 
capacity as contrast agents for magnetic resonance imaging. While relaxivity 
data for Co3O4 proved poor, Fe3O4 based materials showed relaxivity values 
comparable to some commercial contrast agents.  
 
To conclude, a summary of the work detailed in this Thesis is delivered in 
Chapter 6. The most pertinent findings from this work are put forward, followed 
by a discussion of future work which could lead on from this Thesis. 
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Chapter 1 
 
1 Background 
 
This Chapter will introduce the concept of nanotechnology and define 
some key terms. The relevance of this research field will be discussed, thereby 
providing the fundamental motivations for this PhD project. The history of 
nanotechnology will only be described briefly; instead this Chapter will focus 
more on the current technologies employed in the synthesis of nanomaterials, 
and how these can be, or currently are, applied at a commercial level. 
 
1.1  Introduction to Nanotechnology  
 
It can be argued that whilst nanoparticles (NPs) have existed naturally for 
millions of years, the µnotion¶ of nanotechnology was first introduced in 1959 by 
5LFKDUG)H\QPDQ LQKLVWDON³7KHUH¶V3OHQW\RI5RRPDWWKH%RWWRP´ZKHUHKH
described the potential to develop a system of manipulating individual atoms and 
molecules. Since then, the field of nanotechnology has acquired great interest, 
particularly in the last thirty years or so, as techniques to study and analyse 
particles have advanced. The field of nanotechnology encompasses the 
synthesis, study and manipulation of particles which are between one and one 
hundred nanometres in at least one dimension; where a nanometre is defined as 
one billionth (or 10-9) of a metre. 
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1.2  Advantages of Nanoscale 
 
What makes nanomaterials such an interesting area of research is that it 
is not simply the miniaturisation of particles. At the nanoscale, some material 
properties are affected by the laws of atomic physics, and so behave in a 
different way or exhibit properties unlike those of the traditional bulk material. 
This is not the case for a macro to micro size transition and is described as the 
quantum size effect phenomenon  (Bhushan, 2010). Depending on the material 
in question, a range of properties can be enhanced at the nanoscale ± a few 
examples are highlighted in the subsequent Sections. As a result of these 
enhanced properties, nanomaterials have been utilised in a plethora of 
applications, as summarised in Figure 1.1. 
 
Furthermore, the enhanced properties are often seen for significantly lower 
weight loadings of nanoscale material compared to the bulk scale equivalent. In 
an applied sense, this translates to less nanomaterial additive required in a 
product, compared to the same micron - or larger - scale compound, to give the 
same effect. This means, for most applications, lower production and processing 
costs for the manufacturers which can be passed on to consumers; for some 
niche fields, such as electronics, devices can be made smaller without 
compromising on performance. 
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Figure 1.1. A summary of the different fields in which nanoparticles have 
be applied (Tsuzuki, 2009). 
 
 Melting Point 1.2.1
 
At bulk scale, gold has a melting poLQW RI  Û& Eut for gold 
nanoparticles with a diameter of 5 nm, the melting point decreases to about 600 
Û& (Buffat and Borel, 1976). This is due to the increase in surface area to 
volume ratio from bulk material to nanoscale particles, as depicted in Figure 1.2.  
In this instance, the gold nanoparticles are potentially easier to melt and 
manipulate as they require a lower energy input than the bulk material, which in 
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turn, means costs are lowered and any detrimental effect on the environment 
(through mass extraction and unsustainable consumption) is reduced.   
 
 
Figure 1.2. Illustration showing the increase in specific surface area 
with smaller particle size (Nano.gov, 2013). 
 
  Magnetic Properties 1.2.2
 
It was first speculated in 1930 that ferromagnetic particles (those which 
form permanent magnets or are permanently attracted to magnets) could 
display super-paramagnetic behaviour (this is where the magnetisation is at an 
average of zero, but particles can become magnetised by an external magnetic 
field), if the particles were small enough (Frenkel and Dorfman, 1930). Since 
then, this theory was proved and ferrite particles of particle size 10 nm were 
shown to exhibit super-paramagnetic behaviour with low magnetic coercivity, Hc, 
that is the intensity of field required to demagnetise the particles (Sato et al., 
1987). It is believed that such phenomena seen in magnetic nanoparticles is due 
to the large proportion of atoms at the particle surface, a magnetic dead layer, 
where atoms cannot maintain ferromagnetism over a distance (Willard et al., 
2004).  
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  Catalytic Properties 1.2.3
 
Due to the increased surface area to volume ratio of nanoparticles, 
compared to bulk or even micron-scale particles, nano-catalysts have 
demonstrated higher efficiencies or rates of conversion with a smaller mass of 
material. For example, TiO2 nanoparticles were shown to be more effective than 
larger particles in the photocatalytic degradation of pollutants (Loryuenyong et 
al., 2013). 
 
  Advantages in Biomedicine 1.2.4
 
Many of the building blocks of biological systems, namely DNA and 
proteins, are sized in the nanometre range; for example, haemoglobin has a 5.5 
nm diameter while insulin measures 3 nm in width and a DNA double helix has 
intra-strand spacing of 2 nm  (Alberts et al., 2002). As pharmaceutical research 
begins to focus on developing drugs at a nanoscale level, the ability to directly 
target erroneous proteins, usually the cause of many biochemical disorders, 
becomes feasible (Liu and Webster, 2007). Furthermore, nanoparticles ± due to 
their small size ± have the potential to penetrate cell membranes and bind to 
DNA (Geinguenaud et al., 2012) or penetrate the blood brain barrier (Krol et al., 
2013). While much research exploits this possibility as an opportunity to treat 
genetic mutations or abnormalities, this also gives rise to the thought that 
nanomaterials could pose a massive health and safety risk, an issue which is 
discussed in Section 1.3. 
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1.3  Safety of Nanomaterials 
 
While the advantages of nanomaterials in biomedicine have been reported 
in the literature, and highlighted in Section 1.2.4, there has been much 
speculation in the scientific community, and in the wider public, over the hazards 
involved with nanotechnology. As this field of research receives more attention, 
particularly in the public eye, more studies are being conducted globally to 
ascertain a definitive answer on whether µnano¶ should be considered 
synonymous with µtoxic¶DQGZKDWLWPHDQVWRKDYHQDQRSDUWLFOHVpresent in our 
everyday products. One such study was initiated by BMBF, the German Federal 
Ministry of Education and Research, and led by BASF - one of the biggest 
chemicals companies in the world. The three year project concluded that 
chemical composition remains the most important factor contributing to toxicity 
and health risks, and the particle size is of secondary importance. The study also 
found that functionalization of particles could reduce toxicity as the surfaces 
became shielded (BASF, 2013). It is generally agreed that a degree of caution 
should be exercised when handling nanomaterials, as it is a relatively new area 
of research, and handling dry powders should be avoided to minimise the risks of 
particle inhalation. Nevertheless, more emerging nanotoxicology studies are 
finding that nanoparticles should not be feared in the way that mass media tend 
to portray them. 
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1.4  Synthesis of Nanomaterials 
 
 The size, morphology and surface area of the nanomaterial are crucial to 
its function and application. Generally speaking, these characteristics are 
determined by the method employed to prepare the material. As such, the 
synthesis method is a highly significant step in determining the characteristics 
and properties of the nanomaterial product. Typically, the methods of 
nanoparticle synthesis are categorised as one of two approaches: top-down or 
bottom-up. These terms will be elaborated upon in Sections 1.4.1 and 1.4.2. 
 
  Top-Down Approaches 1.4.1
 
The most common example of top-down production of nanoparticles is 
mechanochemical milling of micron-scale or bulk scale materials, where larger 
particles are broken down to smaller ones. There are several reports in the 
literature describing the use of different types of milling to produce magnetic 
materials (Manh et al., 2009, Sampathkumaran et al., 2011); materials for 
electronic applications (Chen et al., 2010, Hallmann et al., 2011, Zaghib et al., 
2011); and for the synthesis of nanoscale drugs in the pharmaceutical industry 
(Laaksonen et al., 2011, Basa et al., 2008). In these papers, the length of time 
of milling and the milling speed is described as affecting the structure of the final 
product. As well as milling, laser ablation has also been used for NP synthesis  
(Amendola et al., 2011). 
 
However, compared to bottom-up approaches, the volume of reports using top-
down methods to synthesise nanoparticles is severely lacking; this is likely to be 
due to the inherent drawbacks of top-down methods relative to bottom-up 
procedures.  Examples of such disadvantages include limited control over particle 
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size and morphology, wide particle size distributions and, in some cases, can be 
time intensive where processes can take up to 20 hours (Manh et al., 2009). 
These shortcomings mean most researchers tend to prefer bottom-up 
approaches instead. 
 
  Bottom-Up Approaches 1.4.2
 
Converse to top-down methods, the bottom-up approach generally builds 
larger structures from the smaller building blocks, namely atoms (Rotello, 2004). 
The main examples of bottom-up synthesis are chemical, and can be further 
classified depending on phase; these will be subsequently elaborated upon.  
 
 Solid State Reactions 1.4.2.1
 
In these reactions, solid reactants tend to be mixed then heated at high 
temperatures either in air, or another gas flow of choice (Sohrabnezhad and 
Valipour, 2013). Reports have described the use of solid-state reactions to 
produce CuO (Sohrabnezhad and Valipour, 2013) and Si3N4 (Dasog and Veinot, 
2012) amongst other materials. These types of reactions have the disadvantages 
of being inherently energy intensive and producing dry powders which can pose 
health risks if inhaled. 
 
  Vapour-Phase Methods 1.4.2.2
 
Vapour-phase approaches, such as spray pyrolysis, involve a salt solution 
which is mixed with a carrier gas (e.g. nitrogen) and nebulised or atomised to 
produce droplets, into a furnace at high temperatures ± typically >800 °C. The 
high temperature leads to solvent evaporation and chemical reaction. This 
method has reportedly been used to synthesise GaN (Ogi et al., 2009) and TiO2 
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(Figgemeier et al., 2007) nanoparticles, amongst other materials. Although this 
method is continuous and produces particles with a narrow size distribution, its 
energy intensive nature is a drawback. In addition, like solid state reactions, 
products are typically nanopowders, which must be handled with care. 
 
  Liquid-Phase Methods 1.4.2.3
 
This classification of synthesis technique for the manufacture of 
nanomaterials is perhaps the most relevant and important because the method 
used in this PhD (and which will be described in subsequent Sections) falls under 
this category. As a result, liquid phase processes will be described in a little more 
detail than for previous techniques. 
 
Co-Precipitation 
Co-precipitation techniques are widely utilised due to the facile nature of the 
process. Typically, aqueous metal salts are mixed, at ambient or raised 
temperatures, with a base which acts as a precipitating agent. Co-precipitation is 
a widely used technique for the synthesis of ferrite nanomaterials (Rahman et 
al., 2013, Amiri and Shokrollahi, 2013) and in some cases, the process is 
performed in an inert atmosphere (Lu et al., 2007). While the method benefits 
from its simplicity, it has been seen that particle size, morphology and 
composition of the product is heavily reliant on the type of precursor used, pH, 
and the reaction temperature. Furthermore, particles produced by co-
precipitation have been hindered by a wide particle size distribution. Usually, a 
short nucleation phase followed by a slow growth period leads to a narrow size 
distribution ± which is not the case with this method (Lu et al., 2007). 
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Microemulsion 
Microemulsions are systems which contain two immiscible liquids - usually water 
and oil - and a surfactant (Fanun, 2010). The water generally contains dissolved 
metal salts, and small droplets of the water in oil are stabilised by the surfactant. 
Likewise, droplets of oil can be stabilised in the water, depending on the ratio of 
the two. The droplet size can be manipulated by altering different parameters, 
and can fall within the nanometer range. These tiny droplets then act as 
µQDQRreactors¶ LQVLGHZKLFK particle synthesis can occur. The size of the droplet 
subsequently dictates, and limits the size of the final particle (López-Quintela et 
al., 2004). The microemulsion method has been utilised to synthesise BaTiO3, 
CaCO3, CeO2, ZrO2, and SnO2, amongst other materials (Ganguli et al., 2008). 
The reaction mechanisms to control particle size and size distribution are still not 
fully understood, limiting the wider use of this method. 
 
Sol-Gel 
Sol-Gel methods are a commonly reported route for nanoparticle synthesis, 
particularly for metal oxides (Bezzi et al., 2003, Senthilkumaar and Selvi, 2008, 
Isasi-Marín et al., 2009). Typically, precursors are converted to a colloidal 
VROXWLRQRUµVRO¶ZKLFKJUDGXDOO\GHYHORSVLQWRDµJHO¶QHWZRUN- a matrix of solid 
nanoparticles dispersed in a liquid phase - over time (or gelling agents may be 
used to speed the process up). Through centrifugation, filtration or evaporation, 
the nanoparticles can then be isolated to yield the product. As a low cost, facile 
method which does not require any specialist equipment, sol-gel remains one of 
the most popular methods of nanoparticle synthesis.  
 
However there are some disadvantages to these techniques, such as the need 
for templates, which can be costly and need to be removed after synthesis (Chon 
Chen et al., 2013, Tang et al., 2013); low purity; or require additional steps to 
process the material (such as calcination and milling steps) (Dawson, 1988, 
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Hakuta et al., 1998).  Moreover, the high cost of some processes (these can 
either be high cost of equipment, precursors, or running costs)  coupled with low 
yield and long reaction times can mean that, even if the method produces 
extremely high quality nanoparticles, there is little to no potential of scaling-up 
the technology to a commercially-viable level (Tighe et al., 2013). 
 
Conversely, hydrothermal synthesis has been demonstrated to allow greater 
control over the composition and morphology of products. Furthermore, 
additional processing steps are minimal, and products are dispersed in water 
rather than as a nanopowder, making this a preferential method for 
nanomaterial synthesis.  
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1.5  Hydrothermal Synthesis of Nanomaterials 
 
Hydrothermal synthesis has been described as the use of aqueous 
solvents in conditions of high temperature and pressure to dissolve and 
recrystallise materials which, under standard conditions, are relatively insoluble 
(Ballman and Laudise, 1963). In addition, µhigh temperature¶ has been defined 
as a temperature exceeding the boiling point of the solvent being used as the 
reaction medium, and as a result, elevated pressure must be involved 
(Demazeau, 2010).  
 
Within the field of hydrothermal synthesis, processes can be further classified 
depending on the temperature and pressure of the water reaction media.  Where 
the water has a temperature and pressure above its critical point (Tc  Û&
and Pc=22.1 MPa), it is termed supercritical. The properties of supercritical water 
(ScW) are described in Section 1.5.1. 
 
In the last three decades, there has been an increasing interest in using 
hydrothermal processes to synthesise nanomaterials (Ioku et al., 1988, Somiya 
and Roy, 2000, Adschiri et al., 1992, Adschiri et al., 2000). Because the main 
reaction media is water, rather than noxious solvents, the technology attracts a 
ORWRI LQWHUHVWDVDVXVWDLQDEOHRU³JUHHQ´WHFKQRORJ\Furthermore, the diverse 
research devoted to hydrothermal synthesis has shown a wide range of 
nanomaterials can be produced via this route ± including, but not limited to: 
metals (Aksomaityte et al., 2013), metal oxides (Adschiri et al., 2001, Cabanas 
et al., 2000, Cabañas et al., 2007, Leybros et al., 2012, Lester et al., 2012), 
metal organic frameworks (Gimeno-Fabra et al., 2012), hydroxides (Wang et al., 
2013), carbonates (Nassar, 2013, Ni et al., 2011), phosphates (Chaudhry et al., 
2006, Lester et al., 2013), and sulfides (Liu et al., 2001). This demonstrates the 
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versatility of hydrothermal synthesis, and that it is relevant to a wide range of 
applications. 
 
  Supercritical Water (ScW) and Sub-critical Water 1.5.1
 
Under ambient conditions, water is polar - making it a good solvent for 
dissolving ionic salts, but not for non-polar compounds. Yet, when water is 
heated in a pressurised environment towards its critical point (Tc Û& DQG
Pc=22.1 MPa), the hydrogen bonds between water molecules break down. This 
leads to a decrease in dielectric constant and an increase in dissociation 
constant, Kw, meaning the breakdown of water molecules to H
+ and OH- ions 
(Lester et al., 2006). At and above the critical point, water becomes a 
supercritical fluid and exhibits unique behaviour. It has greatly reduced surface 
tension and acts as a solvent but diffuses as a gas (Wandeler and Baiker, 2000). 
Figure 1.3 summarises the changes in density, dielectric constant and ionic 
product of water with changes to temperature, at a constant pressure of 24 MPa. 
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Figure 1.3. A graph illustrating changes to ionic product, density and 
dielectric constant of water with increasing temperature, at a constant 
pressure of 24 MPa (Kritzer et al., 1999). 
 
Unlike water at ambient conditions, ScW is weakly-polar; it can dissolve non-
polar molecules while having low solubility for inorganic ionic salts. 
Consequently, the latter precipitates out of ScW; this principle forms the basis 
for the synthesis of fine inorganic particles in ScW. Due to this principle, and the 
interesting properties of ScW, it has been increasingly used in recent years as a 
reaction medium for the production of nanoscale metals and metal oxides. The 
reaction mechanism for particle formation in ScW is given in Section 1.5.1.1. 
 
Still, it is important to note that not all hydrothermal processes require or use 
water above its critical point; many described methods use temperatures as low 
as 150 Û& and pressures below 24 MPa (Wang et al., 2013). Thus, pressurised 
water at tempeUDWXUHVEHWZHHQÛ&DQGÛ&LVWHUPHGVXE-critical or near-
critical.  
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It has been shown that for some materials, particle size, particle morphology, 
and product yield are affected by the reaction temperature. In the case of ZrO2, 
particle size and the precursor conversion rate increase with elevated reaction 
temperatures (Hobbs et al., 2009). For hydroxyapatite, Ca10(PO4)6(OH)2, 
different particle shapes are produced with varying reaction temperature (Lester 
et al., 2013). Therefore, depending on the requirements of the particle 
properties, or in the interest of balancing yield with energy consumption, lower 
reaction temperatures may be utilised. 
 
  Reaction Mechanisms and Metal Oxide Formation in ScW 1.5.1.1
 
As described by Adschiri et al. (Adschiri et al., 1992) and subsequently 
Lester et al. (Lester et al., 2006), the proposed formation of metal oxides begins 
with a metal salt in ScW readily undergoing hydrolysis without addition of any 
base, due to the high Kw, and high OH
- concentration in the solvent. The metal 
hydroxide consequently experiences a dehydration step which results in the 
formation of metal oxide nanoparticles as described by the following, where ML 
is a metal salt: 
 
Step 1, Hydrolysis : MLx + xOH
í ൺ M(OH)x +xLí 
Step 2, Dehydration : M(OH)x ൺ MOx/2 + x/2 H2O 
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  Other Applications of Supercritical Water 1.5.1.2
 
The properties of ScW described in Section 1.4.1 make it a solvent of 
interest for applications other than for the synthesis of nanoparticles. 
 
One of the major applications of ScW is the oxidation and breakdown of 
hydrocarbons (for example, to treat waste water). Due to the non-polar nature 
of ScW, it becomes completely miscible with organic compounds meaning it can 
transport molecules more effectively. Compared to other methods of 
hydrocarbon breakdown ± such as incineration ± ScW oxidation is less energy 
LQWHQVLYHDQG LVSURYLQJ WREHDVXVWDLQDEOH³JUHHQ´ WHFKQRORJ\ (Al-Duri et al., 
2008). 
 
ScW has also reportedly been used to chemically recycle carbon fibre by 
dissolving epoxy resins which were bound to the fibres (Piñero-Hernanz et al., 
2008). This method of chemical recycling showed the recovered fibres to have 
up to 98% of the tensile strength, compared to virgin fibres. Again this shows 
that ScW is fast becoming a media for many sustainable applications. 
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1.6  Solvothermal Synthesis of Nanomaterials 
 
Where organic solvents, such as alcohols, are used in the place of 
aqueous solvents, the synthesis is termed solvothermal instead (Xu and Wang, 
2012). In the same way as water, the solvent is termed supercritical when it is 
at its critical point. This point varies for different solvents; the critical 
temperatures and pressures for methanol, ethanol, and acetone or given in Table 
1.1. 
 
Table 1.1. The critical temperatures and pressures of three solvents. 
(Fang, 2010). 
Solvent 
Critical Temperature 
(TcÛ& 
Critical Pressure  
(Pc, MPa) 
Methanol 239 8.1 
Ethanol 241 6.1 
Acetone 235 4.7 
 
As with hydrothermal methods, the solvent can also be used as a reaction media 
below its critical point, while increases in reaction temperature beyond Tc may 
lead to increased yield. Although not as sustainable or cost-effective as using 
water, the use of organic solvents the synthesis of materials which are not 
favoured in water ± in particular, metal nanoparticles without the need for toxic 
reducing agents (Choi et al., 2010, Shin et al., 2010), or provides better 
compatibility for phase transfer or formulation into other media (Veriansyah et 
al., 2009). 
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1.7  Batch and Continuous-flow systems 
 
Chemical processes can generally be categorised as being conducted 
using either batch or continuous flow systems ± this is not exclusive to 
hydrothermal synthesis of nanomaterials, or indeed to the synthesis of 
nanomaterials overall. Like many researchers in their respective chemical fields, 
the nanotechnology community is divided over which type of system is superior 
for the production of nanomaterials. 
 
For hydrothermal synthesis of nanoparticles, batch systems typically employ an 
autoclave-type reactor into which the reactants are placed; this is then heated 
by an oven, or a sand or oil bath. Conversely, continuous systems use pumps to 
drive reactants through a heated, pressurised pipework reactor system. While 
batch systems are arguably simpler and easier to design, operate and maintain, 
continuous systems are known for high reaction rates within a very short 
residence time (< 1 minute) (Fang, 2010). While short reaction times carry 
several benefits, there are some reactions which appear to require long reaction 
times and, to date, have only been produced by batch methods (Kasuga et al., 
1998, Sekino et al., 2006, Bavykin et al., 2004). In addition, batch reactors 
allow the use of reagents which are water or solvent insoluble, but continuous 
reactors require salts to be dissolved to prevent blockages at the pumps or other 
points of the system. Nevertheless, batch systems are more difficult to 
reproduce at larger scale compared to continuous-flow systems. Thus, if batch 
synthesis reactions can be tailored for a continuous-flow system, the products 
could be manufactured at a volume more meaningful for commercial use. 
Continuous-flow hydrothermal systems which are currently used at a commercial 
scale are described in Section 1.8. 
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In general, during the synthesis of nanomaterials, particle size, size distribution, 
morphology and crystallinity of the product can be controlled by altering 
individual process parameters; these being temperature, pressure, concentration 
and pH of precursors, and flow rates (Lester et al., 2012, Adschiri et al., 2000, 
Sue et al., 2006). Continuous systems allow more control over these 
experimental parameters, and carry more potential to be scaled up (Tighe et al., 
2013, Fang, 2010). With these benefits over batch processes, continuous-flow 
systems which have been described in literature for the synthesis of 
nanomaterials will be discussed in more detail in Section 1.7.1. 
 
  Continuous-flow Hydrothermal Reactors  1.7.1
 
Many researchers see the benefits of continuous flow reactors, which 
were discussed in Section 1.7. It is generally understood that the method of 
mixing reactant streams in continuous flow systems plays a vital role in 
determining the size and size distribution of the synthesised particles. As such, 
several groups have built and experimented with different mixer/reactor designs 
for the hydrothermal synthesis of nanomaterials. Each research group has 
produced different materials, and for varying applications. A brief history of how 
research into continuous hydrothermal synthesis began, and a selection of the 
most prominent work will be discussed in the subsequent Sections. The reactor 
design used for the work described here will then be discussed in Section 1.7.2. 
 
  Adschiri et al. (Tohoku University) 1.7.1.1
 
The process of hydrothermal fine particle synthesis was first transferred 
from batch to continuous-flow reactors by Professor Tadafumi Adschiri and his 
research group at Tohoku University in Sendai, Japan (Adschiri et al., 1992). 
This pioneering work described the use of ten different water-soluble metal salts 
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for the synthesis of seven different metal oxides, with residence times below 2 
minutes. Later publications also focussed on the use of their continuous flow 
reactor for the production of CeO2 (Hakuta et al., 1998), ZrO2 and TiO2 (Adschiri 
et al., 2000), and AlOOH (Adschiri et al., 2001). The equipment set up used for 
synthesis is given in Figure 1.4, where the mixing point was a T-piece fitting. As 
well as being a readily available, off-the-shelf part, this configuration allowed the 
rapid heating of precursor streams, especially compared to batch processed. The 
published works typically used metal salts of concentrations up to 0.1 M, total 
flow rates up to 10 ml/min and thus produced dry weight equivalents of metal 
oxide nanoparticles up to 10 g/h (Adschiri et al., 2000). Since these publications, 
other researchers have discussed the drawbacks of using T-piece mixers ± these 
will be elaborated upon in Section 1.7.2. 
 
 
 
Figure 1.4. Schematic diagram of the apparatus typically used by 
Adschiri et al. for continuous hydrothermal synthesis of nanoparticles 
(Adschiri et al., 2000). 
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Adschiri et al. recently published some very interesting research, where they 
used neutron radiography to visualise the flows of water inside their mixing point 
(Takami et al., 2012). The mixing patterns inside continuous flow reactors have 
long plagued researchers in the field; due to the high temperatures and 
pressures required for synthesis, reactors are typically constructed from stainless 
steel tubing and fittings thus the internal flows cannot be seen. As such, 
researchers have had to rely on computational fluid dynamics (CFD) and other 
forms of modelling to visualise flow arrangements. However, the use of a 
neutron beam is a breakthrough in the field and Adschiri et al. have shown that 
it is possible to use this form of radiography to observe flow arrangements within 
the reactor, as seen by the image shown in Figure 1.5. 
 
 
Figure 1.5. Image showing the internal structure and water flow in the 
T-piece reactor used by Adschiri et al., collected using neutron 
radiography (Takami et al., 2012). 
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Still, despite the development of this continuous flow reactor, the research group 
of Prof. Adschiri has recently published work using batch type reactors to 
synthesise nanoparticles of HfO2 (Sahraneshin et al., 2012a), yttrium aluminium 
garnet (YAG) (Sahraneshin et al., 2012b), and zirconium dioxide (ZrO2) (Taguchi 
et al., 2012). Unlike many reported batch methods of hydrothermal synthesis, 
the described protocols required a relatively short reaction time of 10 minutes. 
Conversely, the disadvantage of this method is the small reactor volume; with 
only 5 ml of product yielded per reaction, there is little scope for scale up. This 
small reactor volume appears to be by design but may be a requirement for 
successful synthesis. In addition, reverting to a batch process despite the 
availability of a hydrothermal flow system suggests these nanomaterials may not 
be producible on their flow reactor. 
 
Other work published by Adschiri et al. in recent years, described the use of both 
their 5 ml batch reactor and flow reactor to synthesise cobalt aluminate 
nanoparticles (Lu et al., 2013). Their results showed that they were able to 
synthesise their intended material, CoAl2O4, using their flow reactor while their 
batch system produced Co1-xAlx layered double hydroxide (Co-Al-LDH) as the 
principle phase. This was due to the discrepancies between heating in the two 
systems; the reactants in the autoclave reach their reaction temperature after 5 
minutes while in the flow reactor, heating takes <1 second. The slower heating 
in the batch reactor produced the LDH as an intermediate and lead to a growth 
phase for the remainder of the reaction. The authors speculate that a much 
longer reaction time (>10 hours) is required to dehydrate the LDH to CoAl2O4. 
Meanwhile the rapid heating in the flow reactor lead to total dehydration of the 
precursors, and therefore highlights the further benefits of continuous flow 
reactors with rapid heating systems. 
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  Hakuta et al. (AIST) 1.7.1.2
 
Yukiya Hakuta, Hiromichi Hayashi and Kunio Arai are researchers in the 
field of hydrothermal synthesis of nanoparticles, using both batch and 
continuous-flow reactors to produce materials. They are associated with the 
National Institute of Advanced Industrial Science and Technology (AIST) in Japan 
and Tohoku University, and have often collaborated with Prof. Adschiri. As such, 
they conduct much of their research using flow reactors with a similar T-piece 
mixer geometry as Prof. Adschiri. A diagram of the reactor system typically used 
for their work is shown in Figure 1.6. After the T-piece, the flow passes into a 
KHDWHGµUHDFWRU¶ZKLFKDOORZVSDUWLFOHGHYHOopment. After the reactor, the product 
stream is quenched by mixing with a flow of deionised water at ambient 
temperature. 
 
Between the three researchers, they have published works using continuous flow 
hydrothermal synthesis to generate AlOOH (Hakuta et al., 2005), CuO, Fe2O3, 
NiO, ZrO2 (Sue et al., 2006), BaTiO3 (Matsui et al., 2008), ferrites (Sato et al., 
2008), perovskite oxide (Lu et al., 2008) and Al2O3 (Noguchi et al., 2008). 
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Figure 1.6. Schematic of the reactor system used by Arai et al. 
(Kawasaki et al., 2010). 
 
Although this work is similar to that previously described by Adschiri, Arai et al. 
have also developed microreactor T-pieces for the synthesis of NiO (Kawasaki et 
al., 2010). Cross sectional images of the three microreactors used can be seen in 
Figure 1.7. This study found that quicker heating rates resulted from smaller 
internal volumes of the T-pieces, which in turn, lead to small particles being 
produced. The microreactor T-piece has also been employed for the synthesis of 
Ni nanoparticles (Sue et al., 2009). 
 
While the production of smaller particles may be advantageous, the 
microreactors used have internal diameters as small as 0.3 mm, which may lead 
to problems with blockages if the particles begin to aggregate (see Section 1.9 
for more details on particle aggregation). With such small reactor volumes being 
vital to determine particle size, there is also a limitation on the quantity of 
material that can be manufactured. 
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Figure 1.7. Cross sectional photographs and drawings of the T-piece 
reactors used by Arai et al. (Kawasaki et al., 2010). 
 
In 2011, a publication from Hakuta and others (including some from AIST) 
recognised some problems associated with T-piece mixers ± particularly the 
creation of nanoparticles with a wide size distribution. As a result, a new mixing 
configuration was described, named the Central Collision Mixer (CCM), and is 
depicted in Figure 1.8 (b). The metal salt solution is pumped in a downflow and 
is met by four streams of heated water flowing in horizontally. This reactor 
configuration was used to synthesis nickel ferrite nanoparticles and the authors 
found that the CCM yielded smaller particles which had a narrower size 
distribution compared to using a conventional T-piece mixer (Sue et al., 2011).  
 
This mixer design is a recent development, with only a few publications 
describing its use, and so the details of its reliability and reproducibility are 
currently unclear.  Still, the CCM geometry appears to show it as a custom made 
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part which could provide problems if reproducing this reactor, and increase 
costs. 
 
 
Figure 1.8. (a) Reactor system design used by AIST, incorporating (b) 
the Central Collision Mixer (CCM) (Sue et al., 2011). 
 
In addition to the reactor designs described previously, Hakuta et al. introduced 
a swirling micro mixer reactor in 2007, which created a vortex to mix the metal 
salt flow with the superheated water flow (Wakashima et al., 2007). However, 
future publications by the authors revert to the use of T-piece mixers and 
discussions using this swirling mixer are limited.  
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  Darr et al. (University College London) 1.7.1.3
 
Prof. Jawwad Darr and his research group are based at University College 
London (UCL) and have been conducting work in the field of continuous 
hydrothermal synthesis since 2007. Until recently, Darr et al. have been using 
the counter current reactor design (Lester et al., 2006) which was used for the 
course of the work described in this Thesis, and which will also be discussed in 
Section 1.7.2. Schematic diagrams of the reactor configuration are given in 
Figure 1.9. Darr et al. also draw reference to the original research article in 
several of their papers (Boldrin et al., 2007, Tighe et al., 2012). 
 
 
 
Figure 1.9. (a) Diagram of the equipment used by Darr et al. (b) A 
diagram of the counter-current reactor geometry (Tighe et al., 2012). 
 
Darr et al. have published a series of papers describing the use of this counter 
current reactor in the continuous flow hydrothermal synthesis (CFHS) of an array 
of nanomaterials. These include hydroxyapatite (Chaudhry et al., 2006), spinel 
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structures (Boldrin et al., 2007), titanium dioxide (Zhang et al., 2009b), sodium 
titanate (Zhang et al., 2010), indium oxide (Elouali et al., 2012) and 
nanophosphors (Gruar et al., 2012).  
 
Additionally, Darr et al. have also developed a high throughput system for 
producing Zn-Ce oxides based on the counter current reactor, named the High-
throughput Continuous Hydrothermal (HitCH) synthesis. Using the HitCH system 
at lab scale (total flow rates up to 40 ml/min), the research group showed that 
they were able to produce a large array of samples in a short time frame, which 
they were able to rapidly obtain X-ray diffraction patterns for, using the 
beamline at Diamond Light Source (Weng et al., 2009, Parker et al., 2011). 
Furthermore, the group have converted the process to be automated; using a 
robot, the system produced, cleaned and printed lab scale samples of 
nanoparticles. Named RAMSI (Rapid Automated Materials Synthesis Instrument), 
the equipment was used to produce europium-doped yttrium oxide, Y2O3:Eu
3+ 
phosphors. In some cases, the authors found that the produced nanoparticles 
had to be heat treated in air at up to 1200 °C for them to display fluorescent 
properties (Lin et al., 2010). As well as being time consuming, and energy 
intensive, heat treatment at such high temperatures is known to cause 
densification, grain growth (Ostwald ripening) and in turn, eliminate the 
nanoscale aspect to the particles (German, 2010). Currently, only this material 
has been reportedly synthesised using RAMSI. 
 
In 2012, Darr et al. published a paper detailing observations (from in situ 
temperature measurements) of jetting effects in the counter current reactor; this 
is where the superheated flow of water infiltrates the flow of metal salt and may 
lead to non-homogenous mixing and in turn, a wide particle size distribution. 
This jetting effect was only noted for certain flow ratios and may be affected by 
the types of pumps used in the system. More recently Darr et al. developed a 
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new reactor configuration, which they named the Confined Jet Reactor (CJR) ± 
shown in Figure 1.10 (Tighe et al., 2012).  
 
Contrary to the previous counter current reactor used by the group, the CJR uses 
a co-current mixing regime. Here, the heated water stream is pumped through 
an inner tube, as an upflow, into the bottom of the reactor. The precursors (at 
ambient temperature) are pumped into the sides of the reactor cross piece, 
entering below the outlet of the water stream. The formed nanoparticles then 
flow upwards to the heat exchanger. Whilst Darr et al. explained that particle 
DFFXPXODWLRQDQGEORFNDJHVLQSLSHV³RIWHQRFFXUVGXHWRVXEVWDQWLDOSUHKHDWLQJ
of the incoming metal salt precursor stream prior to being brought into contact 
with the much hotter water streDP´ (Gruar et al., 2013) the CJR does exactly 
this, i.e. the cool precursor feeds come in to contact with the hot inner pipe 
carrying the water stream, before they actually meet and mix with the heated 
water. This suggests that precipitation and particle accumulation, to some 
degree, could occur on the surface of the heated inner tube. 
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Figure 1.10. Diagram showing the geometry of the Confined Jet Reactor 
(CJR) used by Darr et al (Gruar et al., 2013). 
 
The CJR has apparently been scaled up from lab (total flow rates up to 40 
ml/min to produce 1-10 g/h) to pilot scale (total flow rates up to 800 ml/min >1 
kg/h) by Darr et al. to produce cerium and zinc oxides (Gruar et al., 2013, Tighe 
et al., 2013). The researchers showed high reproducibility of particles at the two 
different scales. 
 
  Kim and Lee et al. (KIST and SNU) 1.7.1.4
 
Between the Korea Institute of Science and Technology (KIST) and Seoul 
National University (SNU), Jaehoon Kim and Youn-Woo Lee have published a 
selection of papers describing continuous hydrothermal and solvothermal 
methods to produce a wide range of nanomaterials. 
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In the published collaborative works of Kim and Lee, they recognise that 
clogging or blocking in reactors is a common problem associated with continuous 
hydrothermal synthesis of nanoparticles. However, rather than addressing the 
issue by changing their reactor or mixer geometry, they opted for a change in 
reaction media from water to methanol instead (Kim et al., 2008, Veriansyah et 
al., 2010b). They found that using methanol led to a greater availability of 
soluble surface modifiers which could be used to bind to particles, while 
methanol itself acted as a surface modifier as well. However, the biggest 
drawbacks of using methanol instead of water are the implication of increased 
running costs and health and safety risks.  
 
The continuous flow reactor used in these works is shown in Figure 1.11. Like 
the reactor setups used by the Japanese research groups described in Sections 
1.7.1.1 and 1.7.1.2, their reactor system consists of a T-piece mixing point 
where the heated water or methanol stream flows from the top of the T-piece as 
a downflow, and meets the cooler metal salt stream which flows in from the side 
arm of the T-piece. The mixed feeds then flow down into a heated cylinder with a 
volume of 14.58 cm3, which is the reactor. This vessel extends the residence 
time of the reaction, which can aid particle growth or increase reaction 
conversion. 
 
This reactor has been used by KIST and SNU to synthesise CeO2 (Kim et al., 
2008), ZnO (Veriansyah et al., 2010b) and Fe3O4 (Veriansyah et al., 2010a) in 
supercritical methanol. For the study of ZnO synthesis, the products from the 
solvothermal process were compared to those from hydrothermal; the 
researchers found that using methanol as a solvent affected the surface groups 
of particles, as well as size, morphology and dispersability into ethylene glycol. 
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Figure 1.11. A schematic diagram of the continuous flow reactor system 
used by Kim et al. for the synthesis of metal oxide nanoparticles in 
supercritical water or methanol. B: balance; C: condenser; F: 0.2 ǋm 
metal filter; L: liquid container; P: pressure gauge; R: supercritical 
reactor; T: thermocouple; V1: needle valve; V2: relief valve; V3: three-
way valve; V4: safety valve; FT1: DI water/methanol feed tank; FT2: 
precursor solution feed tank; HP1: high pressure pump for DI 
water/methanol; HP2: high pressure pump for precursor solution; PH: 
preheater; PR: back pressure regulator; RH: reactor heater; WP: water 
preheater line (Kim et al., 2008). 
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Kim et al. have recently published work which investigated the mixing patterns 
inside T-piece reactors with three different geometries, and how these affected 
the properties of synthesised LiFePO4 particles for use in battery materials (Hong 
et al., 2013); the three different T-piece geometries are shown from the CFD 
images in Figure 1.12. While the 90° Tee is an off-the-shelf part from Swagelok, 
The 50° and Swirling Tees are both custom made by the research group. The 
study also examined the effect of different temperatures, flow rates and 
concentrations on the structure and properties of the product. 
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Figure 1.12. CFD simulations of the three tee reactors investigated at 
the Korea Institute of Science and Technology for the synthesis of 
LiFePO4 nanoparticles (Hong et al., 2013). 
 
Data from X-ray diffraction (XRD) obtained during the study found that the 
Swirling Tee mixer produced LiFePO4 particles with a higher degree of 
crystallinity than the other two mixers, as well decreasing the ratio of Fe3O4 
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impurity detected. The authors put this down to a more efficient mixing regime 
in the Swirling Tee, which in turn provides more rapid nucleation of LiFePO4 
particles while inhibiting the formation of impurities. This effect was accentuated 
with higher flow rates, hence likely to cause more turbulent mixing. 
 
Images collected using Scanning Electron Microscopy (SEM) found that, at 
various flow rates tested, the Swirling Tee produced much smaller particles 
(100-400 nm diameter spheres) compared to the 90° Tee (platelets with lengths 
of 200-600 nm) and the 50° Tee (platelets with lengths between 300-700 nm). 
Moreover, using higher flow rates for each mixer type saw a decrease in particle 
size ± again, likely due to more rapid fluid mixing and faster heat transfer 
between fluids. 
 
As a result of the smaller particle size, higher crystallinity, and lower degree of 
impurities, the LiFePO4 particles synthesised using the Swirling Tee showed 
much more promise as a battery material than those made using the other Tee 
geometries. As such, this reactor design could be promising for production of 
other nanomaterials. On the contrary, a disadvantage of the Swirling Tee is the 
custom-made design, which will inherently be more expensive than off-the-shelf 
parts. Furthermore, the products described in this paper exhibit wide particle 
size distributions, which may be due to a large range of residence times in the 
reactor, rather than rapid heating of the precursor stream followed by quick 
cooling.  One possible reason for this could be that the product stream is hotter, 
and therefore less dense, than the cold precursor stream entering the top of the 
Swirling Tee. Therefore, the less dense product stream will naturally rise to the 
top of the mixer, rather than being drawn to the reactor outlet at the bottom. In 
between pulses of incoming precursor (pulsing caused by the pumps), a degree 
of flow (and particle) recirculation will occur - leading to more growth of these 
particles compared to those which are quickly pushed out of the reactor due to 
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the positive pulse from the precursor being pumped in. Of course, this theory 
depends on the ratio of buoyancy and inertia forces acting on the product 
stream, but provides speculative reasoning for particle size distribution. 
 
  Aymes et al. (University of Burgundy) 1.7.1.5
 
Based in Dijon, France, research into continuous hydrothermal synthesis 
of nanoparticles by the research group of Daniel Aymes began when a reactor 
was built in 2001, as shown in Figure 1.13 (Aimable et al., 2009b). This reactor 
setup used aQ ³; JHRPHWU\´ to mix the superheated water flow with two 
precursor solutions. To create this geometry, the flows were created by drilling 
into a solid block of Inconel 625, shown in Figure 1.14. After the mixing point, 
the fluids WKHQ IORZHG LQWR D  PHWUH ORQJ ,QFRQHO UHDFWRU WXEH LQ D ³]LJ]DJ´
configuration. The paper states that this geometry maintains a constant 
temperature throughout the reactor length, while minimising particle 
agglomeration. Using this reactor design, Aymes et al. were able to synthesise 
BaZrO3 (Aimable et al., 2008); LiFePO4 (Aimable et al., 2009a); ZrO2; anatase 
TiO2 and a range of spinel ferrites (Aimable et al., 2009b). 
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Figure 1.13. A schematic diagram of continuous hydrothermal reactor 
system built by Aymes et al. in 2001 (Aimable et al., 2009b). 
 
Inconel 625 is a strong alloy, allowing high temperatures and pressures to be 
used and, unlike stainless steel 316, is not corroded through exposure to halides. 
This advantage of Inconel also means it is significantly more expensive than 
stainless steel, and drives setup costs up; this means the overall cost of 
nanoparticle production is greater than using stainless steel equipment. While 
using Inconel parts provides more corrosion resistance if using halide precursors 
(which are generally cheap, and so the cost of Inconel can be justified), the 
published works of Aymes et al. describe the use of non-halide based precursors, 
therefore negating the need for this expensive alloy. Furthermore, the Inconel 
block used by Aymes et al. is a specialised design, as opposed to using off-the-
shelf parts, which can require additional pressure safety steps (prior to 
commissioning) and drive costs up further. 
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Figure 1.14. Diagram showing the X configuration of the mixing point, 
drilled into a block of Inconel 625, used in the systems by Aymes et al. 
 
After conducting heat transfer studies, the research group found that they could 
reach the necessary temperatures for supercritical water by using shorter 
lengths of pre-heater and reactor tubing, thereby reducing residence times as 
well. A diagram of their revised reactor system is given in Figure 1.15. However, 
the Inconel block used as the mixing device (Figure 1.14) remained the same. 
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Figure 1.15. Revised system design by Aymes et al., built in 2006. 
 
Despite the published papers describing the reactor designs shown in Figure 
1.13, Figure 1.14 and Figure 1.15, a paper was later published by Demoisson et 
al. (contemporaries of Aymes at the same institution) describing a very different 
reactor design, which they patented with Aymes (Aymes et al., 2011, Demoisson 
et al., 2011); this suggests that the previous X reactor geometry had operation 
issues which were not discussed in the patent. Interestingly, the authors draw 
reference to the benefits of the Nottingham counter-current reactor design which 
will be discussed in Section 1.7.2.  
 
Their new reactor design, shown in Figure 1.16, was patented in 2011 and like 
their earlier designs, uses a block of Inconel 625 into which holes are drilled and 
bored. Therefore the reactor has the inherent advantages and drawbacks 
described previously for their earlier designs. However, the main difference from 
WKHLUSUHYLRXV³;´UHDFWRUJHRPHWU\LVWKHDGRSWLRQRIDFRXQWHU-current system. 
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Figure 1.16. Model depicting the geometry of the reactor patented by 
Aymes et al. (Aymes et al., 2011). 
 
A schematic diagram of the whole continuous reactor system used by Aymes et 
al. is given in Figure 1.17. The principle differences between this and earlier 
designs are the reactor, and the elimination of a separate mixing point and 
reactor; instead, these two entities are combined into one chamber. 
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Figure 1.17. Schematic diagram of the continuous hydrothermal reactor 
system used by Demoisson et al. (Demoisson et al., 2011). 
 
  The University of Nottingham Counter-Current 1.7.2
Reactor 
 
Since the transition from batch to continuous-flow hydrothermal synthesis 
by Prof. Adschiri et al. in the 1990s, the process has been hindered by blockages 
in the reactor, as highlighted in previous Sections. In the late 1990s and early 
2000s, research into continuous hydrothermal synthesis of nanoparticles was 
started at The University of Nottingham by the Clean Technology Group. They 
employed a T-piece reactor for the synthesis of cerium-doped, zirconium oxides 
(Cabanas et al., 2000) and ferrites (Cabañas and Poliakoff, 2001). However, the 
use of this reactor type led to problems with inconsistent products, and 
blockages which meant experiments had to be aborted before completion. In 
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response to this, work was conducted by SChEME (School of Chemical, 
Environmental and Mining Engineering) at The University of Nottingham to 
investigate the fluid dynamics and mixing mechanism within the T-piece reactor 
(Blood et al., 2004). Where previous studies used CFD to model mixing regimes, 
Blood et al developed light adsorption imaging (LAI) - a method which used 
fluids of similar density and viscosity to supercritical water and the metal salt 
precursor feed, to visualise their interaction when mixed. By adding a dye to the 
stream representing the metal salt feed, the researchers were able to use image 
analysis techniques to quantitatively conclude the positions oI µVWDJQDQW]RQHV¶
ZKHUHORFDOLVHGPL[LQJRUUHFLUFXODWLRQRFFXUUHGRUµIORZSDUWLWLRQLQJ¶ZKHUHWKH
two streams would flow separately with improper mixing. The study concluded 
that, regardless of the orientation of the flows in the T-piece, the reactor 
geometry would lead to poor mixing conditions and, in turn, particle build-up and 
blockages. This was consistent with experimental observations. 
 
Continuing on from this work, the researchers within SChEME used LAI and CFD 
analysis, alongside experimental data to model alternative reactor designs 
(Lester et al., 2006). This paper presented a novel reactor design which 
exploited the natural convection forces in the system to drive turbulent mixing, 
and prevented the previously seen problems of flow partitioning, or development 
of stagnant zones. The new reactor design, termed the counter-current Nozzle 
Reactor, was then patented (Lester and Azzopardi, 2005) and is shown in Figure 
1.18. This reactor was used for the work described in this Thesis, the details of 
which will be described in Sections 1.7.2.1. 
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Figure 1.18. Diagram showing the configuration of the counter-current 
Nozzle reactor, invented at The University of Nottingham (Lester and 
Azzopardi, 2005, Lester et al., 2006). 
 
  Reactor Geometry 1.7.2.1
 
During the research conducted for this work, the equipment setup 
displayed in Figure 1.20 was used. A photo of the system is also provided in 
Figure 1.21. There are some slight differences from the setup previously 
described in literature (Lester et al., 2006). Firstly, the in-line filter before the 
back pressure regulator (BPR) was removed.  A filter was originally incorporated 
to remove large aggregates from the sample, and to preserve the BPR. However, 
it was found that, compared to previous reactor geometries, fewer large 
aggregates were produced. Moreover, without the filter, the collected particles 
are more representative of the reaction product. While the filter prevented 
blockages at the BPR (which would cause loss of pressure), the filter itself served 
as a potential point of blockage if large aggregates were present. As such, it was 
better to conduct experiments without it. 
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In addition, two extra pumps have been introduced for a second metal salt feed, 
DQG D ³FDSSLQJ SRLQW´ IHHG WR LQWroduce surfactants (typically organic 
compounds) after the reactor, but before the BPR. Depending on the reaction, 
these pumps are not necessarily required so are not used, without affecting the 
rest of the experimental setup. 
 
In the initial publication describing the counter current Nozzle reactor, some 
experiments described the addition of a cone (a Swagelok ferrule) to the end of 
the inner pipe, while others omitted it. The function of the cone was to mimic a 
spinning disc reactor and dissipate flow of the heated water, therefore 
maximising mixing. However, for the reactor used here, the cone was not used 
in order to maximise the flow area available. 
 
 
Figure 1.19. Orientation of parts used to construct the counter current 
Nozzle Reactor (Lester et al., 2006). 
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A diagram of the reactor geometry is given in Figure 1.19. It is a pipe-in-pipe 
configuration where the heated water feed enters through the thinner inner tube 
(1/8´ RXWHU GLDPHWHU DQG WKH FRROPHWDO VDOW IHHG LV IORZHGXS LQWR WKH RXWHU
pipe (3/8´RXWHUGLDPHWHU0L[LQJDQGSDUWLFOHIRUPDWLRQRFFXUVDWWKHLQWHUIDFH
then the product is carried up and out of the side arm of the cross piece to the 
cooling loop.  
 
 
 
Figure 1.20. Schematic diagram of the counter current reactor system at 
the University of Nottingham. 
 
For nanoparticle synthesis experiments, a vessel of water (or if required, a 
thermally-stable precursor) was pumped at a pre-set flow rate up to 25 ml/min, 
using a Gilson HPLC pump (Model 305 equipped with a 25 SC pump head). This 
then flowed through a check valve and into a coiled tube around an electrical 
heater block, where the heater set point could be controlled up to 500 °C. A 
thermocouple within the water heater block provided an electronic reading 
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UHIHUUHGWRDVWKH³:DWHU+HDWHU7HPSHUDWXUH´as well as acting as a feedback 
control. After the heater, the feed flowed SDVWDWKHUPRFRXSOHWRJLYHWKH³$IWHU
+HDWHU7HPSHUDWXUH´then into the inner pipe of the reactor. 
 
Meanwhile, the metal salt feed(s) were pumped, each with a maximum flow rate 
of 10 ml/min, using Gilson HPLC (high-performance liquid chromatography) 
pumps (Model 305, equipped with a 10 SC pump head) through check valves 
and into the bottom of the counter current reactor as an upflow. As the product 
rose and exited the reactor through one side arm of the cross piece, a 
thermocouple attached at the other cross piece side arm monitored the 
temperature. This gave WKH³3RVW0L[LQJ3RLQW7HPSHUDWXUH´ 
 
Upon leaving the reactor, the product stream was partially cooled by one cooling 
loop. Here, a flow of mains tap water moved over the pipe carrying the product 
stream without directly coming into contact with it. After this first cooling loop, 
there was a cross piece at which another feed (e.g. a surfactant or capping 
agent), could be pumped in. A check valve on this feed meant the process was 
unaffected if this pump was not operating. A thermocouple was present on the 
RWKHU DUP RI WKH FURVV SLHFH DOORZLQJ WKH ³&DSSLQJ 3RLQW 7HPSHUDWXUH´ WR EH
monitored. 
 
The product stream subsequently flowed through a second cooling loop which 
brought the temperature to around ambient. The two cooling loops could be 
operated independently, permitting the temperature of the capping point to be 
µtuned¶. The product stream passed through the back pressure regulator, BPR, 
(manufactured by Tescom, USA) and the product suspension flowed out at 
ambient pressure into a collect vessel. 
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The BPR constricted the flow to an adjusted level or set point and maintained it, 
hence controlling the system pressure. Being a continuous system, the pressure 
throughout the entire equipment was consistent. BPRs can be pneumatic or 
manual, where the former is air-actuated and the latter is spring loaded. The air 
or the spring pushes a needle down onto a seal causing restriction in the flow. 
 
To measure the system pressure, a piezoelectric pressure transducer and 
bourdon gauge were attached in the water feed. The piezoelectric transducer 
was attached to a control box to give an electronic reading. 
 
 
Figure 1.21. A photo of the counter-current reactor system.  
 
  Advantages of the Counter Current Design 1.7.2.2
 
Much of the early work into continuous hydrothermal synthesis used a T-
piece fitting as a mixing device, as described in previous Sections of this 
Chapter. In many cases, the T-piece was upright with the heated water feed 
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entering through the side arm and the cold metal salt flowing down; the bottom 
arm of the Tee then formed the product outlet. When Blood et al. performed LAI 
analysis on their T-piece pseudo reactor, as described in Section 1.7.2, they 
found that the water would rise into the top arm of the Tee. This was due to the 
lower density and consequent higher buoyancy of the superheated water. By 
flowing upwards, the metal salt feed became heated, causing the nucleation of 
particulates. Without a strong flow to transport the particles away, this led to 
accumulation and blockage at the top arm of the Tee. This observation caused 
researchers to see the importance of differences in density between the two 
flows. 
 
The counter-current Nozzle reactor has the superheated water feed flowing down 
the inner pipe before meeting the cold metal salt feed. The counter current 
geometry ensures the metal salt stream is not heated prior to mixing, as this 
could cause precipitation of the salt and in turn, blockage. Furthermore, as the 
two streams meet, mixing and heating of the metal salt feed is rapid and 
immediate - leading to the nucleation of particulates. After particle formation, 
the product stream is hotter, less dense and thus more buoyant than the metal 
salt upflow; therefore particles inherently flow upwards toward the reactor 
outlet. The flow from both the water and metal salt also drives particle 
movement, thereby preventing particle build-up, as well as creating a short 
residence time which can prevent particle growth. Subsequent to leaving the 
reactor, particles are quickly cooled in the cooling loop to inhibit particle growth. 
 
Unlike the reactor designs from Adschiri, Arai and others (Adschiri et al., 2000, 
Hakuta et al., 1998, Kawasaki et al., 2010, Aimable et al., 2009b), the Nozzle 
reactor combines the mixing device and reactor into one entity which also 
promotes instant and rapid heating of the precursor stream, and short residence 
times. 
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  Continuous Hydrothermal Scale Up 1.7.2.3
 
While developing the counter current Nozzle reactor, Lester et al. had the 
aim of designing a reactor system which was capable of making the process of 
synthesising nanoparticles industrially viable. This meant it needed to be capable 
of being scaled up without having a detrimental effect on product quality. 
Moreover, the scale up process needed to be economically feasible, as any 
nanomaterial synthesis (or any emerging technology) that presents high 
manufacturing costs will have difficulty in gaining widespread industrial interest.  
 
In 2007, Lester et al. succeeded in building a pilot scale reactor system based on 
the technology of the counter current Nozzle reactor, a photo of which is shown 
in Figure 1.22, and is owned by Promethean Particles Ltd. (see Section 1.8.2). 
The water and precursor flows are driven by two dosing pumps from Milton Roy 
(Milroyal B) ± each with a maximum flow rate of 400 ml/min. The water stream 
is heated using a custom-built electrical heater (Watlow, output of 9 x 4.3 kW). 
All pipes and fittings within the system are from Swagelok; where the lab scale 
reactor uses a Swagelok cross-piece with an outer diameter of 3/8´FP
the pilot scale reactor contains a cross-piece with an outer diameter of 11/2´
(3.81 cm) and a wall thickness of 1/4´FP Likewise, at the lab scale, the 
inner pipe which carries the heated water stream has an outer diameter of 1/8´
(0.3175 cm). The equivalent pipe on the pilot reactor measures ò´ as its outer 
diameter with a wall thiFNQHVV RI ´  FP. The system pressure is 
maintained by a pneumatic back pressure regulator (Tescom) and the product 
stream is cooled to ambient by a mains water fed heat exchanger built using 
Swagelok parts. Typical synthesis experiments on the lab scale equipment 
employ a total flow rate ca. 30 ml/min to generate g/h of equivalent dry 
material, while the pilot reactor system is capable of flow rates up to 800 
ml/min, to produce kg/day. 
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Figure 1.22. Photograph of the Pilot Scale reactor system which 
incorporates the counter-current Nozzle reactor technology, courtesy of 
Promethean Particles Ltd (see Section 1.8.2). 
 
Currently, The University of Nottingham are involved in an EU-funded, Seventh 
Framework Programme (FP7) project entitled SHYMAN (Sustainable 
Hydrothermal Manufacture of Nanomaterials). One of the main objectives within 
this project is the design and build of a commercial scale plant (production at 
1000 tonnes per annum) based on the counter-current Nozzle reactor - making 
it the largest scale production plant, using continuous hydrothermal technology, 
in the world. The SHYMAN project will be discussed further in Section 1.8.2.1. 
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1.8  Commercialisation of Hydrothermal Synthesis 
 
  Hanwha Chemical 1.8.1
 
Hanwha Chemical is a Korean company established in 1965. Traditionally, 
they have produced plastics, such as polyethylene (PE) and polyvinyl chloride 
(PVC), and battery materials, as well as having biopharmaceutical departments 
dedicated to drug development and production (Hanwha, 2013). In recent years 
they have turned their attention to nanotechnology and built a pilot plant for the 
hydrothermal synthesis of a range of metal oxide nanoparticles, via a continuous 
process. Their pilot scale facility has the capacity to produce the equivalent of 4 
kg of dry powder per hour, and was built to gather scale-up data in order to 
develop an even larger plant. 
 
At the end of 2010, Hanwha Chemical built a commercial plant for the 
manufacture of lithium iron phosphate, LiFePO4 ± a material gaining much global 
interest for battery applications. This plant employs the process of continuous 
supercritical hydrothermal synthesis, and has a capacity of >200 tons per annum 
± the current largest plant of this type in the world (Adschiri et al., 2011).  
 
  Promethean Particles Ltd. 1.8.2
 
A spin-out company was formed in 2008 called Promethean Particles to 
take advantage of the patented Nozzle reactor. The company conducts 
gram/hour scale feasibility studies to develop bespoke nanoparticle dispersions 
for industrial customers in a diverse range of applications. In addition, a Pilot 
scale reactor (as described in Section 1.7.2.3) is capable of producing 
nanomaterials at a scale of 1 ton per annum, to meet larger demands. 
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As well as commercial projects, Promethean Particles participate in EU-funded 
FP7 Projects, providing nanomaterials to Consortium Partners. At the time of 
writing, there are 3 FP7 projects running in parallel ± POINTS (Printable Organic-
Inorganic Transparent Semiconductor Devices) started in May 2011 and runs 
until May 2014; NanoMILE (Engineered nanomaterial mechanisms of interactions 
with living systems and the environment: a universal framework for safe 
nanotechnology) began in March 2013 and runs until March 2017; and SHYMAN 
(Sustainable Hydrothemal Manufacture of Nanomaterials), which started in May 
2012 and will conclude at the end of April 2016. The SHYMAN Project revolves 
DURXQGWKHµ1R]]OH¶UHDFWRU. 
 
  The SHYMAN Project 1.8.2.1
 
The SHYMAN Project is an EU funded Seventh Framework Programme 
(FP7) study which started in May 2012 and will run over the course of 4 years 
(SHYMAN, 2013). With 16 Consortium partners from academia, industry and 
SMEs (small and medium enterprises), the aims of the project fall into three 
main categories:  
 
x The design, commission and build of a commercial scale plant, with the 
ability to produce nanomaterials at a capacity of up to 1000 tons per 
annum. As such, it will become the largest continuous hydrothermal 
production plant in the world. Modelling (e.g. computational fluid 
dynamics, CFD, and pseudo-fluids modelling) will be employed to 
determine the deviations in fluid mixing with increasing scale while 
engineers from academia and industry will consider and design solutions 
for minimising the energy consumption of the plant, and maximising 
product yield.   
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x The development and characterisation of existing and novel 
nanomaterials (produced by the University of Nottingham and 
Promethean Particles) which can be formulated by industrial partners into 
their current products, in order to replace less sustainable additives, or 
enhance their existing properties.  Industrial partners include multi-
national companies Solvay, Repsol, PPG, and Fiat. 
 
x The analysis of waste products generated during the manufacturing 
process, and development of waste water recycling schemes, in order to 
reduce waste emissions and other detrimental effects on the 
environment. Moreover, Life Cycle Analysis (LCA) will be performed to 
assess if nanomaterials produced using this technology are more 
sustainable compared to from other existing technologies. As with many 
chemical and engineering methods, particularly at pilot or commercial 
scale, a lot of focus falls on environmental impact, and whether the 
process adheres to the Principles of Green Engineering (Tang et al., 
2008). 
 
By reaching these aims, the SHYMAN Project will develop commercial products 
containing nanomaterials, as well as a plant capable of manufacturing these 
nanomaterials to meet global demand. A highly interesting and exciting project, 
SHYMAN demonstrates the real potential of the technology described in this 
Thesis. 
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1.9  Challenges of Nanomaterial Synthesis 
 
In previous Sections of this Chapter, the wide variety of benefits from 
nanoparticles has been described. However, the synthesis of nanoparticles is not 
without its challenges. This is true for most methods of synthesis, not just 
continuous hydrothermal routes. A major challenge facing the synthesis of 
nanomaterials, is achieving particles which are stable and do not agglomerate. 
This issue will be discussed in Section 1.9.1. 
 
  Particle Stability 1.9.1
 
Due to the small size of nanoparticles, a high proportion of the 
component atoms within each particle are present on the surface. Coupled with 
the high surface area-to-volume ratio, nanoparticles have a much higher surface 
energy compared to bulk material (Nanda et al., 2003). This results in 
nanoparticles inherently being drawn to each other to minimise their surface 
energy. The net result, if no opposing forces prevent them from doing so, is that 
nanoparticles will coagulate into larger clusters. There are two forms of 
coagulation: flocculation, which is reversible; and agglomeration, which is 
irreversible. While flocculation can usually be solved by agitation of particles and 
dispersing them in high viscosity media, agglomeration is not as simple. It poses 
a huge disadvantage as, in many cases, the particles no longer move as 
individual particles, but as larger micron-scale aggregates. The properties of the 
particle can also be affected, no longer exhibiting the advantageous properties 
seen at the nanoscale; in these cases, measures should be taken to prevent it 
from occurring, otherwise the principle of having nanoparticles becomes void. 
Preventing particle aggregation is particularly pertinent in continuous systems, 
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as large clusters are more likely to cause blockages ± especially at bench scale 
where pipes are narrow. 
 
  Methods of avoiding Particle Coagulation 1.9.2
 
Depending on the degree of coagulation between nanoparticles, a few 
different methods can be used to break particles up or keep them apart. These 
can be classified into mechanical or chemical methods. For flocculated particles, 
mechanical methods can be employed; here, equipment is used to physically 
break up flocculates, such as sonicators, homogenisers or dispersers. These use 
physical force, such as sound energy or shear forces, to disrupt clusters and 
disperse them into a carrier media. If the media has a high viscosity, the 
particles disperse more slowly through the fluid, reducing the chance of re-
flocculation. 
 
However, without altering the surface charge or chemistry of the particles, they 
are able to re-coagulate. Hence, chemical methods are often more effective at 
preventing particle coagulation. Capping agents or surfactants (surface active 
agents) can be added to bind to the particle surface which, in turn, provides 
either steric stabilisation (generally the case when polymeric surfactants are 
used) or charge stabilisation (such as the use of acids or bases). Choosing a 
suitable surfactant for each nanoparticle species can be difficult, as it should be 
compatible with the solvent media, as well as able to chemically bind to the 
particle surface. In addition, the concentration ratio between nanoparticles and 
surfactant needs to be balanced; insufficient surfactant means incomplete 
coverage and exposed particle surfaces are still able to bind and coagulate, while 
WRR PXFK VXUIDFWDQW FDQ OHDG WR µRYHUFURZGLQJ¶ RQ WKH SDUWLFOH VXrface, a 
compression of surfactant layer, and a similarly detrimental effect. This is 
depicted in Figure 1.23. Of course, this ratio is also dependent on particle size - 
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smaller particles have a larger surface area and therefore require more 
surfactant molecules to bind to it (Lubrizol, 2013). 
 
 
 
Figure 1.23. Ratios of surfactant to nanoparticle where (a) shows 
insufficient surfactant concentration resulting in partial coverage, (b)  
displays optimum surfactant coverage and maximum stability, and (c) 
shows too much surfactant leading to layer collapse and unstable 
particles (Lubrizol, 2013). 
 
It has also been shown that surface modification can be used to transfer 
nanoparticles into different solvent phases (Ohara et al., 2008); improve particle 
dispersability into fluids (Kim et al., 2008); limit crystal growth in a particular 
direction which then affects particle morphology (Mousavand et al., 2006, 
Mousavand et al., 2007); or alters particle size (Taguchi et al., 2012). 
 
 Methods of Determining Particle Stability 1.9.3
 
If particle coagulation occurs, the clusters typically become denser than 
the carrier solvent (in most studies, this solvent is water or basic alcohols) and 
fall to the bottom of the vessel resulting in phase separation. Therefore, it is 
very easy to observe by eye if coagulation is evident. Consequently, many 
assessments of particle stability are empirical. 
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Still, the particles in a suspension may have sufficient surface charge to remain 
stable in the short term, but will coagulate over time. Therefore the degree of 
surface charge (attractive or repulsive forces acting on a particle) should be 
measured to ascertain if the particles are truly stable. Zeta potential is a widely 
used method to quantify particle charge. Although the technique does not 
conclusively give information about whether particles have a positive or negative 
charge, it is a reliable method for measuring long term particle stability. Zeta 
Potential, and other structural characterisation techniques, will be discussed in 
more detail in Chapter 2. 
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1.10  Aims of this PhD 
 
Through the course of this Chapter, the benefits of using nanoparticles 
have been described for a vast range of applications. While nanotechnology as a 
field of research has existed for decades, its emergence into industrial 
application remains in its infancy. With increasing numbers of studies 
highlighting nanoparticles as safe to use, coupled with the exceptional data 
obtained from research, more and more industries want to test and apply 
nanoparticles into their products. This developing demand calls for synthesis 
procedures which stretch far beyond the lab-scale, while keeping costs and 
negative environmental impacts down. 
 
The merits of continuous hydrothermal synthesis have been described in this 
Chapter, with the importance of optimised reactor design being highlighted. In 
response to this need, the counter-current Nozzle reactor was designed and 
constructed at the University of Nottingham at both lab and pilot scale. While 
studies have been conducted using the Nozzle reactor for the synthesis of a few 
different nanomaterials (Hobbs et al., 2009, Lester et al., 2012, Aksomaityte et 
al., 2013), the immense range of nanomaterials which could potentially be 
produced by this method, largely remains unchartered territory. Because reactor 
geometry plays such a vital role in the structural properties (size, shape, 
crystallinity) of the synthesised particles, the products from the Nozzle reactor 
may be vastly different to those made using a different continuous hydrothermal 
reactor, even though synthesis is based on the same principle method. Since 
particle structure ultimately dictates functional performance, products from two 
different reactors could exhibit very different properties. 
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Therefore the invention of the Nozzle reactor opens up a vast field of research - 
comprising the synthesis of a material, optimisation of the process, structural 
characterisation of the products, and application testing. The latter provides 
assessment of how materials can be applied to give real-world meaning. All the 
while, this technology has been proven to be scalable, with high product 
reproducibility. This principle forms the motivation of this PhD work. 
 
The aims of this work are to use a novel continuous hydrothermal reactor (the 
counter current Nozzle reactor) in the synthesis of a range of nanomaterials for 
three different biomedical applications, to characterise the structure of those 
nanomaterials, and finally to test the particles for properties which are specific to 
that application. Testing performance properties and characteristics is key to 
assessing the viability of applying the nanoparticles in a specific end application. 
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Chapter 2 
 
2 Structural Characterisation 
Techniques 
 
This chapter will discuss the analysis techniques used in Chapters 3, 4 
and 5 to characterise the structural properties of nanomaterials. For each 
procedure, the principles of each technique will be discussed, along with the data 
which can be obtained from it.  The methods of sample characterisation which 
are more specific to each individual Chapter, such as testing of application 
properties, will be discussed in the relevant Chapter. 
 
2.1 Scanning Electron Microscopy (SEM) 
 
SEM is a surface imaging technique which allows the user to study the 
particle size, topography, and morphology of samples using magnifications 
between 100 and 100,000 times. With standard optical microscopes, light is 
used to form an image. With SEM, images are formed with an electron beam 
generated from an electron gun. Electrons are a type of ionizing radiation; using 
them not only means that higher magnifications are possible due to their shorter 
wavelength compared to visible light, but there is also a larger field of depth 
compared to light microscopy. This means a large area of the sample is in focus 
at one time, giving an image which is a good 3-dimensional representation of the 
sample. 
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Figure 2.1. An illustration showing the components in a typical scanning 
electron microscope (Flegler et al., 1995). 
 
Samples of powders or particles are held on an aluminium stub using adhesive 
carbon tape. If required, the surface of the sample and stub can be coated with a 
very thin layer of metal such as gold, to enhance conductivity and in turn, 
improve the flow of electrons across the sample surface. The stub is then loaded 
into the sample chamber. The electron beam travels down the microscope under 
vacuum from the gun, through a series of apertures and electromagnetic lenses 
to control and modify the beam, as well as prevent electron spray, before 
reaching the sample (the beam can be controlled to scan across a specific area 
of the sample). The orientation of these components is shown in Figure 2.1. 
When the beam of electrons hits the sample, they interact and different signals 
are generated, including secondary electrons (SE), backscattered electrons 
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(BSE), and X-rays. Detectors are in place to pick up each of these signals. The 
detected electron intensity is converted to light intensity which gives a visual 
image that can be digitally viewed. SE are electrons expelled from the sample 
atoms as a result of interactions with the (primary) electrons of the beam. SE 
generally have low energy and are used to give the best imaging resolution, 
where contrast in the image is principally due to sample topography. On the 
other hand, BSE are electrons from the beam that have been scattered back 
after collisions with the nuclei of sample atoms, where nuclei with a higher 
atomic number cause more electrons to be scattered back. As a result, these 
atoms appear brighter in BSE images and in turn, contrast in these images can 
give information about sample composition (Griffith and Danilatos, 1993). 
 
Simple sample preparation, rapid data acquisition, high magnification imaging, 
and being a non-destructive technique (meaning samples can be analysed 
repeatedly) make SEM a very useful technique. However, disadvantages are that 
only solid material can be analysed, which has to fit in the sample chamber 
(usually a maximum of 10 cm). Samples usually have to be stable under high 
vacuum, although microscopes with low vacuum or environmental modes are 
available. In addition, some samples (particularly organic samples) are beam 
sensitive and can become damaged (Flegler et al., 1995). 
 
The SEM kit used in this study is a FEI Quanta 600 with a lanthanum hexaboride 
(LaB6) filament to generate an electron beam. In most cases, an accelerating 
voltage of 25 or 30 kV is used. 
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2.2 Transmission Electron Microscopy (TEM) 
 
TEM operates using a similar principle to SEM, where electrons are used 
DVD³OLJKW´VRXUFH+RZHYHUXQOLNH6(0WKHHOHFWURQEHDPWUDYHOVWKURXJKWKH
sample (Figure 2.2 (a)). Some electrons may become scattered depending on 
the density of the material, but those that are not, hit a screen at the bottom of 
WKHPLFURVFRSH WR IRUP D ³SURMHFWLRQ´ RI WKH VDPSOHZKHUH SDUWVPD\ DSSHDU
darker than others depending on density. Thus, TEM can be useful for visualising 
hollow structures (Figure 2.2 (b)) (Williams and Carter, 2009). 
 
 
 
 
 
Figure 2.2. (a) A simplified depiction of how a typical TEM operates; (b) 
a schematic showing a 3-dimensional tube is viewed as a 2-dimensional 
image under a TEM. 
 
(a) 
(b) 
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There are different types of TEM, for example Scanning TEM (STEM), high 
resolution TEM (HRTEM) and analytical electron microscopy (AEM), providing a 
choice over image analysis.  TEM also allows higher magnifications than SEM and 
can determine, to an extent, the internal structure of particles.  In addition, the 
crystal lattice of particles can even be observed with HRTEM.  Nevertheless, the 
trade-off of higher magnifications is the decreased sample area, which questions 
if an image obtained using TEM is truly representative of the full sample.  
Furthermore, there can be confusion when interpreting images; after all, these 
are 2D images of 3D samples (Williams and Carter, 2009).  Like SEM, some 
samples can be sensitive to the ionizing radiation of the electron beam; as a 
result, some materials (particularly organic materials) may suffer heat or 
chemical etching damage. 
 
In this work, samples were prepared for TEM analysis using one of two methods; 
nanoparticles produced in water from the reactor were washed and diluted with 
deionised water before being loaded onto the copper-JULG PRXQWHG µKROH\¶
carbon films and allowed to air dry on filter paper. Dry powder samples were 
suspended in alcohol, typically ethanol or methanol, and sonicated. A few drops 
of the suspension were loaded onto the grids and air dried. Alcohol is used 
because it tends not to react with the samples, but has relatively low surface 
tension (compared to water, for example) thereby allowing the particles to be 
well distributed over the sample grid. 
 
Images were obtained using a JEOL 2100F HRTEM equipped with a field emission 
electron gun (FEG) and operating at 100 kV accelerating voltage. 
 
 
 
Chapter 2. Structural Characterisation Techniques 
 
65 
 
2.3 Energy Dispersive X-Ray Spectroscopy 
(EDX/EDS) 
 
EDX analysis is an additional feature of most SEM and TEM instruments.  
As previously mentioned in Section 2.1, electron interaction with a sample can 
also produce X-rays. This signal can be specifically detected to give information 
on the elements present within a sample. In the case of the FEI Quanta 600 SEM 
equipment mentioned in Section 2.1, collected EDX data was interpreted using 
Genesis software by EDAX. 
EDX analysis can be a very helpful confirmatory tool, but very light elements 
such as H, He and Li cannot be detected. 
 
2.4 X-Ray Diffraction (XRD) 
 
This analysis method is used to ascertain information about the crystal 
structure (or arrangement of atoms) in a sample. Figure 2.3 illustrates how data 
can be obtained; X-UD\VRINQRZQZDYHOHQJWKǊDUHILUHGDWWKHVDPSOHZKLFK
then interact with the electrons of atoms on each crystal plane. As a result, the 
X-rays are scattered to give a signal (elastic scattering) and are identified by the 
detector component of the equipment. 
 
During analysis, X-rays are directed at the sample at a range of angles (incident 
DQJOHǇVHHQLQFigure 2.3). As the rays hit the sample, they are diffracted by the 
lattice structure of the crystal. A detector moves around the sample and 
measures the intensity of these peaks at each angle. Thus, signal intensity at 
each angle depends on the orientation and spacing between crystal planes.  
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Figure 2.3. A diagram showing the basis of XRD analysis. 
 
The relationship between the X-ray wavelength, the d-VSDFLQJDQGWKHDQJOHǇ
FDQEHVXPPDULVHGE\%UDJJ¶V/DZ ݊ߣ ൌ  ?݀ݏ݅݊ߠ 
 
where: ݊  is an integer, 
 ߣ is the wavelength of the beam, 
 ݀ is the spacing between diffracting planes, and 
 ߠ is the incident angle 
 
Each crystal structure has a unique diffraction pattern, giving signal peaks of 
GLIIHUHQW LQWHQVLW\ DW GLIIHULQJ DQJOHV RI Ǉ RQFH WKH GLIIUDFWLRQ SDWWHUQ RU
corresponding d-VSDFLQJVLIFDOFXODWHGXVLQJ%UDJJ¶V/DZRIDVDPSOHKDVEHHQ
measured and the constituent elements are known, it can be matched to an 
existing library of known structures in order to identify the crystal phase and the 
component compound(s) in the sample. 
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With specific analysis, the diffraction pattern of a sample can be used to infer 
much more information than just compound identification.  The shape of peaks 
in a diffraction pattern can be an indication of the degree of crystallinity in a 
sample. For example, a highly crystalline sample will have consistent d-spacings 
and in turn, high signal intensity for a narrow range of angles. Therefore, the 
resulting diffraction pattern will have sharp narrow peaks. Conversely, samples 
with a lower degree of crystallinity will have more irregular d-spacings and the 
subsequent diffraction pattern will show broader, less intense peaks. Amorphous 
samples (those which contain atoms arranged in a random order with no distinct 
crystal planes) will not create a detectable signal and so, do not give any peaks 
or diffraction patterns. 
 
It is important to note, however, that peak shape and size can also be ascribed 
to factors other than the degree of crystallinity in the sample. The instrument 
used can play a role in the peak profile obtained, and for small particles 
(principally <200 nm) - crystallite size. The Scherrer equation establishes the 
relationship between peak broadening and crystallite size: 
 ܦ ൌ ܭߣߚܿ݋ݏߠ 
 
Where: ܦ = crystallite size ܭ = the Scherrer constant, which takes into account the shape of 
the crystal 
  ߣ = X-ray wavelength ߚ = the full-width of the peak at half maximum (FWHM), in 
radians 
  ߠ = the Bragg angle 
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The Scherrer equation demonstrates that crystallite size is inversely proportional 
to peak broadening, i.e. a wider peak indicates a smaller crystallite.  Because 
this effect is mainly seen for small particles, size analysis by other techniques 
such as TEM should be used concurrently with XRD analysis, in order to infer the 
cause of peak broadening. It should also be noted that crystallite size is not the 
same as particle size, as a particle may be made up of different crystallites. 
 
In this work, dry powder samples were analysed using a Bruker D8 Advance 
diffractometer, using Cu Kɲ1 UDGLDWLRQǊ QPZLWKDVWHSVL]HRI04 
and step time of 5 seconds. 7\SLFDOO\VFDQVZHUHWDNHQIRUDǇUDQJHEHWZHHQ
DQGÛ. Diffraction patterns were analysed using EVA processing software 
for phase identification, while Xfit (Cheary and Coelho, 1996) and Celref 
(Laugier, 1999) software were used to calculate crystallite size and cell 
parameters, respectively. 
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2.5 Time-of-Flight Secondary Ion Mass 
Spectrometry (ToF-SIMS) 
 
ToF-SIMS is a method for analysing the chemical composition of the 
surface of a solid sample. It uses a pulsed ion beam (Bi3+) to remove molecules 
from the very outermost surface of the sample in a chosen square area. Particles 
are removed from atomic monolayers on the surface (secondary ions). These 
particles, which could be full or fragmented molecules, are then accelerated into 
a "flight tube" and their mass is determined by measuring the time taken to 
reach the detector (i.e. time-of-flight). Three operational modes are available 
using ToF-SIMS: surface spectroscopy, surface imaging and depth profiling 
(Vickerman and Briggs, 2001). 
 
This method has the advantages of being non-destructive, easy to use and with 
little sample preparation, and high sensitivity for trace elements or compounds.  
Nevertheless, the equipment collects a spectrum for each pixel of the chosen 
square area of analysis.  This can provide too much data which can be very 
time-consuming to interpret. 
 
Data obtained from ToF-SIMS analysis will be described in Chapter 3. 
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2.6  Dynamic Light Scattering (DLS)  
 
DLS is a particle sizing technique, also referred to as photon correlation 
spectroscopy (PCS) or quasi-elastic light scattering (QELS), which measures the 
rate of particle diffusion in a suspension by Brownian motion and correlates this 
to particle size. In a sample of a liquid dispersion, solvent molecules move 
around in sROXWLRQGXHWRWKHLUWKHUPDOHQHUJ\,QWXUQWKHVHERPEDUGRU³NLFN´
particles that are also present in the suspension and this is known as Brownian 
motion. As such, particles must be suspended in a solvent, to be analysed by 
DLS. 
 
For DLS analysis, a monochromatic laser illuminates the particles in a liquid 
dispersion and the light is scattered.  The intensity of this scattered light varies 
depending on the size of the particles because smaller particles are pushed 
further by solvent molecules and move faster. By measuring the changes in 
intensity of scattered light, the velocity of the Brownian motion can be found; 
the particle size is then calculated using the Stokes-Einstein equation: 
 ݀ሺܪሻ ൌ ݇ܶ ?ߨߟܦ 
 
where: ݀ ሺܪሻ = hydrodynamic diameter 
 ݇  %ROW]PDQQ¶V&RQVWDQW 
 ܶ = absolute temperature 
 ߟ = viscosity 
 ܦ = translational diffusion coefficient 
 
The particle size calculated by DLS relates to how the particle diffuses in the 
suUURXQGLQJGLVSHUVDQWDQG LV FDOOHG WKH µK\GURG\QDPLFGLDPHWHU¶ Figure 2.4). 
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This value is dependent on the particle core, as well as any surface modifications 
to the particle, and the surrounding ions present in the solvent. The particle 
shape affects the reported size as well, and the measured hydrodynamic 
diameter for non-VSKHULFDOSDUWLFOHV LVJLYHQDV ³WKHGLDPHWHURID VSKHUHZLWK
WKH VDPH WUDQVODWLRQDO GLIIXVLRQ VSHHG DV WKDW SDUWLFOH´ (Malvern, 2013).  
Consequently, the measured particle size can be larger than that seen using 
electron microscopy (where a particle may be out of its natural environment). 
 
 
 
Figure 2.4. A diagram of the hydrodynamic diameter of a particle which 
is reported by DLS analysis (Malvern, 2013). 
 
The application of DLS analysis will be principally discussed in Chapters 4 and 5; 
DLS data was obtained using a Zetasizer Nano-ZS by Malvern Instruments, 
which can measure particles in the range of QPWRǋP7KLVLQVWUXPHQW
uses a He-Ne laser with a wavelength of 633 nm. Where required, the Refractive 
,QGLFHV IRU VDPSOH PDWHULDOV ZHUH WDNHQ IURP WKH ³'LVSHUVLRQ DQG 5HIUDFWLYH
,QGH[ *XLGH´ IURP 0DOYHUQ ,QVWUXPHQWV 'DWD DQDO\VLV ZDV SHUIRUPHG Xsing 
Zetasizer software Version 7.20 from Malvern Instruments. The obtained particle 
size data is initially given as an intensity distribution for the scattered light. In 
this instance, ܫ ן ݀଺ where I is the signal intensity and d is the particle diameter; 
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larger particles provide a much stronger signal than smaller particles meaning 
data can be skewed if larger particles, dust or agglomerates are present in the 
sample. 
 
For samples which contain different sized particles, i.e. where there is more than 
one peak in the intensity distribution graph, it may be necessary to convert the 
data to a volume based distribution. To do this, the refractive index and 
adsorption value of the particles needs to be added to the software.  Using Mie 
theory, the software then converts the data to a volume-basis so that the 
aforementioned data-skewing due to larger particles is not seen. 
 
This technique benefits from being a non-invasive method that requires 
practically no sample preparation. Moreover, data acquisition takes only a few 
minutes ± significantly shorter than most other particle sizing techniques, and a 
fraction of the running costs compared to electron microscopy. On the other 
hand, particles must be stable and well dispersed in the solvent in order to 
obtain a viable measurement; if particles are coagulated, the size of the clusters 
is measured and no information on the primary particle size can be gathered.  
Thus, samples with particles which have coagulated and phase separated due to 
gravity can be visually identified, and analysing these with DLS is redundant. 
 
 
 
 
 
 
 
Chapter 2. Structural Characterisation Techniques 
 
73 
 
2.7  =HWDǅ ) Potential 
 
The Zetasizer Nano ZS from Malvern Instruments can also measure the 
zeta potential of colloidal systems, which gives an indication of the particle 
stability i.e. if the particles are likely to coagulate over time. 
 
In aqueous media, particles in dispersion carry a surface charge.  This is 
GHSHQGHQWRQWKHSDUWLFOH¶VVXUIDFHJURXSV )RUH[DPSOHGLVVRFLDWLRQRIDFLGLF
surface groups will lead to a negative change, while basic groups dissociate and 
give rise to positive charge. In addition, the presence of anionic or cationic 
surfactants around particles affects the surface charge. Figure 2.5 shows an 
example particle with a negative surface charge. Depending on the pH and ionic 
strength of the solution, ions of opposite charge to the surface are strongly 
bound to the particle, called the Stern layer. Around this layer are more loosely 
bound ions ± part of the slipping plane. As a result, each particle has an 
electrical double layer which is considered a stable entity and moves in solution 
with the particle. Outside of this electrical double layer, the ions are considered 
as part of the bulk dispersant and do not move with the particle. Zeta potential 
is a measure of the net electrical charge for a particle and its electrical double 
layer. 
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Figure 2.5. A schematic representation of what is measured by zeta 
potential (Malvern, 2013). 
 
To measure zeta potential, an electric field is applied across a sample. Charged 
particles will move towards the electrode of opposite charge at a speed that is 
proportional to the size of its charge. The Zetasizer measures this velocity and, 
considering the viscosity of the dispersant, can calculate the zeta potential value. 
This data can give information on the attractive or repulsive forces present in a 
dispersion and in turn, how likely particles are to coagulate. A high zeta potential 
is considered as <-30 mV or >+30 mV (Malvern, 2013), and the particles in that 
suspension can be considered to be stable. 
 
The zeta potential of particles varies with the pH and conductivity of the 
surrounding media, so measurements can be taken over a pH range in order to 
ascertain the conditions where particles begin to aggregate. This is known as the 
point of zero charge (PZC) or iso-electric point (IEP). 
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Zeta potential is crucial analysis for understanding colloidal systems, and in the 
development of stable, non-aggregating dispersions. This technique holds the 
advantage of rapid data acquisition as measurements generally only take a few 
minutes, but drawbacks include the need to prepare samples with accuracy as 
pH, conductivity and presence of surfactants can significantly affect zeta 
potential.  
 
The application of zeta potential measurements will be discussed in Chapter 4. 
Measurements were taken for dilute suspensions of each sample (0.1 mg/ml) 
over a pH range, while the background electrolyte (sodium chloride, NaCl) was 
maintained at 0.01 M. Hydrochloric acid, HCl, or sodium hydroxide, NaOH, were 
used to alter the pH.  Samples were loaded into disposable zeta cells and for 
each sample, three measurements were obtained using a Malvern Zetasizer 
Nano ZS, and standard deviations calculated. Data were analysed using Malvern 
Zetasizer software. 
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Chapter 3 
 
3 Hydroxyapatite 
 
3.1 Introduction 
 
Prior to this project, hydroxyapatite had been established as a material of 
interest in the Nottingham group and some preliminary experiments have been 
described previously (Li, 2008). As a result, one of the objectives of this work 
has been to continue the synthesis of hydroxyapatite using the Nozzle reactor, to 
explore the experimental parameters governing formation, and to test material 
properties for biomedical application.  
 
  Hydroxyapatite (HA), Ca10(PO4)6(OH)2 3.1.1
 
Apatites are a group of phosphate minerals which are widely found in 
nature.  These are isomorphic compounds which exhibit the same hexagonal 
dipyramidal crystal structure. HA has unit cell dimensions of a = 9.432 Å and c = 
6.881 Å (Posner et al., 1958) (See Chapter 2 for general details on crystal 
structure and how it is analysed). The OH- ion of HA can undergo substitution 
with carbonate (CO3
2-), fluoride (F-) or chloride (Cl-) ions to give carbonate-
apatite, fluorapatite and chloroapatite respectively. In addition, the molar ratio 
of calcium to phosphorus can vary from the stoichiometric ratio of Ca/P = 1.67; 
as such, calcium-deficient HA exists. These isomorphs display different 
properties to HA. For example, fluorapatite is chemically more stable than HA 
(Montazeri et al., 2011). Such property changes can be exploited to tailor apatite 
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materials suitable for specific applications. Hydroxyapatite, and chemically 
similar forms of HA, make up the inorganic component of teeth and bones in 
mammals. For this reason, HA has been widely utilised in the biomedical industry 
for many decades. This is described in more detail in Section 3.1.2. 
 
  Current applications using HA 3.1.2
 
The biocompatible and bioactive nature of HA, namely that it can interact 
with living tissue without being rejected or causing infection, makes it a very 
desirable material for biomedical applications. It is already widely used in 
dentistry (Whitters et al., 1999), plastic surgery (Gladstone et al., 1995) and 
orthopaedics (Block and Thorn, 2000). In this Section, applications of HA in 
tissue engineering will be discussed further. 
 
  Bone Scaffolds 3.1.2.1
 
Ideally, bone scaffolds should be temporary structures which are 
implanted onto or into damaged bone, gaps caused by trauma or infection, or 
where fusion of joints is needed. Once implanted, the scaffold should facilitate 
the formation of new bone by being either osteoinductive (recruiting and 
stimulating immature cells to become young bone cells, or preosteoblasts) or 
osteoconductive (allowing the formation of new osteoblasts - cells that regulate 
bone tissue synthesis on the surface of or within the structure of a bone scaffold 
or graft). The scaffold will eventually decompose once the bone has healed.  
Both osteoinduction and osteoconduction are vital for the bone healing process; 
however, subsequent to many bone fracture incidents, much of the bone healing 
procedure is reliant on osteoinduction (Albrektsson et al., 2001).  In craniofacial 
implantology, high rates of osseointegration have also been reported (Gladstone 
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et al., 1995), where direct bone-to-implant contact is achieved to provide the 
implant with a firm basis, and have led to efficient bone healing. 
 
Through introducing or increasing porosity of HA scaffolds, an improvement in its 
osteoconductive properties has been demonstrated (Mastrogiacomo et al., 
2006). Upon implantation, osteoblasts are able to weave into and through the 
HA scaffold, promoting new cell, blood vessel and bone matrix development. 
Nevertheless, the disadvantage of these scaffolds is the brittle nature of HA.  The 
porosity has a further detrimental effect on the mechanical strength of the 
scaffold.  As a result, it is not possible to use these bone grafts alone in a 
position where load bearing is required. In these cases, HA is applied as a 
coating instead. 
 
 Coating on Prosthetics 3.1.2.2
 
Many materials used for prosthetic implants such as titanium, titanium 
alloys, copper, and bone cements are exploited for their capability of load 
bearing duties. They are however, limited by their low biocompatibility. In turn, 
they demonstrate little or no osteoconduction. To solve this problem, implants 
are coated with HA to increase biocompatibility and in some cases, 
osseointegration. Implants are principally coated with HA by the plasma spray 
process. Here, HA powder is heated in a plasma jet until molten and then 
propelled towards the substrate. As it solidifies, the HA hardens onto the implant 
material (Zhou and Lee, 2011). 
 
 Other Applications 3.1.2.3
 
 Hierarchical microspheres of HA have been used as drug delivery 
vehicles, namely in the slow release of ibuprofen (Yang et al., 2012b), while HA 
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has also been used for protein purification (Orlovskii et al., 2002), separation of 
biomolecules (Bio-Rad, 2013) and as a component of dietary supplements (Shen 
et al., 2007). 
 
 Potential Applications for HA 3.1.3
 
Researchers have recently been focussing their studies on HA with other 
materials incorporated into the structure, such as cations (Kalita and Bhatt, 
2007, Oh et al., 2004, Webster et al., 2004), or drugs (Leprêtre et al., 2009) ± 
these studies report on the synthesis and characterisation of such materials. 
 
The doping of different cations into the HA structure has been found to improve 
upon the existing biocompatible and osteoconductive nature of HA, afterall 
natural apatite tends to contain a range of cations other than calcium (Webster 
et al., 2004). For example using silver as a dopant can induce antimicrobial 
activity (Oh et al., 2004, Stanic et al., 2011), while magnesium-doped HA has 
been shown to display improved cell adhesion (Mroz et al., 2010), and HA doped 
with zinc was shown to be biocompatible after in vivo tests (Saraswathi Amma et 
al., 2008), as well as possessing antimicrobial activity (6WDQLüHWDO) and 
can be used for the controlled release of bone growth proteins (Azizian-
Kalandaragh and Khodayari, 2010). In addition, drugs such as statins have been 
used to produce composite materials with HA in order to enhance osteogenic 
effects (Griffiths and Cartmell, 2007, Jadhav and Jain, 2006).  
 
This research shows that although HA is a widely used material, and has been 
for several decades, it remains the focus for current research as there are still 
ways to manipulate the structure and further enhance its beneficial properties. 
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 Current Methods of Producing HA 3.1.4
 
Due to its excellent properties and wide range of applications, several 
methods of generating HA have been reported, where products are of the nano- 
or micron- scale. A few of these techniques will be detailed in this Section, 
including some advantages and disadvantages of each. 
 
 Naturally Occurring 3.1.4.1
 
Many HA based ceramics and cements that are already commercially 
available for bone graft implants are derived from natural sources. For example, 
Endobon® and Pro-Osteon® are produced from bovine and coral HA respectively, 
and have a structure like that of human bone (Habraken et al., 2007). However, 
there are limitations in altering their mechanical strength and porosity, which in 
turn limits their applicability (e.g. as bone scaffolds). Moreover, naturally 
occurring HA is a limited resource. 
 
 Precipitation Method 3.1.4.2
 
Synthetic HA powders which are analogous to naturally occurring HA can 
be produced from a range of different precursors and using several different 
synthetic routes. A commonly used technique for manufacturing HA is the wet 
FKHPLFDO PHWKRG RI SUHFLSLWDWLRQ  $V GHVFULEHG E\ 2VDND¶V UHVHDUFK JURXS
(Osaka et al., 1991), orthophosphoric acid solution was added to calcium 
hydroxide in a controlled, dropwise manner with stirring. This was conducted 
ZLWKYDULRXVUHDFWLRQWHPSHUDWXUHVEHWZHHQDQGÛ&ZLWKWKHS+PRQLWRUHG
throughout. The study showed that higher reaction temperatures led to the 
formation of a more crystalline product, and processing at a pH lower than 9 led 
to the formation of calcium deficient HA. 
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Another study (Zhang and Lu, 2008) described the use of calcium nitrate 
tetrahydrate and diammonium hydrogen phosphate, Ca(NO3)2.4H2O and 
(NH4)2HPO4 respectively, ZKLFKZHUHPL[HGDQGNHSWDWÛ& IRUKRurs in 
the presence of urea, which underwent hydrolysis and then yielded calcium 
phosphate (CaP) crystals. The group found that the urea concentration dictated 
the type of CaP produced, either dicalcium phosphate or octacalcium phosphate. 
They went on to immerse these two CaPs in ammonium hydroxide solution (pH 
 DW  Û& IRU  KRXUV DQG +$ SDUWLFOHV ZHUH REWDLQHG ZLWK QDQREHOW
morphology. With this method, the reactants were continually stirred after the 
precursors were mixed, and left to age. This allowed the calcium to be slowly 
integrated into the apatite structure, thus aiding the material to reach the 
stoichiometric Ca/P ratio. This method yielded particles with a narrow size 
distribution; however, the lengthy time required for synthesis forms the major 
disadvantage of the precipitation method as both the described procedures took 
several days before HA powder could be obtained. In turn, this creates difficulty 
in producing material at commercial scale, problems with batch to batch 
reproducibility, and the implication of high cost. 
 
 Sol-Gel Method 3.1.4.3
 
7KLV SURFHGXUH HVVHQWLDOO\ XVHV D VROXWLRQ ³VRO´ ZKLFK LV OHIW WR
gradually form a gel-like substance, containing a liquid and solid phase. The 
solvent is then removed by drying or centrifuging and decanting, to yield a 
powder. 
 
Vijayalakshmi and Rajeswari (Vijayalakshmi and Rajeswari, 2006) reported the 
use of sol-gel method to produce microcrystalline HA. Here, they dissolved 
calcium acetate, Ca(C2H3O2)2, in water as the calcium source. To this they added 
Chapter 3. Hydroxyapatite 
82 
 
a triethyl phosphate solution, (C2H5)3PO4, dropwise until a calculated 
stoichiometric Ca/P ratio of 1.67 was achieved. After stirring at room 
temperature, the solution was left to age for 24 hours. This allowed gel 
formation which was theQGULHGDWÛ&IRUKRXUVWRJLYHD powder product, 
which was then washed and dried again. It was found that the samples needed 
WREHFDOFLQHGDW WHPSHUDWXUHVXS WRÛ&EHIRUHKLJKO\FU\VWDOOLQHSURGXFWs 
could be obtained. The methodology is relatively simple but, again, this 
procedure is time-consuming, with limitations to scalability. Moreover, the 
calcination step can be energy intensive. 
 
 Microwave Synthesis Method 3.1.4.4
 
In recent years, various groups have used microwave radiation to 
produce different sizes and morphologies of hydroxyapatite powders, where the 
reported microwave power has ranged between 175 W and 900 W. For example, 
Kalita and Verma (Kalita and Verma, 2010) stirred calcium nitrate tetrahydrate 
with EDTA (ethylenediaminetetraacetic acid, which acts as a chelating reagent) 
and sodium phosphate dibasic, Na2HPO4, for 240 minutes at room temperature. 
After the pH was adjusted to 9 using ammonium hydroxide, NH4OH, the 
suspension was loaded into a 600 W domestic microwave oven with a 
customised reflux system, and heated on a cycle for 19 minutes. The product 
was reported as being highly crystalline HA with particles having a size 
distribution between 5-30 nm and a mixture of elliptical and rod morphologies. 
Unlike precipitation and sol-gel, microwave synthesis is less time-consuming, but 
the main disadvantages are the high equipment costs and problems associated 
with scaling up the technology. 
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 Hydrothermal Synthesis of HA 3.1.4.5
 
Hydrothermal synthesis is a commonly used method for producing HA. A 
process using a Teflon-lined batch hydrothermal reactor has been described 
previously (Earl et al., 2006). In this study, calcium nitrate tetrahydrate and 
ammonium phosphate dibasic of stoichiometric ratios were dissolved into 
distilled water. The solution was placed in the reactor and oven heated to 200 °C 
for a range of time between 24 and 72 hours, then subsequently washed with 
distilled water by centrifuging and decanting several times. Where reaction time 
exceeded 24 hours, monetite (CaHPO4), was found to be produced as well as HA. 
 
Most reported hydrothermal methods of HA production, like the aforementioned, 
are batch processes, where pressure is a difficult parameter to monitor and alter. 
This is because most off-the-shelf batch vessels do not incorporate pressure 
transducers. Instead, these are typically custom-designed and manufactured; 
even then, the pressure inside the autoclave is autogeneous and dependent on 
the reaction temperature.  
 
Conversely, the reaction temperature and pressure are arguably easier to control 
and monitor in continuous systems. The full benefits of continuous hydrothermal 
processing is outlined in Chapter 1; in brief, the ability to use this method for 
reliable synthesis has been dependent on a reactor geometry which allows 
homogeneous mixing without causing blockages in the system ± the counter-
current Nozzle reactor has been shown to demonstrate these qualities (Lester et 
al., 2006, Lester and Azzopardi, 2005) 
 
There have been publications from a different research group using a continuous 
hydrothermal system to produce HA (Chaudhry et al., 2006). The reactor used in 
this study is described in Chapter 1, Section 1.7.1.3. In their report, the 
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researchers used water in one flow which was pressurised and heated to 
supercritical conditions. In the reactor, it was met by a cold aqueous flow of 
NH4HPO4 and Ca(NO3)2, leading to the production of HA nanorods with diameters 
measuring 40 nm and lengths up to 140 nm. 
 
Following this publication by Chaudhry et al., our research group at Nottingham 
chose to experiment with the synthesis methodology, altering various process 
parameters.  It was found that, rather than having water in the downflow and 
two metal salts in the upflow, the aqueous NH4HPO4 could be pumped into the 
heater and be used as the superheated downflow. This precursor solution 
remains stable at high temperatures (i.e. the precursor does not precipitate out 
of solution), and does not cause blockages in the heater. Moreover, HA synthesis 
was at successful at sub-critical conditions, with the heater temperature at 200 
ȗC, instead of supercritical conditions of Û& (Li, 2008). These optimisation 
measures meant the need for an extra pump was eliminated, and a more 
energy-efficient synthesis temperature could be adopted. These preliminary 
experiments also found that the synthesis parameters could be tuned to produce 
three different morphologies of HA ± sheets, rods and tubes (Li, 2008). 
 
 Chapter Aims 3.1.5
 
Subsequent to the results obtained by other researchers in the group (Li, 
2008), this current work set out to explore the effect of each experimental 
parameter on the morphology and crystallinity of the resulting product, in order 
to shed light on the formation mechanism of the different morphologies. As 
mentioned previously in Section 3.1.3, the incorporation of cations and drugs 
into HA is desirable. Because the continuous hydrothermal method employed in 
WKLVSURMHFWLVD³ERWWRP-XS´DSSURDFKWKHZRUNUHSRUWHGLQWKLV&KDSWHUDLPHG
to demonstrate the synthesis of HA composites (containing drugs or dopants), 
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and to assess the effect these nanomaterials have on mouse embryonic stem 
cells (Lester et al., 2013). 
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3.2 Methodology 
 
 Synthesis of HA 3.2.1
 
The fundamental experimental conditions for the synthesis of 
hydroxyapatite were taken froP 6HFWLRQ  RI /L¶V 7hesis (Li, 2008). The 
production of HA sheets or platelets was described, and so the protocol was 
replicated and is reported in Section 3.2.1.1. 
 
The precursors used were ammonium phosphate dibasic, (NH4)2HPO4 (ш98% 
purity, Sigma Aldrich, UK); calcium nitrate tetrahydrate, Ca(NO3)2.4H2O (ш99% 
purity, Sigma Aldrich, UK); ammonium hydroxide, NH4OH (35%, Fisher 
Scientific, UK); sodium hydroxide, NaOH (ш97%, Sigma Aldrich, UK); zinc nitrate 
hexahydrate, Zn(NO3)2 · 6H2O (98%, Sigma Aldrich, UK); simvastatin, C25H38O5 
 6LJPD $OGULFK 8. DQG GHLRQLVHG ', ZDWHU All reagents were used 
without further purification. 
 
 Synthesis of HA Platelets 3.2.1.1
 
An aqueous solution containing 0.015 M (NH4)2HPO4 was pumped at a 
rate of 20 ml/min through a preheater, and into the counter-current Nozzle 
reactor as a downflow. Simultaneously, aqueous Ca(NO3)2.4H2O at a 
concentration of 0.05 M was used as the upflow and pumped at a rate of 10 
ml/min to meet the downflow. The temperatures at different points in the 
system are outlined in Table 3.1, where the thermocouple positions were stated 
in Chapter 1, Section 1.7.2.1. The system pressure was maintained at 240 bar 
by the BPR. Images demonstrating the experimental setup are shown in Figure 
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3.1 while Table 3.1 shows the measured temperatures at different points within 
the system during HA synthesis. 
 
The product appeared as a white aqueous mixture, where the white particles 
settled over time. This sample will be referred to as HA-1. 
 
 
 
Figure 3.1 Images illustrating the continuous hydrothermal reactor 
system. The reactor section is highlighted in (b), showing the 
superheated aqueous (NH4)2HPO4 (red) solution mixing with the 
ambient Ca(NO3)2.4H2O (yellow) to form particles at the interface (c). 
 
Table 3.1. Reactor system temperatures for synthesis of HA-1 
Water Heater 
Set Point (°C) 
After Heater 
(°C) 
Post Mixing 
Point (°C) 
Capping Point 
(°C) 
Post Cooler 
(°C) 
220 215 116 52 23 
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Other experiments conducted for the synthesis of HA were based on the above 
protocol, with slight deviations. With this reactor system and the experimental 
setup, several different parameters can be changed ± including precursor type, 
precursor concentration and ratios, precursor pH, flow rates and ratios, 
temperature, pressure, reaction solvent, and the addition of dopants or capping 
agents. To investigate the effect each of these parameters has on the product 
(be it particle size, morphology, crystallinity, stability and/or functional 
properties) would lead to a massive matrix of experiments and would be too 
time consuming for the scope of this work. Thus, a limited set of parameters 
have been selected for experimental investigation, based on previous work in the 
group. These being precursor concentration and ratios, precursor pH, 
temperature, and the addition of dopants and are described in Sections 3.2.1.2 
to Section 3.2.1.5. 
 
 Investigating the Effect of Precursor pH 3.2.1.2
 
Synthesis of HA with rod morphology was described previously by Dr Li.  
This involved the same reaction conditions as mentioned in Section 3.1.6.1., but 
with one difference ± the pH of the downflow (NH4)2HPO4 solution was increased 
to 10 (compared to an as-prepared pH of 8). This was achieved by the dropwise 
addition of NH4OH, whilst being monitored by a pH meter (Hanna Instruments). 
All other reaction parameters remained unchanged. By eye, the product in this 
scenario looked the same as sample HA-1 ± with the white particles settling over 
time. This sample shall be referred to as HA-2. 
 
To determine if morphology changes are solely caused by pH alterations to the 
downflow solution, or if the same product is yielded from upflow precursor 
changes, a sample was produced using as-prepared (NH4)2HPO4 in the downflow 
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(at pH 8), and Ca(NO3)2.4H2O with pH increased to 10 (compared to its 
unaltered pH of 5), using NH4OH. The product was labelled as HA-3. 
 
To establish whether rod formation is base-specific (i.e. if rods are only formed 
when NH4OH is used as a pH buffer), or more generally pH-specific (i.e. if any 
base can be used to alter the pH of the downflow and still result in this 
morphology being produced), experiments were conducted using NaOH as a 
buffer to increase downflow solution pH. To do this, a 1 M solution of NaOH was 
prepared using solid pellets (4g NaOH in 100 ml deionised water) and added 
dropwise to the (NH4)2HPO4 solution whilst the pH was constantly being 
monitored. 
 
The precursors were pumped into the system at the flow rates stated in Section 
3.1.6.1, with the preheater set point ranging between 200 and 45Û&DWÛ&
increments, giving rise to samples HA-4a, 4b, 4c, 4d, 4e and 4f.  Table 3.2 
presents the thermocouple measured temperatures at the points in the system. 
A summary of experimental parameters for each sample is given in Table 3.3. 
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Table 3.2. System temperatures during synthesis of HA-4 sample 
Sample 
Water 
Heater 
Set Point 
(°C) 
After 
Heater 
(°C) 
Post 
Mixing 
Point (°C) 
Capping 
Point (°C) 
Post 
Cooler 
(°C) 
HA-4a 215 210 115 51 21 
HA-4b 265 261 179 106 28 
HA-4c 315 314 218 124 30 
HA-4d 365 365 266 144 31 
HA-4e 410 405 362 178 35 
HA-4f 455 453 378 202 35 
 
Following on from the work previously conducted in the group, experiments were 
performed using the precursors and flow rates as described for synthesis of HA-2 
(i.e. downflow solution had been adjusted to pH 10 with NH4OH), but using a 
higher preheater temperature of 350 ȗC, to give sample HA-5. This temperature 
was chosen because it was established that using reaction temperatures near the 
supercritical point of water yielded novel and interesting morphologies ± 
specifically nanotubes (Li, 2008). Nevertheless, little work had been done to 
explore the factors governing the formation of this morphology, and so this work 
aims to test the reproducibility of those findings, and to elucidate the formation 
mechanism. 
 
To investigate if these tube structures are reliant on pH alterations in a specific 
precursor feed, the upflow (Ca(NO3)2.4H2O) had NH4OH added to it until a pH of 
10 was reached. The experimental temperature was held at 350 °C, consistent 
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with experiment HA-5 where tube structures were produced. This yielded sample 
HA-6. 
 
With the goal of identifying how morphology is affected when the pH of both 
precursors are as-prepared (as for HA-1) but reaction temperature is increased 
to 350 °C (as for tube synthesis), the sample HA-7 was produced. Table 3.3 
gives a summary of experimental parameters used for the synthesis of samples. 
 
 Investigating the Effect of Precursor Concentration 3.2.1.3
 
There are several questions surrounding the effect of precursor 
concentration on the manufactured product:  
 
1. What are the limits of reaction conversion? 
2. Will HA remain the principle species produced when concentrations are 
increased? 
3. How will particle size be affected, as the dynamic of particle nucleation 
versus particle growth changes? 
4. In terms of reactor design, what are the limitations of the reactor 
system?  
 
The latter point exists because the reactor system is composed of several 
constricted pipes and a BPR, all of which can become blocked if there are simply 
too many particles which are coagulating. To address these questions, a range of 
experiments were conducted where precursor concentrations were changed from 
those specified in Section 3.2.1.1. 
 
In the first experiment, the stoichiometric ratio of Ca:P was retained at 1.67, but 
reactant concentrations were doubled from the protocol described for HA-1; 
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namely 0.03 M (NH4)2HPO4 and 0.1 M Ca(NO3)2.4H2O solutions were used. Here, 
all other parameters were unchanged ± giving rise to sample HA-8. 
Similarly for the second experiment, reactant concentrations were increased 
five-fold from the protocol for HA-1, using 0.075 M (NH4)2HPO4 and 0.25 M 
Ca(NO3)2.4H2O solutions. This resulted in the synthesis of sample HA-9. 
 
Subsequent to this, a question exists: what morphological effect is observed if 
the pH of the downflow was increased to 10 at these increased concentrations? 
To solve this, the precursor concentrations described for HA-9 were used, while 
the downflow pH was adjusted to 10 using NH4OH - yielding sample HA-10. This 
leads to another question ± what happens to product morphology if, at these 
increased concentrations, the downflow pH is adjust using NH4OH and the 
system temperature is increased to 350 °C? These parameters were hence 
employed in the synthesis of sample HA-11. 
 
Finally, to address a change in ratios of precursor concentrations, the Ca:P ratio 
was changed from the stoichiometric to 2. This ratio was chosen, not only 
because it is a simple ratio, but with a secondary motive of producing 
tetracalcium phosphate (TTCP).  With a formula of Ca4(PO4)2O, TTCP has been 
shown to  improve resorption  of bone scaffolds and cements (the process 
whereby a scaffold is broken down by osteoclasts to release minerals for the 
formation of new bone), making it more beneficial to the patient in the long term 
(Moseke and Gbureck, 2010). 
 
For this experiment, reactant solutions were prepared as 0.0125 M (NH4)2HPO4 
in the downflow, and 0.05 M Ca(NO3)2.4H2O in the upflow. Precursor pH, flow 
rates, system temperatures and pressure were maintained as for HA-1. The 
yielded sample was called HA-12. 
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The HA samples described in this Section, and their corresponding reaction 
conditions, are summarised in Table 3.3. All samples were white in colour and 
the particles settled over time. SEM and XRD analysis was conducted for each 
sample. 
 
 Incorporation of Simvastatin into HA 3.2.1.4
 
As described in Section 3.1.4.5, an aim of this sub-project is to produce 
HA nanocomposites containing drugs or cations which will enhance its properties. 
 
Also stated previously in Section 3.1.4.5, statins are a group of drugs which, 
although primarily used to tackle high blood pressure, have been shown to 
exhibit secondary osteogenic effects. In the literature, simvastatin is described 
as an example of such a statin (Griffiths and Cartmell, 2007). For this reason, 
and because a supply of this drug can be readily obtained commercially, 
simvastatin was chosen as a drug candidate for incorporation into HA. It is 
important to note that the chemical structure of simvastatin (depicted in Figure 
3.2.) can degrade under high temperature or high pH (Park, 2009) ± therefore, 
it will be used in the manufacture of HA platelets (HA-1), rather than other 
morphologies. 
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Figure 3.2. Chemical structure of (a) Simvastatin in its inactive lactone 
form, and (b) Simvastatin in its active hydroxyl acid form. 
 
The simvastatin was activated using the procedure and concentrations described 
by Griffiths and Cartmell (2007), transforming it from its inactive lactone form 
(Figure 3.2. (a)) to its active hydroxyl acid form (Figure 3.2. (b)). Following this, 
a 5 µM solution of the statin was added to a prepared solution of Ca(NO3)2.4H2O 
and the experiment was conducted as described for sample HA-1 in Section 
3.2.1.1. The sample was called HA-SIM. 
 
 Incorporation of Zinc into HA 3.2.1.5
 
Of the potential cations to be used as a dopant, zinc was chosen due to 
its availability, its low cost and because it has previously been reported as a 
dopant into HA by other research groups (Webster et al., 2004, De Lima et al., 
2010, 6WDQLüHWDO). For this synthesis, a 0.05 M Ca(NO3)2.4H2O solution 
containing 0.0046 mol Zn(NO3)2. 6H2O (equivalent to 15 
w/w% Zn) was prepared 
and the experiment carried out as described for HA-1 in Section 3.2.1.1.  The 
sample will be referred to as HA-Zn. 
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All the aforementioned samples were white products, where particles flocculated 
and settled to the bottom of the vessel. By eye, all the products looked the 
same. A summary of the reaction conditions for each sample is shown in Table 
3.3. 
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Table 3.3. A summary of experimental details for synthesis of various HA samples. 
 
Sample 
(NH4)2HPO4  
Concentration 
(NH4)2HPO4  
pH 
Ca(NO3)2.4H2O  
Concentration 
Ca(NO3)2.4H2O  
pH 
Reagent for 
pH alteration 
Reaction 
7HPSÛ& 
Particle 
Morphology 
Approximate Particle Size 
HA-1 0.015 M 8 0.05 M 5 - 200 Sheet <2 µm width <80 nm thick 
HA-2 0.015 M 10 0.05 M 5 NH4OH 200 Rod Diameter: 30±40 nm 
HA-3 0.015 M 8 0.05 M 10 NH4OH 200 Sheet/rod Diameter: ~80 nm 
HA-4a 0.015 M 10 0.05 M 5 NaOH 200 Rod Diameter: 20 nm 
HA-4b 0.015 M 10 0.05 M 5 NaOH 250 Rod Diameter: 20-70 nm 
HA-4c 0.015 M 10 0.05 M 5 NaOH 300 Rod Diameter: 25 - 140 nm 
HA-4d 0.015 M 10 0.05 M 5 NaOH 350 Rod Diameter: 30 - 120 nm 
HA-4e 0.015 M 10 0.05 M 5 NaOH 400 
Low aspect 
Ratio Rods 
Diameter: <25 nm 
Length: < 110 nm 
HA-4f 0.015 M 10 0.05 M 5 NaOH 450 
Low aspect 
Ratio Rods 
Diameter: <20 nm 
Length: <100 nm 
HA-5 0.015 M 10 0.05 M 5 NH4OH 350 Tubes 
Outer Diameter: <0.5 µm 
Inner Diameter: 30-70 nm 
HA-6 0.015 M 8 0.05 M 10 NH4OH 350 Rod/tube 
Outer diameter: 100-300 
nm 
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HA-7 0.015 M 8 0.05 M 5 - 350 Sheet/Rod Diameter: 80±300 nm 
HA-8 0.03 M 8 0.1 M 5 - 200 Sheet 
<2 µm width <100 nm 
thick 
HA-9 0.075 M 8 0.25 M 5 - 200 Sheet/rod Diameter: <100 nm 
HA-10 0.075 M 10 0.25 M 5 NH4OH 200 Sheet 
<2 µm width <100 nm 
thick 
HA-11 0.075 M 10 0.25 M 5 NH4OH 350 Sheet/rod Diameter: 30-40 nm 
HA-12 0.0125 M 8 0.05 M 5 - 200 Sheet 
<2 µm width <100 nm 
thick 
HA-SIMa 0.015 M 8 0.05 M 5 - 200 Sheet 
<2 µm width <100 nm 
thick 
HA-Znb 0.015 M 8 0.05 M 5 - 200 Sheet 
<2 µm width <100 nm 
thick 
 
a5 µmol of activated Simvastatin was added to the Ca(NO3)2.4H2O solution prior to synthesis. 
b15 w/w% Zn(NO3)2.6H2O was added to the Ca(NO3)2.4H2O solution prior to synthesis. 
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 Characterisation Methods 3.2.2
 
All samples were washed by centrifuging, decanting the supernatant and 
re-suspending in deionised water. They were subsequently freeze dried for 
further characterisation, namely SEM and XRD. Where required, HRTEM was also 
utilised. Particle size analysis was performed using Digital Micrograph software 
(from Gatan Inc., USA). To assess the presence of simvastatin in HA-SIM, ToF-
SIMS was used. 
 
 Material Application Methods 3.2.3
 
An important part of the validation work for this new approach to nano-
HA manufacture has been cell proliferation assays. This is to demonstrate that 
HA produced in this reactor system exhibits no cytotoxic effects on mouse 
embryonic stem cells (mESC). This cell type is regularly used for such 
cytotoxicity studies. Additionally, bone nodule assays were conducted to 
highlight that HA synthesised in this work can promote stem cell differentiation 
into an osteoblast lineage. 
 
 Cell Proliferation Assay 3.2.3.1
 
These assays were used to ascertain if HA produced in the continuous 
hydrothermal reactor system exhibit a cytotoxic effect, rather than determine 
cell response to every sample. Therefore, only nanoparticles from sample HA-1, 
HA-SIM and HA-Zn were used for this study. The samples were firstly sterilised 
by exposure to UV light. The mESC were maintained in either standard culture 
media or osteoJHQLFFXOWXUHPHGLDDWÛC, 5% CO2 at 85% relative humidity. 
Standard culture media contained DMEM growth media, supplemented with 10% 
Fetal Bovine Serum (FBS), 1% Penicillin/Streptomycin 100x solution, 1% L-
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Glutamine and 100 µM 2-Mercaptoethanol. Osteogenic media contained standard 
culture media and additional supplements (0.284 mM L-DVFRUELFDFLGP0ǃ-
glycerophosphate) which guide stem cells towards differentiation into an 
osteoblast lineage. 
 
A 96 well plate was seeded with mESCs (7000 cells/well) and exposed to 
nanoparticles at one of three different concentrations (1, 10 or 100 µg/ml). A 
control sample was kept with no nanoparticles added.  Cell proliferation was 
monitored after 1, 3 and 6 days of culture using a 96® AQueous One Solution 
Cell Proliferation Assay (Promega, USA).  The assay principle is based on the 
MTS tetrazolium compound being bioreduced into a coloured formazan product 
that is soluble in culture media. This conversion is accomplished by NADPH or 
NADH produced by dehydrogenase enzymes in metabolic active cells. 
 
 Bone Nodule Assay 3.2.3.2
 
To study osteogenic differentiation and bone mineralisation, cells were 
cultured in 12 well plates (100,000 cells/well) for 21 days in the presence of 
nanoparticles at one of three concentrations (1, 10 and 100 µg/ml), as well as a 
control. After this time, cells were fixed in 10% formal saline solution for 20 
minutes followed by a histological staining with 1% Alizarin red solution for 5 
minutes. The cells were washed three times with deionised water to reduce the 
background intensity. Clusters which appeared stained with a red-brown colour 
were indicative of mineralised nodules. 
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3.3 Results and Discussion 
 
 HA Platelets (HA-1) and Rods (HA-2) 3.3.1
 
The synthesis of HA-1 and HA-2 were primarily to act as confirmatory 
work on the previously described results within the group. Indeed platelet 
morphology was observed in HA-1, as shown from the SEM and TEM images in 
Figure 3.3. The particles have widths and lengths measuring up to 2 µm while 
the thickness of the platelets is <80 nm.  
 
 
 
Figure 3.3. (a) SEM and (b) TEM images of particles in sample HA-1. 
 
XRD analysis performed on this sample showed that the only crystalline phase 
present was hexagonal hydroxyapatite, matching to ICCD PDF 74-566 (Figure 
3.10). While the peaks match to the expected pattern, they are not sharp; this 
may indicate that the material has low crystallinity, assuming the particle size is 
large (See Chapter 2, Section 2.4 for reasoning). 
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The SEM and TEM images in Figure 3.4 show the nanorod morphology identified 
in HA-2, again confirming the results previously seen in the group. These 
particles have diameters between 30 and 40 nm and lengths measuring up to 1 
µm, and demonstrate that by merely altering the pH of one of the precursors, a 
different product morphology is observed. The XRD pattern for HA-2 is displayed 
in Figure 3.10 and also matches to the expected pattern for hexagonal HA. The 
peaks are sharper that those seen for HA-1, suggesting that the particles in HA-2 
are more crystalline. These data show that as well as changing particle 
morphology, the pH (or indeed the addition of NH4OH itself) is leading to the 
formation of a more crystalline product ± a process which has been described 
before for HA synthesis. Several methods of HA synthesis use NH4OH to increase 
the reaction pH above 9 in order to drive HA formation (Zhang et al., 2009a, Li 
et al., 2007). This is because acidic by-products are usually produced during HA 
synthesis; the acid can degrade the HA, and compromise the crystallinity. In this 
case, a by-product of the synthesis is nitric acid, HNO3, because of the use of 
Ca(NO3)2 as a precursor. Without any post-synthesis washing of HA-1, the HNO3 
is likely to decompose the HA. For HA-2 however, the addition of NH4OH 
neutralises the acid formed, which may lead to higher crystallinity. It is 
important to note that it is apparent NH4OH is also playing a role in the 
mechanism of synthesis, leading to this change in morphology. 
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Figure 3.4. (a) SEM image and (b) TEM image of particles in HA-2. 
 
 The Effect of Precursor pH 3.3.2
 
It was found that the pH of either precursor solution can be increased to 
yield nanorods, not just the downflow (NH4)2HPO4. Figure 3.5 shows that some 
rod shaped particles resulted when the Ca(NO3)2 precursor solution was adjusted 
to pH 10. However, there was still evidence of some platelet-type particles being 
produced, and the rods appear less well defined compared to those in sample 
HA-2. The rods in HA-3 were apparently larger than in HA-2 as well, with 
diameters in the region of 80 nm. 
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Figure 3.5. SEM image of HA-3. 
 
Samples HA-4a to 4f were produced using NaOH as a pH buffer, as opposed to 
NH4OH, over a range of reaction temperatures. This was to investigate if 
morphology changes were dependent on pH alone, or were base-specific. The 
TEM image in Figure 3.6 (a) shows the presence of rod shaped particles in HA-4a 
(reaction temperature ~200 °C); from this it can be inferred that rod 
morphology is a result of pH changes, but is not reliant on NH4OH being used. 
Nevertheless, the size of the particles is not identical to those in HA-2. The rods 
in HA-4a have diameters measuring ~20 nm ± smaller than those seen in HA-2. 
The XRD data for HA-4a (shown in Figure 3.10) confirms that HA is the only 
crystalline phase present, but the peaks are not as sharp compared to HA-2. 
 
Samples HA-4b to 4f use the same precursors as HA-4a, but reflect increases in 
reaction temperature. The TEM images in Figure 3.6 indicate that reaction 
temperature does affect particle size and morphology. It can be observed that 
with increases in temperature up to 350 °C (HA-4b to 4d), the particle diameter 
Chapter 3. Hydroxyapatite 
104 
 
also increases; in HA-4b (reaction temperature ~250 °C) rod diameters measure 
between 20 and 80 nm, in HA-4c (reaction temperature ~300 °C) these are 25-
140 nm, and in HA-4d (reaction temperature ~350 °C), these are 30-140 nm. In 
the latter two samples, some particles may even be classed as having platelet 
morphology rather than rod. It is possible that this trend is due to the increased 
thermal energy causing growth of the existing particles, rather than nucleation of 
new ones. 
 
Interestingly at even higher reaction temperatures, as is the case with HA-4e 
(reaction temperature ~400 °C) and 4f (reaction temperature ~450 °C), the 
particles appear to be smaller than in the aforementioned samples, and the 
morphology can be described as low-aspect ratio rods. In HA-4e, the rods have 
diameters up to 25 nm and lengths up to 110 nm ± aspect ratios between 3.69 
and 6.22. In HA-4f, the diameters typically observed are no more than 20 nm, 
and lengths measure up to 100 nm ± giving aspect ratios ca. 5.3. This is 
compared to the much higher aspect ratio rods seen in HA-4a (aspect ratio ca. 
16.9), HA-4b (ca. 10.9), HA-4c (ca. 10.1), and HA-4d (ca. 9.1). This decrease in 
aspect ratio with increasing reaction temperature relates to the increase in 
particle diameters mentioned previously. XRD patterns were only obtained for 
samples HA-4a and HA-4d; these should be representative of the sample series, 
confirming that HA is the sole crystalline phase, rather than looking at specific 
changes to crystal structure between the samples. Moreover, HA-4d was chosen 
for XRD analysis as a comparison to sample HA-5 because a reaction 
temperature of 350 °C is common to both samples. 
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Figure 3.6. HRTEM images of (a) HA-4a; (b) HA-4b; (c) HA-4c; (d) HA-
4d; (e) HA-4e; and (f) HA-4f. 
 
HA-5 is a very interesting sample; collected SEM images (shown in Figure 3.7 
(D ILUVWO\ VKRZHG µRSHQ-HQGHG¶ URGV 8VLQJ +57(0 DQG GDUNILHOG LPDJLQJ
these particles were shown to have a tube morphology (Figure 3.7 (b) and (c)). 
In these micrographs, the thicker walls are shown darker than the hollow centre 
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(or brighter in the case of darkfield imaging). This morphology has, to date, not 
been previously reported ± making it a significant finding. 
 
 
 
Figure 3.7D6(0LPDJHRIµRSHQ-HQGHGURGV¶EGDUNILHOGLPDJLQJLQ
TEM and (c) TEM image show tube structures while (d) is an SEM image 
showing a tube in the middle of the rolling process (highlighted with a 
red arrow). 
 
There are several potential applications for nanotubes of HA, which could result 
from the ability to fill the tubes with drugs or other nanomaterials. For example, 
these tubes could act as slow-release drug carriers in bone scaffolds or other 
drug delivery systems (Yang et al., 2012b, Netz et al., 2001). To begin this sort 
of research, it is important to understand the formation mechanism of these 
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particles.  Examining the morphology; in Figure 3.7 (c), the tube looks darker in 
the centre, suggesting that it is not completely hollow. By considering that TEM 
essentially shows a projection of an image, it is entirely feasible that the tube 
has formed from the scrolling of a sheet (Figure 3.8), to yield the image in 
Figure 3.7 (c). To reinforce this notion, Figure 3.7 (d) is an SEM image 
apparently showing a particle in the middle of the scrolling process. The TEM 
images obtained for HA-5 showed these tubes to have an inner diameter or pore 
size between 30 and 70 nm, while the outer diameter ranged up to 0.5 µm. 
Therefore, by crude estimation, a sheet or platelet particle with a width of 600 
nm would roll up with 3-4 layers to give a 50 nm pore. Some initial N2 
adsorption data was collected for HA-5, but proved inconclusive. This may be 
due to the scrolls opening up during the measurement as a result of changes to 
the surface charge (Lester et al., 2013). 
 
As discussed previously, only rod structures, not tubes, are seen in HA-4d, when 
NaOH is used as a pH buffer, demonstrating that unlike rod formation, the 
synthesis of HA tubes is base-dependent. 
 
 
 
Figure 3.8. Images illustrating the scrolling of a sheet, so that the 
corners meet. 
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It was found that by adjusting the pH of the upflow precursor rather than the 
downflow, while keeping the reaction temperature at 350 °C (as is the case for 
HA-6), tube structures are again synthesised. The SEM image in Figure 3.9 (a) 
illustrates this. The inner and outer diameters of the particles are not 
significantly different from those seen in HA-5; however, the particles appear to 
be less well-formed with jagged edges apparent. As a result, it can be said that 
addition of NH4OH to the downflow is more effective for the synthesis of tubes, 
than in the upflow. 
 
Sample HA-7 was shown to contain a mixture of rods and high aspect ratio 
platelets, as displayed in Figure 3.9 (b). In this case, the precursors had not 
been treated with any pH alterations, and underwent a reaction temperature of 
350 °C. The particles appear to have diameters between 80 and 300 nm, and 
variable lengths up to a few hundred nanometers. One possible reason for seeing 
these particles with higher aspect ratios is that the higher reaction temperature 
causes the fragmentation of sheet particles (evident from sample HA-1) into rods 
and smaller platelets. However, the XRD data in Figure 3.10 show that HA-7 
produced more intense peaks than HA-1, indicating a higher level of crystallinity 
with increased reaction temperature. As such, it is more likely that the difference 
lies in the formation of particles, i.e. these rods and platelets are formed via a 
different mechanism, in which growth to larger sheets is inhibited, rather than 
fragmentation.  
 
 
 
 
 
 
 
Chapter 3. Hydroxyapatite 
109 
 
 
 
Figure 3.9. SEM images of (a) HA-6, and (b) HA-7. 
 
 
 
 
Figure 3.10. XRD patterns for samples HA-1 to HA-7.  The expected peak 
pattern for hexagonal hydroxyapatite (ICCD PDF 74-566) is shown at 
the bottom. 
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 The Effect of Precursor Concentration 3.3.3
 
Now focussing on the effects of modifying precursor concentration; 
sample HA-8 was the result of doubling precursor concentrations from those 
used for HA-1 (i.e. using 0.03 M (NH4)2HPO4 and 0.1 M Ca(NO3)2). The principle 
test was to determine if HA remains the sole crystalline phase obtained. The XRD 
pattern shown in Figure 3.13 indicates that it is. Nevertheless, the pattern does 
not show sharp peaks, so it can be inferred that, like HA-1, the material is not 
very crystalline (if particle size is large). This corresponds with the reasons 
highlighted earlier in the discussion for HA-1. The obtained SEM images (seen in 
Figure 3.11 (a)) present particles with a very similar morphology and size as 
those in HA-1. Again, these sheets have lengths and widths up to 2 µm, and 
thickness of less than 100 nm. 
 
However, it was found that when the precursor concentration is increased 
fivefold that of HA-1, HA is no longer the sole crystalline phase produced. The 
XRD pattern contains sharp peaks which correspond to monoclinic brushite, 
CaHPO4.2H2O (ICCD PDF 9-77) and some peaks which can be assigned to 
monetite, CaHPO4. These minerals are sometimes used as precursors for apatite 
formation (Monma and Kamiya, 1987) suggesting that these may be 
³LQWHUPHGLDWHV´ LQ WKH UHDFWLRQ SDWKZD\ WR +$ IRUPDWLRQ GXULQJ K\GURWKHUPDO
synthesis. The particles in this sample are a mixture of sheets and rods, the 
latter with diameters less than 100 nm. The morphology differences in this 
sample cannot be fairly compared to HA-1 and HA-2 because of the different 
phases that are present in the sample and it is difficult to distinguish between 
the two phases using SEM and TEM analysis. 
 
,QWHUHVWLQJO\ LW ZDV IRXQG WKDW E\ XVLQJ ILYH WLPHV WKH ³VWDQGDUG´ SUHFXUVRU
concentration, increasing the downflow pH to 10 using NH4OH, and a reaction 
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temperature of 200 °C (as is the case for HA-10), the sole crystalline phase is 
once again HA.  As Figure 3.13 shows, peaks for brushite or monetite are no 
longer evident.  Furthermore, the SEM image displayed in Figure 3.11 (c) shows 
the sheet like particles present in HA-10 which look very similar to the particles 
in HA-1. In addition, pumping these same precursors at a higher temperature of 
350 °C (sample HA-11) produces rods and high aspect ratio platelets (Figure 
3.11 (d)). It can be inferred from these results that NH4OH is playing a wider 
role in the formation of these particles. This evidence indicates NH4OH directs 
the reaction towards HA formation over other calcium phosphates; it increases 
the crystallinity of the product; and the particle morphology changes. 
 
 
Figure 3.11. SEM images of (a) HA-8, (b) HA-9, (c) HA-10, (d) HA-11. 
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With the aim of synthesising TTCP, HA-12 was produced in which the precursor 
concentrations were altered from the stoichiometric ratio; instead, a Ca:P ratio 
of 2 was used. However, the XRD pattern collected for this sample (see Figure 
3.13) showed that the only crystalline phase present was HA. Additionally, it was 
found that the particles were similar to those seen in HA-1, both in morphology 
and size (as seen from the SEM image in Figure 3.12). This data suggests that 
HA is preferentially produced in the Nozzle reactor, over other calcium 
phosphates, when precursor concentrations do not significantly deviate from the 
³VWDQGDUG´ Furthermore, it shows that this method of HA synthesis is not 
sensitive to changes in the ratio of precursor concentrations, and the precise 
stoichiometric ratio does not need to be maintained to produce HA. 
 
 
 
Figure 3.12. SEM image of HA-12. 
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Figure 3.13. XRD patterns for HA-8 to HA-Zn. Patterns for HA-1 and HA-
2 are also shown for comparison. The expected peak pattern for 
hexagonal hydroxyapatite (ICCD PDF 74-566) is shown at the bottom. 
For HA-9, peaks indicated with a black square match monoclinic brushite 
(ICCD PDF 9-77) while other peaks match monetite; for HA-Zn, peaks 
labelled with black triangles correspond to monoclinic parascholzite 
(ICCD PDF 35-495). 
 
 Addition of Simvastatin 3.3.4
 
The SEM and TEM images obtained for HA-SIM (Figure 3.14) showed 
particle size and morphology similar to HA-1. Given the very low concentration of 
simvastatin added to the sample, XRD analysis was not performed in HA-SIM to 
confirm the crystalline phase of the material. Instead, the aim here was to 
assess the presence of simvastatin in the sample. Initially, Fourier-Transform 
Infra-Red (FTIR) spectroscopy was performed on HA-SIM and HA-1 and the two 
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spectra were compared. However, there was no observed difference between the 
two, so it could not be concluded that the drug was present in HA-SIM. It is 
possible the concentration of the statin was too low in the sample, and below the 
sensitivity threshold of the FTIR spectrometer, meaning that if present, the drug 
would not be detected. As a result, the sample was also analysed using ToF-
SIMS. The obtained data (Figure 3.15) showed that a fragment with a 
mass/charge value of 115.08 was present in HA-SIM, but not in HA-1 or HA-2. 
This fragment can be assigned to the molecule C6H12O2, which forms part of 
simvastatin. However, this was the only difference observed in HA-SIM ± which 
again, may be due to the low concentration of simvastatin used in the precursor. 
It should be noted that ToF-SIMS operates by bombarding the sample to create 
fragments which can then be detected; hence, it is difficult to ascertain from this 
data whether the simvastatin has been preserved during the synthesis reaction 
and is present as a whole molecule in the sample, or if the heat and pressure of 
the reaction has caused the breakdown of the drug and what is seen is actually a 
degraded portion of the statin. Ultimately, it is inconclusive whether simvastatin 
is wholly present in HA-SIM. An in vitro cell proliferation was also carried out 
using HA-SIM. The results will be discussed in Section 3.3.6. 
 
 
Figure 3.14. (a) SEM Image and (b) TEM image of HA-SIM. 
 
Chapter 3. Hydroxyapatite 
115 
 
 
Figure 3.15. ToF-SIMS Data for HA-1, HA-2 and HA-SIM. 
 
 Addition of Zinc 3.3.5
 
 HA-Zn was created with the aim of introducing zinc as a dopant into HA. 
The obtained TEM images indicated the particles had a sheet morphology, which 
was expected for the experimental parameters used. An elemental distribution 
map was also collected for the sample, during TEM analysis. The data (Figure 
3.16) confirmed that zinc was indeed present in the particles, as well as the 
expected elemental components of HA. Nevertheless, the concentration of zinc 
present appeared to be higher than that of calcium - seen from the larger 
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number of white spots in Figure 3.16 (e) than (b). This is despite only 15 w/w % 
of Zn was used compared to Ca; this indicates that Zn may be preferentially 
taken up during particle formation. Moreover, the XRD pattern of HA-Zn (shown 
in Figure 3.13 and more clearly in Figure 3.17) showed that, while peaks 
corresponding to HA were present, there were also quite a few other peaks 
detected. The majority of these were ascribed to monoclinic paracholzite, 
CaZn2(PO4)2.2H2O, a mineral first described by (Sturman et al., 1981). This 
confirms that the calcium to zinc ratio is consistent with the elemental map data. 
Since it was first reported, parascholzite has rarely been discussed in literature, 
and synthesis details of this material are hard to come by. Still, this material 
may have applications in the incorporation of zinc into bone-based materials 
(Sepulveda et al., 2000, Dasgupta et al., 2010) and the biocompatibility of HA-
Zn is an important factor.  Consequently, the in vitro cell proliferation assay 
using HA-Zn is reported in Section 3.3.6. 
 
 
 
Figure 3.16. (a) TEM image of sample HA±Zn, and an elemental 
distribution map for (b) Ca, (c) O, (d) P, and (e) Zn. 
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Figure 3.17. XRD pattern of HA-Zn; the predominant phases are 
hexagonal hydroxyapatite (ICCD PDF 74-566, shown at the bottom) and 
monoclinic parascholzite (ICCD PDF 35-495, peaks shown with blue 
triangles). Additional smaller peaks match calcium hydrogen phosphate 
(ICCD PDF 77-128). 
 
 In Vitro Cell Assays 3.3.6
 
The results from the cell proliferation assay (Figure 3.18) show that for 
the duration of the experiment, cell activity (absorbance correlates to cell 
activity) continued to increase for all three HA samples, irrespective of 
nanoparticle concentration.  After 6 days, the cells cultured in control media are 
seen to have lower cellular metabolic activity when exposed to higher 
concentrations of nanoparticles, relative to the control. It is important to note 
that these effects are likely to be due to HA exhibiting an osteogenic effect on 
the cells, directing them towards an osteogenic phenotype - typically associated 
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with a decrease in proliferation.  This is because once mESCs have differentiated 
into a cell line, they stop multiplying. In addition, these effects may be 
influenced by confluency initiated cell death (i.e. too many cells competing for 
resources) rather than the cytotoxic properties of the nanoparticles, the latter of 
which would be evident much earlier in the experiment. 
 
 
 
Figure 3.18. Results from the cell proliferation assay performed using 
three different concentrations of nanoparticles from sample HA-1 and 
sample HA-Zn, after 1, 3 and 6 days of incubation. 
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The bone nodule assay gives an indication of bone mineralisation - a distinctive 
marker of osteogenesis. The data (Figure 3.19) shows that the concentration of 
nanoparticles added to the media plays an important role in bone nodule 
formation. At higher nanoparticle concentrations, more intensive staining results 
and bone nodules can be seen. The frequency of intensely stained clusters also 
increases with higher concentrations of nanoparticles, indicating the formation of 
the extracellular matrix as cells undergo differentiation into the osteoblast 
lineage. The risk of calcium from HA being stained was minimised by excessive 
washing steps to remove residual nanoparticles prior to staining. 
 
 
 
Figure 3.19. Images from the bone nodule assay - Cells cultured in 
osteogenic media with hydroxyapatite from Sample HA-1 at various 
concentrations, (a) 100 µg/ml; (b) 10 µg/ml; (c) 1 µg/ml; (d) control 
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3.4 Conclusions 
 
 Firstly, the work in this Chapter has shown that the counter-current 
Nozzle reactor can be used to reproducibly synthesise HA with three different 
morphologies: platelets, rods and tubes. The synthesis method is also 
significantly faster than other techniques previously reported in literature. 
Results of this study suggest that in this hydrothermal system, NH4OH plays 
several roles in HA synthesis ± it directs precursors towards the formation of HA 
over other CaP minerals, promotes the formation of rods instead of sheets at 
Û&DQGWXEHVLQVWHDGRIURGVDWÛ&7KLVSURFHVVLVPRUHHIIHFWLYHZKHQ
NH4OH is added to the heated downflow, compared to the cooler upflow. 
 
In a continuous system, the process variables are linked thus making it very 
difficult to alter one parameter without affecting the others (Lester et al., 2012). 
This creates difficulty in isolating a single cause and effect, thereby making it a 
challenge to hypothesise a mechanism of formation for the different HA 
morphologies. Still, it is likely that HA sheets are the fundamental morphology of 
FKRLFHXQGHUµVWDQGDUG¶FRQGLWLRQV%\LQFUHDVLQJHLWKHUWKHUHDFWLRQWHPperature 
or pH, the synthesised particles are not only more crystalline, but given the 
observed dimensions of the particles, the sheets become fragmented into 
nanorods. However, the combination of a higher reaction temperature and the 
presence of NH4OH specifically, appear to prevent the fragmentation of sheets, 
but cause the sheets to roll up - giving nanotubes. Further work is undoubtedly 
required to understand the formation mechanism of the different morphologies 
but it is apparent that the mechanisms are linked, rather than three independent 
schemes existing.  
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Experiments were conducted to introduce zinc as a dopant and simvastatin as a 
drug, into the structure of HA. The morphology of particles synthesised with 
simvastatin did not significantly differ from normal HA particles ± again 
producing sheets. ToF-SIMS data for this sample showed the presence of a 
fragment which could be assigned to simvastatin, but it is inconclusive. This is 
likely to be due to the low concentration of statin used during synthesis. For 
future work, the concentration should be increased, although this does implicate 
higher costs. In addition, thermal analysis such as TGA (thermal gravimetric 
analysis) could provide additional data to ascertain the presence of simvastatin 
in the HA sample. 
 
The addition of a zinc salt into the synthesis protocol yielded parascholzite, 
CaZn2(PO4)2.2H2O, a material rarely described in literature but may have 
applications in bone based materials. In the scope of this work, experiments with 
only one concentration of Zn were attempted. For future work, the ratio of Ca:Zn 
can be investigated further, to determine if other calcium-zinc phosphates can 
be produced using the Nozzle reactor. 
 
Finally, cell proliferation and bone nodule assays were conducted using HA 
produced using the Nozzle reactor. Results indicate that the HA particles have no 
cytotoxic effect on mESCs and promote bone nodule formation. 
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Chapter 4 
 
4 Fluorescent Nanomaterials 
 
4.1 Introduction 
 
Following a previously reported hydrothermal method for the synthesis of 
cadmium sulphide, CdS, (Liu et al., 2001) the Nottingham research group 
established a synthesis procedure for the manufacture of CdS particles using the 
hydrothermal Nozzle reactor. Other publications using the Nozzle reactor 
included a method for synthesising nanoparticles of zirconium dioxide, ZrO2, 
doped with europium, Eu (Hobbs et al., 2009). These particles displayed 
fluorescent properties while exhibiting no cytotoxic effects on Chinese hamster 
ovary cells; thus showing potential for use in biological cell imaging. 
Consequently, the motivation in this Chapter is to explore what other fluorescent 
materials are possible.  
 
  Fundamentals of Fluorescence 4.1.1
 
Fluorescence describes the emission of light by particles, upon stimulation 
from a form of electromagnetic radiation. There are different categories of 
fluorescence depending on the source of radiation. 
 
When a molecule absorbs light photons from the UV light range (10 to 400 nm), 
it reaches an excited state with a higher energy level. Hence, this is known as 
excitation. Still, the molecule is unstable at this higher energy level and swiftly 
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emits light photons in order to return to its previous, more stable ground state. 
The emitted energy tends to be less than is absorbed by the molecule; as this 
energy is released in the form of light, the emitted light has a longer wavelength 
than the light that is absorbed (Geszke-Moritz and Moritz, 2013). Molecules 
which exhibit this behaviour are defined as photoluminescent (PL). Typically, PL 
particles emit light within the visible light range (400 to 700 nm); these are 
useful as they can be seen by the human eye without the need for additional 
detection apparatus. Nevertheless, there are particles which have been tuned to 
emit light in the infra-red (>700 nm) range (Hu et al., 2011, Xue et al., 2012, 
Poole et al., 2009).  
 
Rather than reaching an excited state through light energy, particles stimulated 
by an electrical current are electroluminescent (EL), by a chemical reaction are 
chemiluminescent (CL), by sound are sonoluminescent and by a mechanical 
action are mechanoluminescent (ML) (Ronda, 2008).  While electroluminescence 
will be briefly mentioned in subsequent Sections of this Chapter, 
photoluminescent properties of particles will remain the primary focus. 
 
  Quantum Dots 4.1.2
 
Quantum dots (QD) are a subset of fluorescent materials which are 
typically 1 to 20 nm in size (Geszke-Moritz and Moritz, 2013). They can be 
defined as crystalline semiconductor nanoparticles made up of elements from 
transition metals and group VI of the periodic table, such as CdSe or ZnS, or 
groups III and V, such as  InP (Byers and Hitchman, 2011). QDs have gained 
much interest because of the potential to tune the PL properties through size 
manipulation. It has been reported that the relative brightness of QDs is 
dependent on the diameter of the particles and, in turn, the emission wavelength 
(Dickerson, 2005). For example, the intensity or brightness of QDs emitting at 
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525 nm (green) was 17 times lower than QDs emitting at 655 nm (red) (Xing et 
al., 2007). 
 
Commonly reported QDs are comprised of a heavy metal core, usually cadmium 
sulphide (CdS) or cadmium selenide (CdSe), with a zinc sulphide (ZnS) shell to 
increase quantum yield (brightness) and avoid oxidation, as well as prevent Cd 
from leaching out (Byers and Hitchman, 2011). Polymer coatings and 
biomolecules can be attached to the surface to improve particle stability or 
solubility, increase biocompatibility, or target specific sites in a biological system 
(Jamieson et al., 2007). Section 4.1.3.4 will discuss biological applications of 
QDs in further detail. Figure 4.1 illustrates the structure of one example of a QD. 
 
 
 
Figure 4.1. Illustration of a typical QD structure; a CdSe core is 
surrounded by a ZnS shell and functionalised with siloxane and 
methylmethacrylate (MMA) (Park et al., 2010). 
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  Applications using Quantum Dots 4.1.3
 
Nanoparticles with fluorescent properties, particularly QDs, are of great 
interest because they can be applied in a wide range of fields - from electronics 
to medicine. Some of these applications will be briefly explained in this Section. 
 
  Electronic Devices 4.1.3.1
 
As QDs are semi-conductors, they are often reported for use as 
components in electronic devices. For example, SiO2 QDs have been applied for 
memory storage devices (Corso et al., 2003), while PbS QDs have been used in 
fibre-optics amplifiers (Heo and Liu, 2007). Meanwhile, particles with EL 
properties have also found uses in this field. For example, ZnS±based QDs have 
been described in the field of printed electronics (Wood et al., 2009); in this 
study, an inkjet printer was used to deposit nanoparticles in a structured pattern 
onto substrates for use in display panels. Furthermore, InP/ZnS composite QDs 
have reportedly been used in light emitting diodes (LEDs) (Kim et al., 2012), 
while Poole et al. described the use of InAs/InP QDs in lasers (Poole et al., 
2009). 
 
  Solar Panels 4.1.3.2
 
Increasing population and technological advances have resulted in a rise 
in the global demand of energy. Conversely, a limited supply of fossil fuels (coal, 
oil, natural gas) has meant sharp increases in energy prices. Twinned with the 
emission of greenhouse gases from burning fossil fuels, there has been a 
growing need to focus efforts in developing other more sustainable and 
renewable energy sources - including wind, bio-fuels, geothermal and solar cells. 
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The latter has generated a lot of interest as the Earth receives over 120 PW 
(petawatts) of energy from the Sun each day (Tsakalakos, 2008). As such, many 
researchers have developed various materials, including QDs, to capture solar 
energy. Much of the initial work in this area was conducted on silicon, but the 
need for more efficient materials lead to advances with other elements, namely 
Gallium based QDs (Tsakalakos, 2008) and CdS QDs (Santra and Kamat, 2012) 
being used. 
 
  Anti-Counterfeiting 4.1.3.3
 
QDs and other fluorescent materials have been considered for anti-
counterfeiting purposes (Zhang and Ge, 2011), where genuine articles are 
marked with the fluorescent particles and are invisible to the naked eye. Only 
upon excitation with light of a particular wavelength can the distinctive mark be 
seen, thereby distinguishing fraudulent copies from the real article. 
 
  Biological Applications 4.1.3.4
 
In 1998, researchers first began to explore using QDs in the field of bio-
imaging (Bruchez Jr et al., 1998, Chan and Nie, 1998). In this ground-breaking 
study, proteins in mice were attached to, or labelled with, water-dispersible 
fluorescent QDs which enabled them to be detected for the purpose of medical 
diagnostics. The semiconductor QDs proved to be significantly more effective 
than traditional organic dyes. Since then QDs have been widely used for a whole 
host of biological applications. In cell biology, QDs have been used for labelling 
and tracking cells (Jamieson et al., 2007, Byers and Hitchman, 2011). The 
nanoparticles can be conjugated to antibodies which target specific proteins in a 
cell. Once attached to the protein, its path can be tracked and imaged. This 
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process is particularly pertinent in the labelling of proteins specific to cancerous 
cells, potentially allowing the prediction of cancer onset. 
 
Furthermore, ZnO QDs have been described as antimicrobial agents (Jin et al., 
2009), while CdTe QDs were functionalised to bind to specific strands of DNA for 
the detection of leukaemia (Sharma et al., 2012), and QDs have been 
conjugated to antibodies for the detection of microorganisms in water sources 
(Zhu et al., 2004). Other studies using functionalised QDs in the detection of 
pathogens and toxins have also been conducted (Jamieson et al., 2007). In 
terms of live in vivo imaging, studied subjects tend to be mice where cells have 
been labelled to study embryogenesis, stem cell therapy and cancer metastasis 
(Byers and Hitchman, 2011). Each of these applications depends on the right 
biomarker or probe being chosen and attached to the QD, which can then bind to 
the relevant site. As such, the QD itself is very versatile. 
 
  Synthesis of Quantum Dots 4.1.4
 
As described in Section 4.1.2, the fluorescent properties of QDs are 
affected by their particle size. Furthermore, fluorescent properties can be 
optimised if samples contain monodisperse particles with little or no 
agglomeration. Hence, the route of synthesis can play a crucial role in 
determining the structure and function of QDs. 
 
*LYHQ WKDW WKH XPEUHOOD WHUP µTXDQWXP GRW¶ FRYHUV D SOHWKRUD RI PDWHULDOV, 
various synthesis methods have been reported which are dependent on the 
chemistry of reactions. Commonly reported methods of QD preparation include 
aerosol-gel (Firmansyah et al., 2012), precipitation (Lang et al., 2011), 
photochemical (Liu et al., 2012), electrochemical (Li et al., 2013), ultrasound-
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assisted (Ren and Yan, 2012), microwave (Yang et al., 2012a), solvothermal 
(Yang et al., 2011) and batch hydrothermal (Yu et al., 2012). 
 
While these and many other described methods of QD synthesis in the literature 
yield high-quality nanoparticles, they are only capable of producing milligrams of 
material; consequently, there is little potential for scalability. Nevertheless, there 
are processes capable of producing larger quantities of QDs and companies have 
been founded on these technologies. One such example will be described in 
more detail in Section 4.1.4.1.  
 
  Commercial Synthesis of Quantum Dots 4.1.4.1
 
Nanoco Group Plc is a UK based company established in 2001, which 
produces QDs on a commercial scale (approx. 25 kg/annum). They produce both 
QDs which contain heavy metals, and those which are free of heavy metals. 
7KHLU WHFKQRORJ\ LV EDVHG RQ WKH XVH RI D ³PROHFXODU VHHG´ ZKLFK DFWV DV D
nucleation point on which nanoparticle growth can occur. This patented 
technology produces batches of QDs, up to 1 kg each batch (Nanoco, 2013). 
Because QDs can be so effective, only very small volumes of material are 
required for application ± as such, 1 kg of material is considered as commercial-
scale.  
 
Nanoco produce QDs with an array of different compounds, and for a range of 
DSSOLFDWLRQV7KHLU UDQJHRI&DGPLXP)UHH4XDQWXP'RWV &)4'KDYHEHHQ
advertised for use as electroluminescent LEDs in lighting, in electronic displays, 
and for biological applications such as drug-delivery, cell tracking and clinical 
whole-body imaging. Their more recently developed range of CIS, CGS and CIGS 
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QDs are composed of varying elemental ratios of copper, indium, gallium and 
selenium. These particles have been developed in a range of solvents which can 
then be printed onto substrates then cured as components for solar cells to 
capture light energy.  
The successes of commercial manufacturers of QDs such as Nanoco highlight the 
existing high demand for nanomaterials with PL and EL properties. 
 
  Disadvantages of Cadmium-Based Materials 4.1.5
 
The majority of QDs which are described in the literature contain Cd-
based particles, or other heavy metals such as lead, in the core. However, these 
can have highly toxic effects; in humans, Cd can accumulate in the lungs, liver 
and kidneys. As a result, essential proteins are excreted from the body while the 
metal itself is not so easily removed. The consequences are very serious, and 
even fatal. 
 
Meanwhile, there has been much debate over the safety of using QDs containing 
heavy metals in biological applications, as the toxic cores tend to be coated with 
a several layers which prevent the heavy metal leaching out. Although much 
research has gone into the use of QDs for in vitro and in vivo cell imaging, 
toxicity studies of these materials are still lacking. Nevertheless, a publication 
has shown Cd-based QDs to cause apoptosis (programmed cell death) (Chen et 
al., 2012). Consequently, a Cd-free route would have more potential, especially 
if the PL properties are equalled. Typically, CdS particles produced with a ZnS 
shell exhibit peak PL emission at 438 nm, when excited at 370 nm (Saraswathi 
Amma et al., 2008). 
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In addition, the European Commission has been striving to reduce and prohibit 
the use of heavy metals (these being cadmium, mercury and lead) in consumer 
products in order to reduce human exposure to these toxic elements. Hence, 
legislations have been imposed to restrict the use of heavy metals in electrical 
and electronic items (RoHS 2002/95/EC) and in batteries (Directive 
2006/66/EC). Manufacturers of household appliances (namely electronics) must 
limit the concentration of heavy metals to 0.1% (1000 ppm) (Nanoco, 2013). 
Furthermore, official analysis techniques have been imposed to test levels of 
heavy metals in foodstuffs (Commission Regulation (EC) No 333/2007) to ensure 
they do not enter the food chain. These controls indicate the severity of heavy 
metal poisoning and if their use can be avoided, these risks will be bypassed. 
 
  Zinc Sulphide, ZnS 4.1.6
 
Several literature reports state the use of ZnS as a shell around CdS or 
CdSe for the reasons outlined in Section 4.1.2. Unlike the latter two materials, 
ZnS does not carry implications of toxicity. Furthermore, due to the availability 
of low-cost zinc precursors, and an established method of CdS synthesis in place, 
ZnS was opted for as a material of interest in this PhD. The materials properties 
will be primarily assessed with the aim of application in biological fields.  
 
  Capping Agents and Stabilisers 4.1.7
 
Due to the very small size of QDs (<20 nm), the attractive forces on the 
surface of the particles are significant and cause the particles to coagulate and 
cluster, if there is nothing to prevent them from doing so (Geszke-Moritz and 
Moritz, 2013). This can lead to problems if the application calls for non-
agglomerated particles, as most do. Particularly for biomedical applications, 
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particle agglomeration can mean clusters of particles no longer exhibit the 
properties seen in the nano-form, and can lead to undesired cell uptake or 
excretion (Jamieson et al., 2007). Moreover, it has already been described in 
Section 4.1.2 that the fluorescent properties of QDs depend on the size of the 
particles, and so the aggregation of these small particles results in the exhibition 
of bulk-like behaviour and the loss (or reduction) of fluorescent properties 
(Dickerson, 2005). 
 
In this Chapter, three different capping agents have been chosen to stabilise ZnS 
particles. They have all been reported in the literature in stabilising ZnS; 
additional reasons are also described below.  
 
Polyvinylpyrrolidone (PVP) is a low-cost, non-toxic polymer widely used for 
biological applications due to its high biocompatibility (Sharma et al., 2010); 3-
Mercaptopropionic acid (3-MPA) has been described several times as a capping 
agent for QDs, especially ZnS (Luan et al., 2012, Rosli et al., 2012, Azizian-
Kalandaragh and Khodayari, 2010, Geszke-Moritz and Moritz, 2013); and sodium 
hydroxide (NaOH) has been reported in the synthesis of ZnS (Shen et al., 2007) 
to improve the photo luminescent properties of particles. Moreover, all the above 
reagents are water-soluble, meaning experiments can be conducted in a 
completely hydrothermal environment without the need for organic solvents, 
which are potentially detrimental to biological systems. 
 
  Chapter Aims 4.1.8
 
The aim of this Chapter is to use the counter-current Nozzle reactor for 
the continuous synthesis of ZnS nanoparticles, and to assess their properties in 
terms of crystallinity, particle size and photoluminescence. This will be achieved 
by using XRD, SEM and TEM techniques, and fluorometry analysis.  
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4.2 Methodology 
 
The reagents used for synthesis were cadmium nitrate tetrahydrate, 
Cd(NO3)2.4H2O (98% purity); thiocarbohydrazide, (NH2NH)2CS (98% purity); 
zinc nitrate tetrahydrate, Zn(NO3)2.6H2O (98% purity); thiourea, (NH2)2CS 
 SXULW\ -Mercaptopropionic acid (3-MPA), HSCH2CH2CO2+ 
SXULW\ VRGLXP K\GUR[LGH 1D2+  SXULW\ SRO\YLQ\OS\UUROLGRQH, 
(C6H9NO)n (average molecular weight of 10,000). All reagents were purchased 
from Sigma Aldrich, UK and used without further purification. DI grade water 
water used throughout this work. 
 
  Synthesis of CdS using the Nozzle Reactor 4.2.1
 
As mentioned in Section 4.1, a method was previously established for the 
continuous hydrothermal synthesis of CdS. This protocol will be elaborated on in 
this Section. 
 
The method described a 0.01 M Cd(NO3)2.4H2O solution being pumped in one 
metal salt pump at 5 ml/min. Simultaneously, a 0.01 M (NH2NH)2CS solution was 
pumped at 5 ml/min through a second metal salt pump. These met at a T-piece 
before the reactor and subsequently flowed into the reactor section of the 
system together. Here, the feed met a stream of water pumped at 10 ml/min. 
The method described the water downflow being pre-KHDWHGWRÛ&DQGWKH
system pressure maintained at 240 bar. 
 
In the work described in this Chapter, a few samples of CdS were generated 
following this protocol, but employing a range of temperatures ± either 240, 300 
or 400 ȗC and the samples were labelled CdS 240, CdS 300 and CdS 400, 
Chapter 4. Fluorescent Nanomaterials 
133 
 
respectively. Sample CdS 400 was analysed by DLS and TEM. Fluorometry 
analysis was also performed. 
 
  Initial Synthesis of ZnS using the Nozzle Reactor 4.2.2
 
For the preliminary synthesis of ZnS, the methodology for CdS synthesis 
(Section 4.2.1) was adapted: quite simply Zn(NO3)2.6H2O was chosen as the 
metal salt precursor, instead of Cd(NO3)2.4H2O. The precursor concentrations, 
flow orientation and rates were maintained, and the system pressure was again 
kept at 240 bar. A range of samples were produced using five different reaction 
temperatures; these are detailed in Table 4.1. The positions in the system from 
which these temperatures were taken, are outlined in Chapter 1. 
 
Table 4.1. Reaction temperatures for each ZnS Sample. 
Sample 
Name 
Water 
Heater 
Temp 
Û& 
After 
Heater 
Temp 
Û& 
Post 
Mixing 
Point 
Temp 
Û& 
Capping 
Point 
7HPSÛ& 
Post 
Cooler 
Temp 
Û& 
ZnS 200 215 213 102 54 19 
ZnS 250 265 260 120 60 19 
ZnS 300 315 313 156 70 19 
ZnS 350 365 363 262 80 19 
ZnS 400 420 416 304 101 20 
 
Sample ZnS 400 was analysed using TEM, EDX and XRD techniques. 
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  Refined Method for ZnS Synthesis 4.2.3
 
The synthesis method was later simplified to combine both metal salt 
precursors in one flask, thereby eliminating the need for a third pump. The 
aforementioned temperatures for sample ZnS 400 in Table 4.1 were used with 
the experimental setup shown in Figure 4.2 WRSURGXFH WKH VDPSOH ³8QFDSSHG
=Q6´ ± WKLV LV WKH ³EDVLF´ VDPSle of ZnS without any surfactants or capping 
agents introduced. 
 
6(0 ;5' ǅ-potential and Fluorometry analysis was conducted on the sample 
Uncapped ZnS. 
 
 
 
Figure 4.2. A schematic diagram showing the reactor setup for the 
refined synthesis method of ZnS. 
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  Synthesis of ZnS using Thiourea 4.2.4
 
Due to the toxicity of (NH2NH)2CS, it is desirable to use a safer sulphur 
source in the synthesis of ZnS.  Thiourea, (NH2)2CS, was chosen as a potential 
substitute due to its lower toxicity, because literature describes it as working 
well (Wageh et al., 2003, Apte et al., 2011), it is water soluble, and was readily 
available. The same reaction conditions as described in Section 4.2.3 were used 
but using the range of reaction temperatures shown in Table 4.2. The system 
positions from which the thermocouple readings were taken, were outlined in 
Chapter 1. 
 
Table 4.2. Reactor System temperatures for samples synthesised using 
thiourea. 
Sample 
Name 
Water 
Heater 
Temp 
Û& 
After 
Heater 
Temp 
Û& 
Post 
Mixing 
Point 
7HPSÛ& 
Capping 
Point 
Temp 
Û& 
Post 
Cooler 
Temp 
Û& 
ZnS- TU-150 190 162 79 49 19 
ZnS- TU-250 300 260 130 66 20 
ZnS- TU-350 390 352 180 83 22 
ZnS- TU-400 450 409 279 105 23 
 
  Synthesis of ZnS with Surfactants/Stabilisers 4.2.5
 
An issue affecting the synthesis of ZnS nanoparticles is agglomeration, as 
is the case for most QDs and indeed most nanoparticles. The problems arising 
from particle aggregation were described in Section 4.1.7.  
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Consequently, three different stabilising agents were chosen as candidates for 
capping ZnS in the Nozzle reactor during synthesis: 3-MPA, NaOH and PVP.  The 
reasoning behind these choices was described in Section 4.1.7. The methodology 
described in Section 4.2.3 was used as a basic protocol for ZnS synthesis in this 
H[SHULPHQW VHW 7KH VDPSOH ³8QFDSSHG =Q6´ GHVFULEHG LQ 6HFWLRQ  ZDV
used as a control for comparison. 
 
For the experiments outlined in Sections 4.2.5.1, 4.2.5.2, and 4.2.5.3, Figure 
4.3 depicts the schematic setup of the reactor section of the system and the feed 
orientations can be seen. The system pressure was maintained at 240 bar by the 
BPR, and the recorded temperatures are shown in Table 4.3. 
 
 
 
Figure 4.3. A schematic diagram displaying the reactor setup for the 
synthesis reaction of ZnS with capping agents. 
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Table 4.3. System temperatures for synthesis of ZnS with surfactants. 
Water 
Heater Temp 
Û& 
After Heater 
7HPSÛ& 
Post Mixing 
Point Temp 
Û& 
Capping 
Point Temp 
Û& 
Post Cooler 
7HPSÛ& 
415 405 265 102 23 
 
  ZnS and 3-Mercaptopropionic Acid (3-MPA) 4.2.5.1
 
In this experiment set, an aqueous solution of 0.25 M 3-MPA was 
introduced at the second metal salt pump (MS2) while the precursors for ZnS 
were pumped through the first metal salt pump (MS1). The flow rate of the H2O 
downflow was maintained, but the flow rates of MS1 and MS2 were altered for 
each sample. A summary of flow rates for each of the 5 samples produced is 
displayed in Table 4.4. 
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Table 4.4. Flow ratios for the different ZnS:3-MPA Samples. 
Sample 
Name 
H2O 
Feed 
H2O Flow 
Rate  
(ml/min) 
MS 1 
Feed 
MS 1 
Flow 
Rate 
(ml/min) 
MS 2 
Feed 
MS 2 Flow 
Rate 
(ml/min) 
ZnS:3-
MPA 9/1 
H2O 10 
0.02 M 
Zn(NO3)2 
+ 0.02 M 
TCH 
9 
0.25 M  
3-MPA 
1 
ZnS:3-
MPA 8/2 
8 2 
ZnS:3-
MPA 7/3 
7 3 
ZnS:3-
MPA 6/4 
6 4 
ZnS:3-
MPA 5/5 
5 5 
 
MS ± Metal Salt; TCH ± Thiocarbohydrazide; 3-MPA ± 3-Mercaptopropionic Acid 
 
  ZnS and Polyvinylpyrrolidone (PVP) 4.2.5.2
 
For this set of experiments, an aqueous solution of 0.005 M PVP was 
introduced at MS2. As with the samples produced with 3-MPA described in 
Section 4.2.5.1, the flow rates of MS1 and MS2 were altered for each sample.  A 
summary of flow rates for each of the 5 samples produced is displayed in Table 
4.5. 
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Table 4.5. Flow ratios for the different ZnS:PVP Samples. 
Sample 
Name 
H2O 
Feed 
H2O Flow 
Rate 
(ml/min) 
MS 1 
Feed 
MS 1 
Flow Rate 
(ml/min) 
MS 2 
Feed 
MS 2 
Flow 
Rate 
(ml/min) 
ZnS:PVP 
9/1 
H2O 10 
0.02 M 
Zn(NO3)2 
+ 0.02 M 
TCH 
9 
0.005 M  
PVP 
1 
ZnS:PVP 
8/2 
8 2 
ZnS:PVP 
7/3 
7 3 
ZnS:PVP 
6/4 
6 4 
ZnS:PVP 
5/5 
5 5 
 
MS ± Metal Salt; TCH ± Thiocarbohydrazide; PVP ± Polyvinylpyrrilidone 
 
  ZnS and Sodium Hydroxide (NaOH) 4.2.5.3
 
NaOH has been described in literature as a surfactant for ZnS (Shen et 
al., 2007). It was reported that the alkaline environment results in the formation 
of core/shell particles of ZnS/Zn(OH)2 where the surface hydroxyl groups provide 
charge stabilisation as well as improving PL properties. In these reactions, an 
aqueous solution of 0.25 M NaOH was pumped through MS2, with the flow rates 
of MS1 and MS2 altered for each sample, as summarised in Table 4.6. 
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Table 4.6. Flow ratios for the different ZnS:NaOH Samples. 
Sample 
Name 
H2O 
Feed 
H2O Flow 
Rate 
(ml/min) 
MS 1 
Feed 
MS 1 
Flow Rate 
(ml/min) 
MS 2 
Feed 
MS 2 Flow 
Rate 
(ml/min) 
ZnS:NaOH 
9/1 
H2O 10 
0.02 M 
Zn(NO3)2 
+ 0.02 M 
TCH 
9 
0.25 M  
NaOH 
1 
ZnS:NaOH 
8/2 
8 2 
ZnS:NaOH 
7/3 
7 3 
ZnS:NaOH 
6/4 
6 4 
ZnS:NaOH 
5/5 
5 5 
 
MS ± Metal Salt; TCH ± Thiocarbohydrazide 
 
  Structural Characterisation 4.2.6
 
For each of the ZnS samples described in Section 4.2.5 and produced 
with different ratios of precursors and surfactants, a small volume was collected 
for SEM analysis and fluorometry measurements (the latter is outlined in Section 
4.2.6.1). In DGGLWLRQ;5'DQG ǅ-potential analysis were conducted on each of 
the three 5/5 ratio samples. These four analysis techniques were also performed 
on the Uncapped ZnS sample, for comparison. The principles of these structural 
characterisation techniques were discussed in Chapter 2. 
 
Samples were washed by vacuum filtration using deionised water, and then 
either re-suspended in deionised water for SEM and fluorescence analysis, or 
oven dried at 70ȗC for 24 hours to yield a powder for XRD analysis. 
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  Fluorometry Analysis 4.2.7
 
Excitation and emission spectra were collected for each of the aqueous 
CdS and ZnS samples using a Flexstation II fluorometer from Molecular Devices. 
For each sample, 200 µL of material was loaded into a UV-transparent 96-well 
plate, which was then scanned by the fluorometer. 
 
Broad emission sweeps were firstly collected by scanning between 450 and 650 
nm using a step size of 10 nm, with excitation kept at 350 nm. Likewise, broad 
excitation sweeps were conducted by measuring emission at 540 nm while 
excitation was varied between 260 and 450 nm using 10 nm increments. For 
both excitation and emission spectra, each sample was read 6 times. 
 
Subsequently, more specific emission sweeps were performed by measuring 
emission between 430 and 650 nm with 2 nm steps. Excitation was held at 360 
nm. To confirm the emission data, a detailed excitation sweep was conducted by 
varying excitation between 290 and 410 nm with 2 nm increments; the emission 
was measured at a constant 530 nm. For both excitation and emission spectra, 
each sample well was read 12 times. 
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4.3 Results and Discussion 
 
  Cadmium Sulphide, CdS 4.3.1
 
This Section describes the samples of CdS produced from the synthesis 
experiments detailed in Section 4.2.1. At the lower two temperatures, 240 and 
300 °C, the collected samples were transparent and colourless ± photos are 
provided in Figure 4.4 (a) and (b). On testing with a laser pointer, these samples 
did not show a beam through the dispersion. If particles were present and 
therefore scattering light, a beam path would be visible. Consequently, it was 
determined that no particles were apparent in these samples and no further 
tests were conducted on them. Sample CdS 400 produced a bright yellow colour 
(see Figure 4.4), and the particles remained in suspension for a few days. 
 
 
 
Figure 4.4. Photos of (a) CdS 240, (b) CdS 300, and (c) CdS 400. 
 
DLS measurements performed on CdS 400 reported a particle size of 67 nm. 
Meanwhile, TEM analysis of sample CdS 400 revealed it to be composed of 
particles with diameters between 20 and 50 nm, as seen in Figure 4.5 (a). It is 
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likely that DLS was measuring the hydrodynamic radii of these particles, thus 
gave a bigger particle size than observed under TEM. Images obtained with TEM 
at a higher magnification (Figure 4.5 (b)) showed that these particles may in fact 
be clusters of individual smaller particles because crystal planes can be seen in 
different alignments.  Nevertheless, the images do not distinctly show particle 
boundaries, and another possibility is that the particles are composed of different 
crystallites, which explains the presence of differently aligned planes. 
 
Fluorometry analysis was performed on sample CdS 400, but the data was 
inconclusive as there was no discernible difference between the excitation and 
emission spectra for the sample, compared to that of the control water blank. In 
the latter, no excitation or emission activity is expected; instead, the sample 
peaks were seen for both the CdS 400 sample and the water blank. It is most 
likely that the signal for the water blank is caused by the fluorescence of the 
CdS, as the sample well was adjacent to the well holding the water blank during 
analysis ± DSURFHVVNQRZQDV ³EOHHGWKURXJK´Because CdS was not the main 
material of interest in this study, a full data set (XRD analysis etc.) was not 
acquired. Instead, most effort was directed towards ZnS analysis. 
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Figure 4.5. (a) and (b) show TEM images of sample CdS 400. 
 
  Initial synthesis of ZnS 4.3.2
 
The samples produced under the methodology described in Section 4.2.2 
will be discussed in this Section. With the exception of sample ZnS 400, all 
samples were transparent and colourless when collected from the BPR outlet. 
When tested with a laser, there was no indication of the presence of particles ± 
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therefore these samples were not analysed further. Still, sample ZnS 400 was a 
white/grey suspension when collected from the BPR outlet, with the coloured 
particles sedimenting at the bottom of the vessel within a few hours.  The XRD 
pattern collected for this sample is shown in Figure 4.6; the peaks can be 
ascribed to ICCD PDF 80-20, cubic phase ZnS, and 80-7, hexagonal phase ZnS. 
 
 
 
Figure 4.6. XRD pattern for sample ZnS 400, with expected peak 
positions of cubic ZnS (ICCD PDF 80-20) shown in black, and hexagonal 
ZnS (ICCD PDF 80-7) shown in red. 
 
The TEM images which were captured of sample ZnS 400 showed clustered 
particles where each cluster measured between 50 and 100 nm (see Figure 4.7 
(a) and (b)).  At higher magnifications, the clusters appeared to be composed of 
primary particles with diameters <15 nm (Figure 4.7 (c)). Furthermore, at high 
resolution, the crystal lattice of the particles can be observed (Figure 4.7 (d)).   
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Figure 4.7. a) and b) TEM images and c) HRTEM images of sample ZnS 
400. 
 
The elements expected from sample ZnS 400 are indeed present, seen from the 
EDX spectrum in Figure 4.8. The Cu and C peaks can be assigned to the copper 
and carbon of the TEM sample grid. A small peak for oxygen is present which is 
likely to have been introduced during sample preparation as the XRD pattern 
(Figure 4.6) shows a match to the expected peaks for cubic ZnS, rather than a 
crystal structure containing an oxide group. 
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Figure 4.8. EDX Spectrum collected for sample ZnS 400 
 
  Synthesis with Thiourea as the Sulphur Source 4.3.3
 
The experiments described in Section 4.2.4 (using thiourea as a sulphur 
source) resulted in clear, colourless products at reaction temperatures up to and 
including 350 °C. The samples were also shown to be negative when tested with 
a laser. From this, it can be inferred that a minimum reaction temperature of 
400 °C is required for particle formation as a cloudy white suspension was 
obtained for sample ZnS- TU-400.  This sample was dried and the powder 
analysed with XRD. The resulting pattern, shown in Figure 4.9, displayed no 
obvious peaks matching ZnS but the peaks were matched to zinc sulphate 
hydrate and zinc hydrogen sulphate (ICCD PDF 74-1331 and 78-2208 
respectively). 
 
This result shows that thiourea cannot be used interchangeably with 
thiocarbohydrazide to produce ZnS. To maintain the focus of this project, all 
further reactions were conducted using thiocarbohydrazide as the sulphur 
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source. Nevertheless, the method of using thiourea as a sulphur source for ZnS 
synthesis could be optimised in future work. 
 
Figure 4.9. XRD pattern for Sample ZnS-TU-400. Peaks labelled with red 
triangles match zinc hydrogen phosphate and peaks labelled with blue 
crosses match zinc sulphate hydrate. 
 
  Synthesis of ZnS with Surfactants 4.3.4
 
In this Section the results from the experiments described previously in 
Section 4.2.5 will be presented and discussed. For each type of analysis 
performed, the ZnS products synthesised with the three different surfactants will 
be discussed together and compared to each other, and to ZnS particles 
produced in the absence of any surfactants ± Uncapped ZnS. 
 
For all the samples produced, at each flow ratio of the 3 different surfactants, 
samples were collected as cloudy suspensions - white/grey in colour - where the 
particles settled to the bottom of the vessel within a few hours. 
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  XRD Data 4.3.4.1
 
XRD analysis performed on ZnS:NaOH 5/5, ZnS:PVP 5/5, ZnS:3-MPA 5/5 
and Uncapped ZnS produced only peaks which could be assigned to ZnS. 
Therefore, it can be concluded that ZnS is the only crystalline phase present in 
the samples. However, each sample is composed of different crystal phases of 
ZnS ± as such, there are discrepancies between the XRD patterns of the four 
samples. Of the four samples, the patterns for Uncapped ZnS and ZnS:PVP 5/5 
are the most similar to each other. Both have peak positions matching ICCD 
PDFs 80-20 and 80-7 - corresponding to cubic and hexagonal ZnS respectively. 
Nevertheless, the peaks consistent with hexagonal ZnS are more distinct in 
ZnS:PVP, compared to Uncapped ZnS, which suggests either that the hexagonal 
phase is more abundant, or more crystalline. Moreover, the pattern for ZnS:PVP 
contains peaks matching ICCD PDF 12-688, the pattern for another phase of 
hexagonal ZnS. From this, it can be inferred that the presence of PVP in the 
reaction promotes the formation of hexagonal crystal phase over cubic phase. 
 
The XRD pattern for ZnS:NaOH contains peaks which can also be ascribed to 
cubic and hexagonal phases of ZnS (ICCD PDFs 80-20, 5-566 and 12-688), as 
does the pattern for ZnS:3-MPA. The peaks in the latter sample match the 
database pattern file 75-1534. It is difficult to conclude from this data if the 
pattern also matches PDF 12-688, which is hexagonal phase, or PDF 5-566, 
which is cubic phase, as the peaks lie in similar positions. However, as the 
pattern for ZnS:3-MPA is very similar to that of the other ZnS samples, it is 
likely to also be a mixture of cubic and hexagonal phases. 
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Figure 4.10. XRD Patterns of the four ZnS samples with the matched 
peak positions of different ZnS phases shown below. Numbered labels 
indicate the ICCD PDF file number and the corresponding crystal phase 
is given. 
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  Crystallite Size 4.3.4.2
 
In terms of peak shape, the XRD pattern obtained for ZnS:NaOH contains 
peaks which are slightly narrower and sharper than those seen for the other 
three samples. As discussed in Chapter 2, sharper, narrower peaks can either 
mean a higher degree of crystallinity in the sample, or, in the case of 
nanoparticles, a larger average crystallite size compared to samples which 
exhibit broader XRD peaks. 
 
To determine if the crystallite size phenomena is valid in the case of these 
samples, particle size analysis was required. As such, SEM images were collected 
for the four samples. These are presented in Figure 4.11. The micrographs 
indicate the presence of clustered particles where the level of clustering, and the 
size of the clusters varies between samples. In all four samples, the clusters are 
<300 nm and the compositional particles much smaller than this (<50 nm as 
seen under SEM at higher magnification, and based on TEM images collected for 
sample ZnS 400). Hence, the XRD peak broadening can be ascribed to the 
presence of small crystallites. The crystallite size calculations will be discussed in 
this Section, while more in depth analysis of the SEM data will be detailed in 
Section 4.3.4.3. 
 
To calculate the average crystallite size for each sample, Xfit software was used. 
The results, along with the crystal phase data inferred from XRD patterns, are 
presented in Table 4.7. For Uncapped ZnS, the calculated crystallite size is 4.1 
nm while for ZnS:PVP it is slightly bigger at 4.6 nm. For ZnS:NaOH, it appears 
that addition of NaOH to the ZnS synthesis reaction leads to a significant 
increase in the crystallite size, as the calculated value here is 5.8 nm (this 
corresponds to the earlier point of sharper narrower peaks seen in the XRD 
pattern of this sample). This significant increase in crystallite size may be due to 
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NaOH having a neutralising effect on the synthesis reaction; the nitrate 
precursor creates acidic conditions through the generation of HNO3, which leads 
to surface oxidation of the particles and termination of growth. However the 
presence of NaOH counteracts this, the surfaces do not become oxidised, and 
crystal growth prevails. 
 
Finally, the average crystallite size for sample ZnS:3-MPA was calculated as 3.1 
nm ± significantly smaller than the other three samples. A possible explanation 
for this is the efficient binding of 3-MPA to the surface of the ZnS nanoparticles, 
which prevents further crystallite or particle growth. 
 
Table 4.7. Summary of crystal phase and crystalline size for each 
sample, as derived from XRD analysis.  
Sample 
ICCD PDF 
Match 
Crystal Phase^ Crystallite Size* 
Uncapped ZnS 
80-20 
80-7 
Cubic/Hexagonal 4.1 nm 
ZnS:PVP 
80-20 
80-7 
12-688 
Cubic/Hexagonal 4.6 nm 
ZnS:NaOH 
80-20 
5-566 
12-688 
Cubic/Hexagonal 5.8 nm 
ZnS:3-MPA 
5-566 
75-1534 
Cubic/Hexagonal 3.1 nm 
 
^ Crystal phase identified using EVA software 
*Crystallite size calculated using Xfit software 
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  SEM Analysis 4.3.4.3
 
The SEM images shown in Figure 4.11 will be discussed in this Section. As 
mentioned previously in Section 4.3.4.2, the images show clusters of particles. 
To some extent, the clustering effect is due to the sample preparation step prior 
to SEM analysis ± where liquid samples are dried on the sample stub, surface 
tension may cause particles to stick together. Nevertheless, the effect that each 
surfactant has on particle aggregation can be assessed from this data. 
 
SEM images were also collected for the samples synthesised using different flow 
ratios of each of the surfactants; these are shown in the Appendix but in the 
interest of comparison, only SEM images of the samples produced at 5/5 flow 
ratios are presented and discussed here. 
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Figure 4.11. SEM images of (a) Uncapped ZnS; (b) ZnS:PVP 5/5; (c) 
ZnS:NaOH 5/5; and (d) ZnS:3-MPA 5/5. 
 
The sizes of 20 clusters in each sample were measured from the SEM images, 
and an average calculated along with the standard deviation from the mean. This 
data is shown in Table 4.8. The 20 clusters were chosen at random for analysis 
from the top of the sample as seen in the micrograph. This was to ensure any 
differences in scale, due to the sample depth of view, were minimised. 
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Table 4.8. A table showing the average cluster size for each sample, as 
measured from SEM images. 
 
Sample Average Cluster Size (nm) 
Uncapped ZnS 201.7 ± 46.5 
ZnS:PVP 5/5 207.4 ± 39.2 
ZnS:NaOH 5/5 165.3 ± 25.7 
ZnS:3-MPA 5/5 157.2 ± 65.7 
 
The clusters seen in ZnS:PVP are slightly bigger than those present in Uncapped 
ZnS, while in ZnS:NaOH and ZnS:3-MPA, they are smaller.  This difference may 
be due to the effectiveness of each of the surfactants in preventing the 
aggregation of primary particles. It can be deduced, following the data presented 
in Section 4.3.2 for sample ZnS 400, that without the addition of any capping 
agents or surfactants, the nanoparticles in sample Uncapped ZnS aggregate and 
form the clusters seen in Figure 4.11  (a). However, if the presence of NaOH and 
3-MPA are indeed preventing particle aggregation (even if only to some extent), 
then the clusters would be smaller than in the control sample, which is what can 
be observed in Figure 4.11 (c) and Figure 4.11 (d). Therefore, the SEM data 
suggests NaOH and 3-MPA are lessening the degree of ZnS particle aggregation. 
On the contrary, the larger average cluster size seen for ZnS:PVP (in Figure 4.11 
(b)) may be a result of the PVP polymer coating the clustered particles, as 
opposed to the desired effect of coating the individual primary particles. 
 
Unlike the images for the other three samples, the clustered particles present for 
ZnS:3-MPA (in Figure 4.11 G DUH DSSDUHQWO\ PRUH ³WH[WXUHG´ DQG FDQ EH
clearly seen, even at lower magnifications, to be formed of smaller particles. This 
may be further indication of 3-MPA preventing the formation of tightly 
aggregated particles; instead the particles are only loosely coagulated. It is likely 
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that the observed coagulation of particles is due to an insufficient concentration 
of 3-MPA present during synthesis, therefore the nanoparticles have not been 
completely coated with the surfactant. 
 
To further investigate the effect of each surfactant on the stability of ZnS 
particles, zeta potential measurements were taken over a pH range. These data 
are presented and discussed in Section 4.3.4.4.  
 
  Zeta Potential Measurements 4.3.4.4
 
Zeta potential measurements were taken over a pH range for the four 
samples, to ascertain the point of zero charge (PZC) or iso-electric point (IEP). 
These data are shown in Figure 4.12 and with the individual data points for each 
sample given in the Appendix. The zeta potential profile for Uncapped ZnS 
confirms that in acidic conditions, the particles have a positive zeta potential and 
under basic conditions, the particles have a negative zeta potential. From this 
profile, it can be deduced that the IEP of Uncapped ZnS is approximately pH 7.8. 
This means that at this pH, there are little repulsive forces keeping the particles 
apart, and they are likely to coagulate rapidly. The IEP of ZnS particles has 
previously been reported at pH 5.5  (Durán et al., 1995); the IEP measured for 
sample Uncapped ZnS may be higher due to the surface oxidation reactions 
which occur as a result of the acidic conditions of synthesis (due to the nitrate 
precursor used). 
 
Only in basic conditions (pH 10 or higher) is the zeta potential of Uncapped ZnS 
< -30 mV and the dispersion can be considered stable. These data corresponds 
with the problems associated with particle aggregation seen for unmodified QDs, 
which were outlined in Section 4.1 and reinforces the need for viable surfactants. 
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Figure 4.12. Zeta potential profiles for the four samples, as a function of 
pH. 
 
It can be seen that the zeta potential profiles for the four samples are indeed 
different, indicating that the different capping agents are affecting the surface 
chemistry of the ZnS particle. In the case of ZnS:3-MPA the IEP is reached ca. 
pH 4.1 ± a shift compared to Uncapped ZnS ± and at neutral pH, the zeta 
potential is <-30 mV suggesting the particles are stable. In this sample, the 
particles are capped by an acidic species; Figure 4.13 shows the predicted 
surface modification of ZnS particles with 3-MPA. In water, the acid group 
dissociates to leave COO- at the surface.  As a result, the electrical double layer 
of the particle (and in turn the zeta potential) is negative at neutral pH. In 
addition, more H+ ions must be added (i.e. the pH reduced further) in order to 
give a positive zeta potential, compared to the Uncapped ZnS sample. 
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Figure 4.13. A schematic diagram depicting ZnS particles surface 
modified with 3-MPA. 
 
On the contrary, sample ZnS:NaOH - which has been capped with an alkaline 
species ± has a slightly positive zeta potential value at pH 7 and an IEP ca. pH 
8.5, marginally more basic compared to Uncapped ZnS. Like the sample 
Uncapped ZnS, particles in ZnS:NaOH exhibited a zeta potential <-30 mV, and 
are deemed stable, at pH 10 or more.  
 
Unlike NaOH and 3-MPA, PVP is a non-ionic surfactant ± where it provides 
stabilisation through steric hindrance as opposed to surface charge 
modifications. Therefore, the zeta potential profile for ZnS:PVP is largely 
unaffected by changes to pH, and over the pH range tested, the sample did not 
have a zeta potential which could be concluded as stable. Although the resulting 
profile yields an IEP ca. pH 3, it was not possible to measure the zeta potential 
at a lower pH. 
 
At pH values less than 2-3 or more than 11-12, the conductivity of the samples 
were too high to be measured by the same means and equipment; thus accurate 
data could not be obtained at these pH environments.  
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This zeta potential data demonstrates that PVP is not a suitable surfactant for 
the charge stabilisation of ZnS particles. The addition of NaOH to the reaction 
scheme does appear to affect the surface chemistry of the ZnS particles, but the 
zeta potential profile is still similar to that of the Uncapped ZnS particles. The 
most effective surfactant of the three tested is 3-MPA, as the IEP is significantly 
shifted away from neutral pH. Instead, the particles have a zeta potential of <-
30 mV at pH 7. This means that the ZnS particles are less likely to aggregate at 
neutral pH when surface modified with 3-MPA. This is particularly pertinent for 
biological applications, where cellular environments tend to be ca. pH 7.  
 
  Fluorometry Analysis 4.3.4.5
 
The specific excitation and emission sweeps for the four samples, 
Uncapped ZnS and ZnS synthesised with each of the three surfactants at a 5/5 
flow ratio, are shown in Figure 4.14. The intensity of fluorescence is measured in 
relative fluorescence units, RFU. It is important to note that the measured RFU is 
dependent on the concentration of ZnS present in the sample; however, the ZnS 
concentration varies between the samples so the fluorometry data obtained can 
only be assessed qualitatively, and not quantitatively, i.e. the peak positions for 
each sample are of importance, but the signal intensity cannot be compared in a 
meaningful way. For all samples and blanks, the excitation spectra were 
collected with the emission held at 540 nm. The emission spectra were collected 
with excitation maintained at 360 nm. 
 
The excitation spectrum for Uncapped ZnS shows that the unmodified particles 
fluoresce with the highest intensity at 540 nm, when excited with light at 360 
nm.  Parallel to this data, the emission spectrum shows that when excited with 
light at 360 nm, the emission by particles actually covers a broad wavelength 
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range, with the peak intensity at 558 nm ± a wavelength corresponding to green 
colour in the visible light range.  
 
Samples ZnS:PVP and ZnS:NaOH display very comparable excitation and 
emission spectra to Uncapped ZnS, with peaks in similar positions. Nevertheless, 
there are subtle differences. For both these modified samples of ZnS, the 
excitation peak at 360 nm is less intense than at lower wavelengths. Instead, 
the peak falls at 282 nm. However, there is still a fluorescence signal when 
excited at 360 nm; as such, emission data was taken at this excitation 
wavelength for ease of analysis. Figure 4.14 (b) shows that the emission peak 
for ZnS:NaOH is broad, but the most intense emission is at a wavelength of 556 
nm ± very similar to Uncapped ZnS and again, corresponds to green light. This is 
somewhat different to PL data previously reported, where ZnS particles 
synthesised with NaOH showed emission at 440 nm when excited at 323 nm 
(Shen et al., 2007). This is likely to be because the particles prepared in the 
literature by ultrasonication resulted in the formation of ZnS/ZnS(OH)2 core/shell 
nanoparticles where Zn(OH)2 alters the PL properties. 
 
The emission peak for ZnS:PVP also covers a broad range of wavelengths, but 
the highest RFU was detected at 572 nm ± slightly red shifted compared to 
Uncapped ZnS, and correlates to yellow light. Many existing reports using PVP as 
a capping agent discuss QDs with a cadmium-based core and a ZnS shell; as 
such, the PL data cannot be directly compared (Saraswathi Amma et al., 2008). 
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Figure 4.14D7KHH[FLWDWLRQVSHFWUDǊem = 540 nm) and (b) emission 
VSHFWUDǊex = 360 nm) for Uncapped ZnS and ZnS produced with three 
different surfactants using 5:5 flow ratios. The spectra of the precursors 
and water blank were obtained as a control. 
 
The excitation and emission spectra for ZnS:3-MPA is unlike that of the other 
samples. The excitation spectrum exhibits only one peak, as opposed to the two 
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seen in the other three samples. While the excitation peak does reach a 
maximum at 366 nm, similar to that of Uncapped ZnS, the emission spectrum 
was significantly different to that of the other three samples. Although the 
emission signal was detected over a wide range of wavelengths, the most 
intense signal was detected at 450 nm ± violet or blue colour in the visible light 
range. This emission data is comparable to previous reports of ZnS capped with 
MPA; particles synthesised by a chemical precipitation method yielded a broad 
emission spectrum with a peak at 425 nm (blue light) when excited at 310 nm 
(Rosli et al., 2012). Conversely, introducing a dopant appears to have a vast 
effect on PL; ZnS particles doped with Mn and capped with MPA gave broad PL 
emission peaks around 598 nm ± orange light ± when excited at 320 nm (Kong 
et al., 2012). 
 
As a control, the excitation and emission spectra were also collected for a water 
blank, and for each of the precursors. With the exception of PVP, no fluorescence 
signal was detected in these controls. This shows that the fluorescence signal 
detected in the samples can indeed be attributed to the ZnS, rather than their 
starting materials. In the case of PVP, the excitation and emission spectra are 
remarkably similar to that of ZnS:3-MPA, with the emission peak ca. 450 nm. As 
PVP is not expected to fluoresce, the signal is most likely due to bleedthrough 
fluorescence from the ZnS:3-MPA sample which was in the adjacent well during 
analysis. Moreover, the emission peak at 450 nm was not detected in the sample 
ZnS:PVP, reinforcing that bleedthrough is the most likely cause.  
 
To further investigate the effect of 3-MPA on the PL properties of ZnS, the 
excitation and emission spectra for the ZnS:3-MPA samples produced using 
different precursor flow ratios, are displayed in Figure 4.15. The excitation 
spectra, seen in Figure 4.15 (a), shows that ZnS:3-MPA 9/1 has a very similar 
spectra to that of Uncapped ZnS, with peaks at the same wavelength. Increasing 
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the concentration of 3-MPA only slightly, as is the case for the 8/2 sample, saw a 
discernible change in the excitation spectrum from Uncapped ZnS; the secondary 
peak seen ca. 280 nm has flattened out in ZnS:3-MPA 8/2, while the most 
intense fluorescence signal is still produced when excited at 360 nm. When the 
ratio of 3-MPA to ZnS is increased beyond this, the excitation spectra collected 
for the samples are significantly different and show only one peak, around 365 
nm. 
 
Correspondingly, the emission spectra in Figure 4.15 (b) shows that ZnS:3-MPA 
9/1 yields a similar profile to Uncapped ZnS, and there is only a slight red-shift 
in the peak to 548 nm.  Sample 8/2, however, shows a more obvious shift in the 
peak, to 526 nm ± although still in the range of green light.  With a higher ratio 
of 3-MPA in the samples (ratios 7/3, 6/4 and 5/5), the peak shifts to the blue 
light range below 495 nm. 
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Figure 4.15. (a) The H[FLWDWLRQVSHFWUDǊem = 540 nm) and (b) emission 
VSHFWUDǊex = 360 nm) for ZnS:3-MPA samples produced using different 
precursor flow ratios. The spectra of the precursors and water blank 
were obtained as a control. 
 
This PL data suggests that there is a critical concentration ratio of 3-MPA to ZnS 
which changes fluorescent properties. This work can be further investigated in 
future work, to optimise surfactant concentration. The PL data for ZnS samples 
produced with different ratios of PVP and NaOH did not show significant 
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differences from the PL data of Uncapped ZnS, so are presented in the Appendix, 
but will not be discussed in detail in this Chapter. 
 
The difference in wavelengths at which the particles in each sample fluoresce is 
of interest, because there is a correlation to the average cluster size which was 
discussed in Section 4.3.4.3. The crystallite size, cluster size and emission data 
for the four samples is reviewed in Table 4.9. It can be seen that there is a 
trend: the larger the average cluster size, the longer the wavelength at which 
particles peak in emission.  
 
Table 4.9. A summary of the average crystallite size, average cluster 
size, and wavelength of peak emission for each ZnS sample. 
Sample 
Average 
Crystallite Size 
(nm) 
Average 
Cluster Size 
(nm) 
Wavelength of 
emission peak 
(nm) 
Uncapped ZnS 4.1 201.7 558 
ZnS:PVP 4.6 207.4 572 
ZnS:NaOH 5.8 165.3 556 
ZnS:3-MPA 3.1 157.2 450 
 
The differences in wavelength of peak emission between the different ZnS 
samples indicates that the band gap energies of the particles are varied; another 
factor which is affected by the choice of surfactant. 
 
This correlation also suggests that the particles are behaving (namely 
fluorescing) as clusters, rather than as primary particles or crystallites. 
Consequently, this means there is still some degree of particle aggregation in all 
the samples. While the addition of the surfactants has been shown to lessen the 
aggregation, the process has not been optimised to completely eradicate it. The 
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broad emission peaks seen for all four samples in Figure 4.14 (b) also suggests 
that there is a wide particle or cluster size distribution (Bruchez Jr et al., 1998), 
as QDs have size-dependent optical properties as explained by quantum 
confinement theory (Dickerson, 2005). 
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4.4 Conclusions 
 
In this Chapter, the protocol for CdS synthesis was replicated and bright 
yellow particles of diameters 20 to 50 nm were produced at 240 bar and 400 °C 
- consistent with what was seen previously. In addition, it was found that at 
temperatures below 400 °C, no particles were formed. The TEM images captured 
for the sample were not clear enough to distinguish if the particles were 
composed of smaller, aggregated particles, or were just formed of different 
crystallites. The fluorometry data collected for the CdS sample were inconclusive 
within the scope of this Thesis; instead, the aim of the synthesis experiment was 
to demonstrate the reproducibility of the method established by previous 
researchers.  
 
The methodology for CdS synthesis was adapted to produce ZnS nanoparticles. 
Using Zn(NO3)2.6H2O instead of the Cd(NO3)2.4H2O precursor, white/grey 
particles were synthesised at 240 bar and 400 °C. As with CdS, no particles were 
produced at temperatures below this. The XRD pattern collected for the sample 
proved it to contain a mixture of hexagonal and cubic phases of ZnS, but no 
other crystalline phases were detected. The sample was also analysed under TEM 
which showed primary particle sizes <15nm but had aggregated into clusters ± 
50 to 100 nm in diameter.  Furthermore, EDX data confirmed the presence of 
only the expected elements. 
 
Attempts were made to produce ZnS nanoparticles using thiourea as a sulphur 
source, rather than the more toxic reagent thiocarbohydrazide. Consistent with 
previous experiments, no particles were generated at temperatures up to and 
including 350 °C (with the system pressure at 240 bar). However, at 400 °C, 
white/grey particles were synthesised. XRD analysis on these particles revealed 
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them to be a mixture of zinc sulphate hydrate and zinc hydrogen sulphate rather 
than ZnS. This demonstrates that, in the established protocol for ZnS synthesis, 
thiocarbohydrazide and thiourea cannot be used interchangeably to produce 
ZnS. 
 
The final set of experiments described in this Chapter yielded unmodified ZnS 
particles which were compared to ZnS produced with three different capping 
agents ± an acid, a base and a polymer. The samples were analysed using SEM, 
XRD, zeta potential and fluorometry techniques. The results showed that without 
any capping agents, and consistent with previous data, a mixture of hexagonal 
and cubic phases of ZnS was produced. The average crystallite size is 4.1 nm, 
but the particles aggregate into clusters with an average diameter of 202 nm. 
The particles were shown to reach their IEP at a pH ~7.8 and upon excitation 
with UV light at 360 nm, they fluoresced in the visible light range; while the 
emission range was broad, the strongest signal was detected at 558 nm ± green 
light. 
 
Introducing NaOH into the reactor during synthesis of ZnS does not appear to 
affect the crystal phase of the product, but the average crystallite size was 
increased to 5.8 nm. This is likely to be due to neutralisation of the reaction 
environment, meaning crystal surfaces are not oxidised and growth continues to 
a degree. The base did have an effect on aggregation as the average cluster size 
was decreased to 165 nm, and the zeta potential data showed that the pH at 
which the IEP of particle was reached had shifted from 7.8 to 8.5. However, the 
obtained fluorescence data was very similar to that of Uncapped ZnS, with a 
broad emission peak and the optimum fluorescence detected at 556 nm ± again, 
green light. 
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The addition of PVP to the synthesis method did not appear to prevent primary 
particles from aggregating; instead the polymer seemed to coat the clustered 
particles. PVP also did not affect the crystal phase of ZnS produced, but the 
calculated average crystallite size was marginally bigger at 4.6 nm. As PVP is a 
non-ionic surfactant, the zeta potential data collected could not conclusively 
show the IEP of ZnS:PVP. The fluorometry analysis did show this sample had a 
red shifted emission peak compared to Uncapped ZnS, with the highest emission 
at 572 nm ± yellow light.  
 
The work described in this Chapter shows that, of the three surfactants tested, 
3-MPA has the most potential in the stabilisation of ZnS nanoparticles. The XRD 
data indicated that hexagonal and cubic phase crystals were produced with a 
smaller calculated crystallite size than Uncapped ZnS ± 3.1 nm - which may be 
due to the prevention of further crystallite growth after 3-MPA had successfully 
bound to the particle surface. While some degree of particle aggregation was still 
evident from the SEM data, the average cluster size had decreased to 157 nm. 
Moreover, the zeta potential data showed a shift in the profile and the IEP was 
reached at pH 4.1. The excitation and emission data was radically different to 
the other samples, with emission blue shifted and reaching a peak at 450 nm ± 
corresponding to violet or blue light. The difference in emission peak position 
between the four samples is likely due to differences in particle band gap 
energies. In addition, the PL emission data from ZnS:3-MPA is in a comparable 
wavelength range to that previously reported for cadmium-based QDs 
(Saraswathi Amma et al., 2008), thus there is the potential to develop ZnS as a 
heavy-metal free QD alternative. 
 
Prior to this work, continuous hydrothermal synthesis had not been used to 
produce fluorescent nanoparticles of ZnS. Although the samples described in this 
work have not been fully stabilised to isolate the primary particles and prevent 
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them from aggregating, their fluorescent potential has been demonstrated, and 
3-MPA was shown to be the most effective at stabilising these ZnS particles. The 
ratio between surfactant and particle concentration must be carefully balanced in 
order to achieve stabilisation, and is dependent on several factors, including 
particle size. It is therefore likely that the surfactant concentrations used in this 
work were insufficient to effectively cap the particles completely. Consequently, 
there is scope for additional studies which investigate the optimum surfactant 
concentration to coat and stabilise ZnS nanoparticles, while supplementary 
analysis could also quantify the quantum yield of these particles. While 
fluorometry analysis has been conducted in this Thesis to assess the PL 
properties of the ZnS particles, other tests can also be carried out to measure 
their electroluminescent properties. This would allow the material to be applied 
in several different potential applications, such as in electronic devices. 
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Chapter 5 
 
5 Magnetic Resonance Imaging 
(MRI) Contrast Agents 
 
5.1  Introduction 
 
  Principles of MRI 5.1.1
 
While X-rays have been used since their discovery in 1895 to gather 
information about the internal structure of human and animal bodies - from 
diagnostic to research purposes ± they are not without their drawbacks. X-rays 
can only image hard tissue, such as bone, clearly; this means soft tissues such 
as tendons, ligaments, organs and even blood cannot be detected or imaged 
well. Furthermore, X-rays are a form of ionising radiation which can, above 
certain thresholds, cause defects in the DNA of individuals exposed to it, and 
lead to knock-on effects - including cancer formation (Chang and Hou, 2011). As 
such, X-ray exposure in patients must be carefully monitored and only used if 
absolutely necessary. From this, there was no doubt that a more effective 
DOWHUQDWLYHZDVUHTXLUHG,QWKH¶VDWHFKQLTXHFDOOHG0DJQHWLF5HVRQDQFH
Imaging (MRI) was developed and applied to the field of medicine, which could 
image the soft tissues and blood in the body, without the use of any form of 
ionising radiation (Mansfield and Maudsley, 1977, Mansfield and Pykett, 1978). 
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An MRI scanner is composed of several parts. The predominant part is a large, 
powerful magnet (a clinical scanner usually has a 1.5 T magnet) which forms a 
cylinder around the area holding the sample or the patient (see Figure 5.1). MRI 
operates by manipulating and measuring the hydrogen atoms present in a 
sample or a patient. Because humans are predominantly composed of water, 
there are plenty of hydrogen atoms to measure. 
 
The positive charge of the hydrogen nuclei (a single proton), coupled with the 
spin it possesses, gives rise to a magnetic field or magnetic moment. Under the 
influence of a large external magnetic field (such as a body or sample being 
placed into an MRI scanner), the magnetic moments of the hydrogen nuclei 
become aligned. Within an MRI scanner, there are Radio Frequency (RF) coils to 
produce extra gradients of magnetic field; these can be rapidly switched on and 
off to create a non-uniform magnetic field in the body or sample being scanned. 
The RF coils emit an RF pulse which is specific to H atoms only, and the energy is 
DEVRUEHGE\ WKHDWRPV7KLVFDXVHV WKHP WR µIOLS¶ VR WKDW WKHPDJQHWLFGLSROH
now faces 180Û IURPLWVSUHYLRXVGLUHFWLRQWhen the RF pulse is switched off, 
the H atoms flip back to their previous alignment in the magnetic field and 
UHOHDVHDVLJQDORU³VSLQHFKR´DVZHOODVWKHHQHUJ\WKDWLt had absorbed. The 
spin echo is made up of several frequencies, which correspond to the different 
positions along the magnetic field gradient; it is detected by the RF coil and is 
converted to its component frequencies. At each frequency, the signal magnitude 
is related to the density of hydrogen nuclei at that respective position. As a 
result, the spin echo signal also contains spatial information and can be used to 
generate a greyscale image (Conn, 2009). 
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Figure 5.1. An image of an MRI scanner depicting the different 
components (Action, 2013). 
 
Where there is a high concentration of hydrogen atoms present (due to the large 
quantity of water), there will be a large signal, and will show up as bright white 
patches in the image. Conversely, where there is a low concentration of H atoms 
(such as lipid or fatty tissues), the signal will be small, and therefore manifest as 
dark patches in the image (Oldendorf, 1988). 
 
Also present in MRI scanners are gradient coils. These can fine tune the 
magnetic field so that only a specific region of the patient or sample is analysed. 
For example, if the liver is of interest then only a cross-section, down to a few 
millimetres, of the liver can be imaged. This cross-VHFWLRQLVNQRZQDVD µVOLFH¶
The presence of these gradient coils also means that different regions can be 
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imaged and analysed without having to move the patient or sample (Conn, 
2009). 
 
  MRI Scans 5.1.2
 
As the RF pulse is switched off, the H nuclei recover to their natural 
alignment; the magnetisation of the nuclei exists along the direction of the 
applied field (termed the longitudinal component or z plane) and perpendicular 
to the direction (termed the transverse component or xy plane). These planes 
are shown in Figure 5.2. Relaxation times T1 and T2, which are typically 
measured during MRI scans, indicate the time required for the recovery of the H 
nuclei to equilibrium, in the longitudinal and transverse components, 
respectively. This forms the basis of the two main types of MRI scan ± T1-
weighted and T2-weighted.  
 
T1 relaxation is also called spin-lattice relaxation and denotes the rate at which 
the longitudinal component of the magnetization vector recovers to equilibrium 
maximum from zero. It measures the degree to which the spins are being 
disrupted by the surrounding tissue, hence it is known as spin-lattice relaxation. 
The image produced distinguishes between water, which appears darker, and 
fat, which is shown as lighter areas (Oldendorf, 1988). 
 
Conversely, T2-weighted scans measure the time (usually in milliseconds, ms) 
taken for the transverse component of the magnetisation vector to recover and 
decay the signal. In the transverse direction, magnetisation recovery is 
dependent on how spins interact with each other and put each other out of 
phase, so it is also called spin-spin relaxation. T2-weighted images are almost an 
inverse of T1-weighted images ± water and fluids appears lighter while fat, 
darker. The T2 relaxation time is actually the time taken for the signal to decay 
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to 37% of its original value (Brown and Semelka, 2010). Figure 5.2 summarises 
the relationship between T2 relaxation time and spin recovery. 
 
 
 
Figure 5.2. A diagram showing the z (longitudinal) and xy (transverse) 
planes of magnetisation. The relationship between T2 relaxation time 
and spin recovery is also summarised (Oldendorf, 1988). 
 
  Relaxation Time, Rate and Relaxivity 5.1.3
 
It is important to note that the relaxation time of a tissue or a contrast 
agent is not to be confused with its relaxation rate. The latter, represented as 
R2, is an inverse of the T2 relaxation time, or 
1/T2. Moreover, contrast agents can 
be compared by their relaxivity, or their ability to increase the relaxation rates of 
the surrounding water proton spins. The relationship between relaxivity, r2, and 
R2 is shown by the following equation (Brown and Semelka, 2010): 
Chapter 5. MRI Contrast Agents 
176 
 
 
Equation 1   R2 = 
ଵ୘ଶǡୌଶ୓ + r2 [Fe] 
 
Where: R2 is 
1/T2 in s
-1; 
T2, H2O is the relaxation time of protons in water (s);  
r2 is the relaxivity of the contrast agent (mM-1 s-1), and  
[Fe] is the concentration of iron (mM) 
 
Rearranging the equation allows for the relaxivity (r2) to be calculated: 
 
Equation 2   r2 = (
ଵ்ଶ - ଵ୘ଶǡୌଶ୓ )/ (Fe) 
 
As T2 relaxation times are concentration-dependent, comparing contrast agents 
by relaxivity rather than T2 times gives a better indication of how effective each 
material is as a contrast agent. 
 
  Role of Contrast Agents 5.1.4
 
In most cases of clinical MRI scans, the region of interest contains tissues 
with sufficient contrast to allow the operator or consultant to distinguish between 
two different tissues (e.g. normal healthy tissue and a tumour). However, this is 
not always true and the different tissues can manifest as two very similar shades 
of grey in the image. To overcome this problem, contrast agents can be used. 
These are materials which can be introduced to a subject or patient, and improve 
visibility of the organ by reducing the T1 or T2 relaxation time of water protons in 
the tissue of interest, thereby enhancing the contrast. Organs which are 
commonly imaged by MRI include the gastrointentinal tract, the brain, liver, and 
spleen (Conn, 2009).  
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Contrast agents are usually inorganic compounds which can be conjugated to a 
chosen biomarker - which will target and bind to a specific tissue, such as a 
tumour, to ensure the contrast agent highlights only a designated region of 
interest (McCann et al., 2011). Contrast agents which are currently used are 
administered either orally or intravenously, depending on the target organ. 
 
Reports indicate particles to be used as contrast agents for MRI must be smaller 
than 5 µm in order to avoid being trapped in the lungs (Bammer et al., 2005). 
Furthermore, particles with superparamagnetic properties (this is where the 
magnetisation is at an average of zero, but particles can become magnetised by 
an external magnetic field) give the best effects for T2-weighted imaging; thus, 
nanoparticles of iron oxide are typically used for transverse scans. These fall into 
two main categories: superparamagnetic iron oxide nanoparticles (SPIONs) and 
ultrasmall superparamagnetic iron oxide nanoparticles (USPIONs); ultrasmall 
nanoparticles are classed as having a diameter 30 nm or smaller (Thomsen and 
Webb, 2009). A few SPION-based contrast agents are commercially available, 
including Feridex IV®, and Combidex® (Stephen et al., 2011). These and a few 
other commercially available contrast agents will be described in Section 5.1.5. 
Meanwhile, T1-weighted scans typically use paramagnetic gadolinium (Gd) or 
manganese (Mn)-based agents (Conn, 2009); these are materials which become 
slightly magnetised when placed in a magnetic field, but lose this magnetism 
when the field is removed. 
 
Coatings may be applied to the surfaces of contrast agents to improve stability 
and dispersion of the particles, thereby preventing coagulation (Tsai et al., 2010) 
(See Chapter 1, Section 1.9.2); to lengthen the shelf life of the suspension; and 
in some cases, to improve the biocompatibility or to provide an anchor on which 
other materials can be attached (Chekina et al., 2011). Other researchers have 
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reported the use of silica (Casula et al., 2011), oleic acid (Zhang et al., 2006), 
and sodium bis(2-ethylhexyl)sulfosuccinate (AOT) (Zheng et al., 2006) as 
coating materials. 
 
Figure 5.3 (a) shows an MR image of the liver of a patient with cancerous 
lesions, without any contrast agents being administered. By contrast, Figure 5.3 
E LVDQ05 LPDJHRI WKHVDPHSDWLHQW¶V OLYHUPLQXWHVDIWHUD72 weighted 
contrast agent had been injected. The targeted cancerous region can be visibly 
seen as the darker area, making it easier for radiologists locate lesions for 
treatment. 
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Figure 5.3. (a) Native MR Image (no contrast agent present) of liver in a 
patient with cholangiocellular carcinoma (cancer), and (b) MR image 
after T2 weighted contrast agent has been administered. Differentiation 
of the lesion is vastly improved after contrast agent is introduced (AG, 
2013). 
 
After a SPION contrast agent is administered (typically by intravenous injection), 
it enters the bloodstream of an animal model or patient and is subsequently 
taken up into the liver, spleen, lymph nodes and bone marrow, through 
phagocytosis (internalisation and ingestion of foreign materials by phagocyte 
cells as a means of cell defence). Once in these organs, the contrast agents can 
begin localised decay of MR signal to create contrasted images (Wang, 2011). 
USPIONs, on the other hand, are small enough to remain in the blood pool, 
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rather than being taken up into organs (Bammer et al., 2005). Once the contrast 
agent takes effect, the window for optimum imaging lasts only a few hours (this 
varies depending on the contrast agent used) as the particles begin to be 
metabolised by lysosomes. These are cell components which secrete enzymes to 
µGLJHVW¶ ZDVWHPDWHULDOV DQG UHPRYH WKHP WKH FRQWUDVW DJHQW LV FRQVHTXHQWO\
broken down and excreted. In the case of SPIONs and USPIONs, these are 
metabolised to a non-superparamagnetic form of iron which can then be 
µUHF\FOHG¶LQFHOOVVXFKDVLQKDHPRJORELQ 
 
In the current market, the most commonly used contrast agents are gadolinium 
(Gd) based molecules. However, as a heavy metal, Gd is extremely toxic and 
accumulation in the body can be fatal. Consequently, the contrast agents are 
synthesised so that the Gd3+ ion is trapped in a molecular cage or strongly 
bound to ligands, so that it does not bind to cell components (Carbonaro et al., 
2011). Other species, including iron oxide-based agents, are arguably better for 
use in MRI as the particles can be digested by natural cell processes without 
posing toxicity risks. In conclusion, good contrast agents feasible for commercial 
application should strike a balance between having high relaxivity and low 
toxicity, whilst being economically feasible. 
 
  Commercial Contrast Agents 5.1.5
 
A variety of nanoscale contrast agents are currently used, or have been used in 
the past, for clinical MRI scans; the majority of these are based on iron oxide 
nanoparticles. A few will be briefly described in this Section. 
 
 
 
Chapter 5. MRI Contrast Agents 
181 
 
 Feridex IV® 5.1.5.1
 
Developed by AMAG Pharmaceuticals, Feridex IV® are SPIONs coated with 
low molecular weight Dextran. Particle size ranges between 120 and 180 nm, 
and its r2 relaxivity is 98.3 mM-1 s-1 (Wang, 2011). Feridex I.V® is used 
specifically for MR imaging in the liver to detect lesions and is administered as a 
drip infusion which takes roughly 30 minutes. Around 6-8% of the SPIONs are 
taken up by the liver starting within 8 minutes of injection, though optimum 
imaging (maximum signal decay) occurs after one hour. The length of time for 
contrast agent activity varies between patients but is typically between 30 
minutes and 6 hours from administration (Wang, 2011). Although Feridex IV® 
was, and possibly still is, used in a clinical background; its manufacture has 
since been discontinued by AMAG Pharmaceuticals (AMAG Pharmaceuticals, 
2013). 
 
 Resovist®  5.1.5.2
 
Produced by Schering AG, the active ingredient in Resovist® are 
carboxydextrane-coated SPIO particles. These have a reported hydrodynamic 
diameter of 45-60 nm, where larger particles are taken up faster, and a r2 
relaxivity of 151 mM-1 s-1 (Wang, 2011). Resovist® is also used for T1-weighted 
MRI, but with mixed results ± therefore it is principally used for T2-weighted 
imaging in the liver. Quick uptake by the reticuloendothelial system (part of the 
ERG\¶V GHIHQFH PHFKDQLVP PHDQV 5HVRYLVW® is effective in as little as 10 
minutes after injection, with approximately 85% of the administered dose taken 
up by cells in the liver. Furthermore, Resovist® has shown a very good safety 
profile and is widely used by radiologists (AG, 2013). 
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 Ferumoxtran-10 5.1.5.3
 
Known as Combidex in the USA and Sinerem in Europe, this contrast 
agent was developed by AMAG Pharmaceuticals and is based on USPIONs (35 
nm in diameter) coated in dextran (Hudgins et al., 2002). Sinerem was used in 
Europe on a clinical basis, but Combidex did not advance past trial stages in the 
USA. Both products have since been discontinued. 
 
The r2 relaxivity of Sinerem was 60 mM-1 s-1 and due to the small size of 
particles, they tended to build up in lymph nodes. However nodes containing 
cancerous tissue, and lacking certain cell components, could not uptake Sinerem 
and hence did not show a decayed MR signal and could be easily spotted 
(Harisinghani et al., 2003). Nevertheless, it took over 24 hours before particles 
were properly uptaken and MR images could be obtained. 
 
In 2009, a study on 296 patients with prostate cancer assessed the use of 
ferumoxtran-10 and MRI to detect cancerous lymph nodes (Heesakkers et al., 
2009). Findings of a 24.1% false positive rate lead to the clinical development of 
ferumoxtran-10 being halted, and AMAG Pharmaceuticals subsequently 
discontinued production. While Combidex/Sinerem had some flaws, the 
underlying research approach into its development is still considered to be 
promising (Wang, 2011). 
 
 Clariscan 5.1.5.4
 
Composed of SPIONs with a carbohydrate polyethylene glycol (PEG) 
FRDWLQJ &ODULVFDQ ZDV GHYHORSHG E\ *( +HDOWKFDUH IRUPHUO\ 1\FRPHG
Imaging). Total particle diameters lie in the region of 20 nm, with r2 relaxivity 
measuring 35.3 mM-1 s-1 (Bjørnerud et al., 2001) &ODULVFDQ LV SULQFLSDOO\
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uptaken to the liver and spleen, and has been used to characterise tumour 
development by providing contrast in the MRI of blood vessels (Wang, 2011). 
+RZHYHUSURGXFWLRQRI&ODULVFDQZDVGLVFRQWLQXHGDPLGVDIHW\FRQFHUQV 
 
 Omniscan® 5.1.5.5
 
The active ingredient in Omniscan® is the Gd(DTPA-
bismethylamide)(H2O) complex, which yields an r2 relaxivity of 3.4 mM
-1 s-1. 
However, it is principally used as a T1-weighted contrast agent due to its good r1 
relaxivity of 4.9 mM-1 s-1 (Dutta et al., 2008). Manufactured by GE Healthcare, 
Omniscan® has been used in clinical applications, mainly in the USA, for over 20 
years. It is administered intravenously, and can be used to image the brain, 
spine, kidney, intrathoracic, intra-abdominal and pelvic regions (Healthcare, 
2013). 
 
  Current Methods of Synthesising Contrast Agents 5.1.6
 
While there is little information publically available detailing the synthesis 
methods for commercial contrast agents, there is a vast array of journal 
publications describing the synthesis and testing of nanomaterials for MRI use. 
 
As is the case with many nanomaterials, co-precipitation is one of the most 
widely used synthesis methods. One example described this synthetic route for 
the production of Fe3O4, NiFe2O4 and CuFe2O4 nanoparticles (Covaliu et al., 
2011). In this study, chitosan and sodium alginate were used to coat the 
particles but while magnetic measurements confirmed the superparamagnetic 
nature of the coated particles, neither their relaxation times nor relaxivities were 
analysed. 
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Other commonly described methods to manufacture magnetic nanoparticles 
include thermal decomposition (Bateer et al., 2013, Khodadadi-Moghaddam et 
al., 2013), microemulsion (Darbandi et al., 2012, Bao et al., 2006), 
hydrothermal synthesis (Haw et al., 2010, Bae et al., 2012) and sonochemical 
routes (Zhang et al., 2012). 
 
Regardless of the synthesis route chosen, a common observation which 
researchers have identified is the need for particles to be coated in order to 
improve biocompatibility and dispersibility in water (Jadhav and Bongiovanni, 
2012, Karimi et al., 2013). 
 
  Chapter Aims 5.1.7
 
To avoid these issues of toxicity, this Chapter focuses on non-Gd based 
contrast agents, namely iron oxide nanoparticles hematite (Fe2O3) and magnetite 
(Fe3O4). Hence the aim of this Chapter is to use the counter-current Nozzle 
reactor to synthesise materials of interest as MRI contrast agents, and to 
characterise their respective particle sizes, crystallinity, and applicability as a 
contrast agent, where the latter will be measured as the T2 time. These values 
ZLOOWKHQEHXVHGWRFDOFXODWHWKHPDWHULDO¶VUHOD[LYLW\ 
 
Although the principle focus will be on iron oxides synthesised by the continuous 
hydrothermal reactor, and their suitability as T2-weighted contrast agents, cobalt 
oxide (Co3O4) and gadolinium hydroxide (Gd(OH)3) will also be synthesised and 
analysed. These materials were chosen because they have previously been 
manufactured successfully on the counter-current Nozzle reactor (Lester et al., 
2012). Furthermore, cobalt-based nanoparticles have reportedly exhibited 
positive results for MRI (Parkes et al., 2008). Although Gd-based contrast agents 
after typically used for T1-weighted MR imaging, it is possible these particles also 
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exhibit positive results for T2-weighted scans (Dutta et al., 2008); hence, 
Gd(OH)3 will also be tested along with the iron oxide samples. 
 
Products will be produced pure (no coatings or surfactants added), or with one of 
three different polymers added as a coating; these being polyvinylpyrrolidone 
(PVP), dextran or sodium alginate. PVP was chosen due to its known 
biocompatibility, low cost and its widespread availability (Sharma et al., 2010); 
Dextran has been widely reported as a surfactant for Fe3O4 particles in MRI 
applications (Ding et al., 2010, Mornet et al., 2004); and sodium alginate has 
been reported in coating magnetic nanoparticles for biomedical applications (Mu 
et al., 2012, Covaliu et al., 2011). 
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5.2  Methodology 
 
  Hydrothermal Synthesis of Nanoparticles 5.2.1
 
The reagents used for synthesis were hydrogen peroxide, H2O2; iron (III) 
nitrate nonahydrate, Fe(NO3)3.9H22SXULWy); ammonium iron (III) citrate, 
NH3 Fe(C6H5O7) (reagent grade); cobalt acetate tetrahydrate, Co(CH3COO)2·4H2O 
(reagent grade); gadolinium (III) acetate hydrate, Gd(CH3CO2)3·xH2O (99.9% 
purity); polyvinylpyrrolidone (PVP), (C6H9NO)n (average molecular weight of 
10,000); dextran low fraction, (C6H10O5)n, from Acros Organics; and sodium 
alginate, NaC6H7O6. 
 
Unless otherwise stated, all chemical reagents were purchased from Sigma 
Aldrich (UK) and used without further purification. DI grade water was used for 
the work in this Chapter. 
 
 Hematite, Fe2O3 5.2.1.1
 
To produce Fe2O3, a 0.05 M Fe(NO3)3.9H2O aqueous solution was used as 
a precursor. A brief reaction schematic with flows and flow rates can be seen in 
Figure 5.4. Three different reaction temperatures were employed to produce 
samples, ~150, ~200 and ~300 °C, as this has previously been shown to affect 
particle size (Li, 2008). For each of these temperatures, a control sample was 
produced without any surfactants, and then each of the three capping agents, 
PVP 10, dextran or sodium alginate, was introduced. Therefore, twelve samples 
of Fe2O3 were synthesised. The temperatures at different points in the reactor 
system are summarised in Table 5.1, Table 5.2 and Table 5.3. The positions of 
the thermocouples where these temperatures were logged can be found in 
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Chapter 1, Section 1.7.2.1. For all samples, the system pressure was maintained 
at 240 bar by the BPR. Previous unpublished work by other researchers using 
the Nozzle reactor found that adding surfactants or capping agents at the second 
metal salt pump was more effective at coating particles than introducing them at 
the capping point. It is for this reason that the capping agents were introduced 
in this manner. 
 
 
 
Figure 5.4. A schematic diagram showing the reaction setup for 
synthesis of Fe2O3. 
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Table 5.1. Summary of Temperatures and Flows for first set of Fe2O3 
Samples. 
Sample 
Name 
Capping 
Agent Flow 
Temperatures (°C) 
Water 
Heater Set 
Point 
After 
Heater 
Post 
Mixing 
Point 
Capping 
Point 
Post 
Cooler 
HEM A1 Water 
185 154 107 71 29 
HEM A2 
1 wt% PVP 
10 
HEM A3 
1 wt% 
Dextran 
HEM A4 
0.25 wt% 
Sodium 
Alginate 
 
 
Table 5.2. Summary of Temperatures and Flows for second set of Fe2O3 
Samples. 
Sample 
Name 
Capping 
Agent Flow 
Temperatures (°C) 
Water 
Heater Set 
Point 
After 
Heater 
Post 
Mixing 
Point 
Capping 
Point 
Post 
Cooler 
HEM B1 Water 
240 203 135 86 31 
HEM B2 
1 wt% PVP 
10 
HEM B3 
1 wt% 
Dextran 
HEM B4 
0.25 wt% 
Sodium 
Alginate 
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Table 5.3. Summary of Temperatures and Flows for third set of Fe2O3 
Samples. 
Sample 
Name 
Capping 
Agent Flow 
Temperatures (°C) 
Water 
Heater Set 
Point 
After 
Heater 
Post 
Mixing 
Point 
Capping 
Point 
Post 
Cooler 
HEM C1 Water 
345 307 206 117 38 
HEM C2 
1 wt% PVP 
10 
HEM C3 
1 wt% 
Dextran 
HEM C4 
0.25 wt% 
Sodium 
Alginate 
 
The twelve synthesised samples were characterised using a 0.5 T MRI scanner to 
measure their T2 times (see Section 5.2.2), and using DLS to determine the 
particle size of each sample. Samples HEM A1, B1 and C1 were oven dried in air 
at 70 °C overnight to obtain powders; these were then analysed using XRD. 
Details of the DLS and XRD equipment used were given in Chapter 2. 
 
  Magnetite, Fe3O4  5.2.1.2
 
For the synthesis of Fe3O4, a 0.05 M NH3 Fe(C6H5O7) aqueous solution was 
used as a precursor. Figure 5.5 shows a simple reaction schematic of the flow 
orientations and flow rates. Samples were produced with the water heater set at 
two different temperatures: ~350 and ~400 °C. For each of these temperatures, 
a control sample was produced without any surfactants, and then each of the 
three capping agents, PVP 10, dextran or sodium alginate, were introduced. In 
total, eight samples of Fe3O4 were obtained. The temperatures at different points 
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in the reactor system are summarised in Table 5.4 and Table 5.5. The positions 
of the thermocouples where these temperatures were logged can be found in 
Chapter 1, Section 1.7.2.1. For all samples, the system pressure was maintained 
at 240 bar by the BPR. 
 
 
 
Figure 5.5. A schematic diagram showing the reaction setup for Fe3O4 
synthesis. 
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Table 5.4. Summary of Temperatures and Flows for First Set of Fe3O4 
Samples. 
Sample 
Name 
Capping 
Agent Flow 
Temperatures (°C) 
Water 
Heater 
Set Point 
After 
Heater 
Post 
Mixing 
Point 
Capping 
Point 
Post 
Cooler 
MAG F1 Water 
385 353 239 127 40 
MAG F2 1 wt% PVP 10 
MAG F3 
1 wt% 
Dextran 
MAG F4 
0.25 wt% 
Sodium 
Alginate 
 
 
Table 5.5. Summary of Temperatures and Flows for Second Set of Fe3O4 
Samples. 
Sample 
Name 
Capping 
Agent Flow 
Temperatures (°C) 
Water 
Heater 
Set Point 
After 
Heater 
Post 
Mixing 
Point 
Capping 
Point 
Post 
Cooler 
MAG G1 Water 
450 402 340 211 50 
MAG G2 1 wt% PVP 10 
MAG G3 
1 wt% 
Dextran 
MAG G4 
0.25 wt% 
Sodium 
Alginate 
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Samples MAG G1-G4 were characterised using a 0.5 T MRI scanner and a 2.35 T 
MRI scanner to measure their T2 times (see Section 5.2.2). Samples MAG G1 and 
G3 were oven dried in air at 70 °C overnight to obtain powders, and analysed 
using XRD. These two samples were also analysed using TEM, for particle size 
and morphology data. Details of the XRD and TEM equipment used were given in 
Chapter 2. 
 
 Cobalt Oxide, Co3O4  5.2.1.3
 
The synthesis of Co3O4 was performed for a separate study (Moro et al., 
2013), however a sample was also taken for MRI analysis. Here, a 0.05 M 
Co(CH3COO)3 aqueous solution was used as a precursor. Figure 5.6 shows a 
simple reaction schematic of the flow orientations and flow rates. Hydrogen 
peroxide, H2O2, was added to the water feed during synthesis, to provide a more 
oxidising environment for the breakdown of the CH3COO
- ion from the precursor, 
and to drive oxidation of the Co3+ cation. Samples were produced with the water 
heater set at a temperature of ~400 °C. Unlike the samples of Fe2O3 and Fe3O4, 
no surfactants were added to the synthesis of Co3O4 as it was not required for 
the separate study, and so one sample was obtained. The temperatures at 
different points in the system during synthesis are summarised in Table 5.6. The 
positions of the thermocouples where these temperatures were logged can be 
found in Chapter 1, Section 1.7.2.1. For all samples, the system pressure was 
maintained at 240 bar by the BPR. 
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Figure 5.6. A schematic diagram showing the reaction setup for Co3O4 
synthesis. 
 
 
Table 5.6. A Summary of Temperatures for the Synthesis of Co3O4 
Sample. 
Sample 
Name 
Temperatures (°C) 
Water 
Heater Set 
Point 
After 
Heater 
Post 
Mixing 
Point 
Capping 
Point 
Post 
Cooler 
Co3O4 430 427 376 173 32 
 
Chapter 5. MRI Contrast Agents 
194 
 
The sample of Co3O4 was analysed using a 0.5 T MRI scanner (see Section 
5.2.2). Because this material was produced as part of a separate study, XRD and 
TEM was also conducted on the sample and the acquired data will be presented 
in this Chapter. 
 
 Gadolinium Hydroxide, Gd(OH)3  5.2.1.4
 
To synthesise Gd(OH)3, a 0.05 M Gd(CH3COO)3 aqueous solution was 
used as a precursor. Figure 5.7 shows a simple reaction schematic of the flow 
orientations and flow rates. Hydrogen peroxide, H2O2, was added to the water 
feed during synthesis to provide a more oxidising environment for the 
breakdown of the CH3COO
- ion from the precursor, and to drive oxidation of the 
Gd3+ cation. Samples were produced with the water heater set at one of two 
temperatures. At each temperature, a control sample was produced without any 
surfactants, and then each of the three capping agents, PVP 10, dextran or 
sodium alginate, was introduced. In total, eight samples were obtained. The 
temperatures at different points in the reactor system are summarised in Table 
5.7 and Table 5.8. The positions of the thermocouples where these temperatures 
were logged can be found in Chapter 1, Section 1.7.2.1. For all samples, the 
system pressure was maintained at 240 bar by the BPR. 
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Figure 5.7. A schematic diagram showing the reaction setup for Gd(OH)3 
synthesis. 
 
Table 5.7. A Summary of Temperatures and Flows for the Synthesis of 
the First Set of Gd(OH)3 Samples. 
Sample 
Name 
Capping 
Agent Flow 
Temperatures (°C) 
Water 
Heater 
Set Point 
After 
Heater 
Post 
Mixing 
Point 
Capping 
Point 
Post 
Cooler 
GAD D1 Water 
385 352 191 124 46 
GAD D2 1 wt% PVP 10 
GAD D3 
1 wt% 
Dextran 
GAD D4 
0.25 wt% 
Sodium 
Alginate 
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Table 5.8 . A Summary of Temperatures and Flows for the Synthesis of 
the Second Set of Gd(OH)3 Samples. 
Sample 
Name 
Capping 
Agent Flow 
Temperatures (°C) 
Water 
Heater 
Set Point 
After 
Heater 
Post 
Mixing 
Point 
Capping 
Point 
Post 
Cooler 
GAD E1 Water 
450 406 303 185 60 
GAD E2 1 wt% PVP 10 
GAD E3 
1 wt% 
Dextran 
GAD E4 
0.25 wt% 
Sodium 
Alginate 
 
The four Gd(OH)3 samples produced in the second experimental set were 
characterised using a 0.5T MRI scanner (see Section 5.2.2). Sample GAD E1 was 
also oven dried at 70 °C overnight to yield a white powder, which was then 
analysed using XRD to confirm the crystal phase produced. 
 
  MRI Characterisation of Samples 5.2.2
 
  Halbach 0.5T Table-Top Scanner 5.2.2.1
 
Due to the high sample turnover from the continuous hydrothermal 
reactor, a large number of samples were synthesised. A preliminary MRI 
screening process was employed to ascertain an average T2 relaxation time for 
each sample. This was conducted using a 0.5 T Halbach MRI system, based at 
Nottingham Trent University, using a repetition time of 2000 ms and 4 averages; 
thus each scan took 8 seconds. For the majority of samples, 128 echoes were 
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used; however, with the sample of Co3O4 and its precursor, 512 echoes were 
chosen to provide a more reliable result. Data analysis was performed with 
Prospa v2.1 software. This scanner, a photo of which is given in Figure 5.8, 
provided a rapid method for measuring T2 values for each sample. Those which 
were most promising were then characterised further using DLS or TEM, and 
where appropriate, XRD. Details of these techniques were given in Chapter 2. 
Samples with low T2 relaxation times from the 0.5 T Halbach system were also 
tested on a more powerful MRI scanner ± a 2.35 T Bruker kit (described in 
Section 5.2.2.2.). 
 
 
 
Figure 5.8. Photo of the Halbach 0.5 T Table-Top MRI Scanner at 
Nottingham Trent University. 
 
 Bruker 2.35 T Scanner  5.2.2.2
 
A select number of samples were taken forward to be scanned on the 
Bruker Biospin 2.3 T MRI system, based at Nottingham Trent University, and T2 
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images were acquired. A photo of the equipment is shown in Figure 5.9. For each 
scan, a multi slice multi echo (MSME) sequence and the following parameters 
were used: 
Field of View = 7 cm x 7 cm 
Repetition Time = 2000 ms 
Slice Thickness = 3 mm 
Number of Slices = 5 
Echo Time = 10.25 ms 
Number of echoes = 24 
 
It should be noted that 1 pixel in the obtained images corresponds to 
approximately 0.3 mm of real space. 
 
 
 
Figure 5.9. Photos of the Bruker 2.35 T MRI scanner at Nottingham Trent 
University. 
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5.3 Results and Discussion 
 
 Hematite, Fe2O3 5.3.1
 
The four samples of Fe2O3 synthesised at ~150 °C are shown in the 
photograph in Figure 5.10. Likewise, the four samples produced at ~250 °C are 
displayed in Figure 5.11, and the four samples obtained at ~350 °C are shown in 
Figure 5.12. When a laser light was passed through each sample vial, a beam 
path could be seen ± indicative of particles being present in all samples. As the 
synthesis temperature increased, the colour of the samples became darker ± this 
could be an indication of a change to particle size, or a difference in particle 
concentration. 
 
 
 
Figure 5.10. Photograph of Fe2O3 Samples in First Temperature Set. 
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Figure 5.11. Photograph of Fe2O3 Samples in Second Temperature Set. 
 
 
 
 
 
Figure 5.12. Photograph of Fe2O3 Samples in Third Temperature Set. 
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The T2 relaxation times of the 12 HEM samples are given in Table 5.9; these 
were measured using the Halbach 0.5 T table-top scanner. Also shown in Table 
5.9 are the r2 relaxivities of each of the samples, calculated using Equation 2 
which was stated in Section 5.1.3. For a more straightforward comparison of the 
different T2 times, the data is summarised as a bar chart in Figure 5.13. 
 
Table 5.9. Summary of the measured T2 relaxation times for the Fe2O3 
samples, precursor and water blank. The r2 values, calculated using 
Equation 2, are also given. 
 
 
 
Sample Code 
T2 Time 
(ms) 
Error (±) r2 (mM-1 s-1) 
HEM A1 7.44 0.01 8.03 
HEM A2 6.89 0.01 8.68 
HEM A3 6.66 0.01 8.98 
HEM A4 8.56 0.01 6.98 
HEM B1 8.13 0.01 7.35 
HEM B2 7.43 0.01 8.04 
HEM B3 7.25 0.009 8.24 
HEM B4 8.31 0.01 7.19 
HEM C1 8.08 0.008 7.40 
HEM C2 9.18 0.009 6.51 
HEM C3 8.99 0.01 6.64 
HEM C4 9.25 0.01 6.46 
0.05 M Iron Nitrate 
Nonahydrate 
15.6 0.002 1.27 
Water 2122 0.01 - 
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Given the T2 and r2 data presented in Table 5.9, the set of samples with the 
highest and most promising relaxivities are HEM A ± samples synthesised at the 
lowest reaction temperature. These samples were therefore taken for addition 
analysis using the Bruker 2.35 T scanner. The images obtained from these scans 
are presented in Figure 5.14. 
 
 
 
Figure 5.13. A bar chart summarising the r2 relaxivities of the 12 
samples of synthesised Fe2O3, calculated using the T2 times acquired 
using the 0.5 T Halbach scanner, and Equation 2. 
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Figure 5.14. Images collected from the 2.35 T MRI scanner showing T2 
relaxation times (in ms) and R2 relaxation for a) Fe(NO3)3.9H2O, b) HEM 
A1, c) HEM A2, d) HEM A3, e) HEM A4. 
 
The data acquired from the T2 scans indicate that samples HEM A1-4 have the 
highest relaxivity, compared to the samples synthesised at different 
temperatures. The particle size data obtained using DLS is given in Figure 5.15 
and shows that, with the exception of sample HEM A2 (PVP 10 coating), samples 
produced at this temperature contain the smallest particles. From this, it can be 
gathered that smaller particles result in increased proton relaxation and MR 
signal decay, a trend consistent with what has previously been described in 
literature. It can be seen from Figure 5.13 that for each of the capping agents 
used, r2 decreases as synthesis temperature increases.  
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Figure 5.15. A chart summarising the particle size data obtained from 
DLS analysis, for the 12 synthesised Fe2O3 samples. 
 
The DLS data presented in Figure 5.15 shows that, in general, particle size 
increases with an increase in temperature. This is a pattern seen previously for 
Fe2O3 synthesised in the counter-current Nozzle reactor (Li, 2008). Nevertheless, 
sample HEM A2 serves as an exception. One possible explanation for the large 
particles measured in HEM A2 is that these large particles are globules of PVP 
10, as opposed to Fe2O3. At a low reaction temperature of 150 °C, it is possible 
(or altogether probable) that conversion rate of precursor to particles is low. As 
such, the concentration ratio of PVP 10 to Fe2O3 in the product is skewed in 
favour of the former. This excess of polymer could result in it binding to itself 
rather than to the nanoparticles. 
 
The DLS data for samples containing sodium alginate as a capping agent (HEM 
A4, HEM B4 and HEM C4) suggest the particles have a significantly larger 
diameter than the uncoated particles. Parallel to this data, these samples have 
the r2 relaxivities across their sample sets. Moreover, the MR image obtained for 
HEM A4 using the Bruker 2.35 T scanner and displayed in Figure 5.14 e), shows 
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a colour gradient across the circle. This is because the particles, which are 
causing signal decay, are sedimenting at the bottom of the sample cell. 
Conversely, the particles are more dispersed in the uncoated sample HEM A1. 
This data suggests that the addition of sodium alginate FUHDWHV D ³PDWUL[´ RU
network around the particles, forming a large aggregate rather than coating 
individual particles. This amorphous matrix surrounding the particles hinders the 
superparamagnetic effect of the Fe2O3 nanoparticles, as well as enveloping 
particles into a larger entity ± which leads to sedimentation. Moreover, the 
photos of samples HEM A4, HEM B4 and HEM C4 in Figure 5.10, Figure 5.11 and 
Figure 5.12 respectively, show that the dispersions are more opaque than their 
uncoated counterparts; this suggests particle flocculation is occurring which 
could be due to a sodium alginate matrix. 
 
In sample sets HEM A and HEM B, the samples containing dextran as a capping 
agent (HEM A3 and HEM B3) yield the highest r2 relaxivities ± this is 
unsurprising as dextran is commonly used to coat superparamagnetic particles 
for MRI. Interestingly, this is not the case for sample HEM C3, which has a lower 
r2 relaxivity than the equivalent uncoated particles in HEM C1. This could be 
attributed to thermal decomposition of dextran in the reactor during synthesis, 
which has been reported to occur at temperatures ca. 300 °C (Carp et al., 2010) 
± the temperature used to synthesise samples in the HEM C set. The DLS data 
for sample HEM C3 also shows smaller particles than in HEM B3, and does not 
follow the trend of increasing particle size with increasing temperature. This 
result reinforces the notion of thermal breakdown; the resulting fragments of 
dextran would not scatter light in the same way as if there were coated particles, 
and the latter would have a larger hydrodynamic radius. 
 
The XRD data for Samples HEM A1, HEM B1 and HEM C1 are given in Figure 
5.16, along with the expected peak positions for Fe2O3. The three patterns do 
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not exhibit strong peaks, suggesting that the samples are quite amorphous. In 
addition, the XRD data may be influenced by small crystallite sizes in the 
samples, which would give rise to peaks with a broad width. Still, HEM A1 and 
+(0&GRFRQWDLQSHDNVFDǇ 33.1 and 35.7 °, which correspond to Fe2O3. 
For sample HEM B1, these peaks are not obvious but signal intensity does 
LQFUHDVHDOLWWOHDURXQGWKHVHǇUHJLRQVVXJJHVWLQJWKDWWKLVSKDVHPD\DOVREH
present in tKLVVDPSOH,Q+(0&WKHH[WUDSHDNDWǇ FRUUHVSRQGVWR
a peak for iron nitrate hydroxide hydrate, Fe4NO3(OH)11.2H2O (ICCD PDF 44-
519). This composition is similar to the starting precursor, which suggests that 
there may be incomplete conversion during the reaction. 
 
 
 
Figure 5.16. XRD patterns obtained for samples HEM A1, HEM B1, and 
HEM C1. At the bottom are the expected peak positions for Fe2O3 (ICCD 
PDF 86-550). 
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  Magnetite, Fe3O4 5.3.2
 
The samples produced at a temperature ~350 °C (MAG F1-4) were a 
similar colour to the precursor. When a laser light was passed through each 
sample vial, no beam path could be seen, suggesting that no particles were 
produced at this temperature. It is likely that this temperature is insufficient to 
drive synthesis of Fe3O4. Therefore, samples MAG F1-4 were not characterised or 
analysed further. 
 
The samples synthesised at a temperature of ~400 °C (MAG G1-4) are shown in 
Figure 5.17. All four samples were dark brown in colour and the particles 
sedimented to the bottom of the vial over time. Due to this sedimentation, the 
samples could not be analysed using DLS (the reasons for this were discussed in 
Chapter 2 Section 2.6). 
 
 
 
Figure 5.17. Photo of Fe3O4 Samples in Second Temperature Set. 
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The four samples, along with the precursor, were tested on the 0.5 T Halbach 
MRI Scanner and their T2 times obtained. These values, as well as the T2 time of 
water for comparison, are presented in Table 5.10. It can be seen that the T2 
times for all four samples are significantly shorter than that of water, and much 
shorter than that of the precursor ± confirming that the synthesised particles are 
having a positive effect on proton relaxation. The data shows that, while the 
DGGLWLRQRI393KDV OLWWOHHIIHFWRQ WKHSDUWLFOH¶V72 time (MAG G1 compared to 
MAG G2), the incorporation of dextran shortens the T2 time significantly (as seen 
from MAG G3). This, in turn, increases the r2 value from 22.68 to 33.47 mm-1 s-
1. On the contrary, the addition of sodium alginate appears to have a detrimental 
effect on the relaxation effect, as the T2 time for MAG G4 is much higher than 
that of MAG G1. 
 
Table 5.10. Summary of the T2 relaxation times for the Fe3O4 samples, 
precursor and water blank, measured using the Halbach 0.5 T MRI 
Scanner. The r2 values, calculated using Equation 2, are also given. 
 
The Fe3O4 samples were tested using a 2.35 T Bruker MRI scanner; the obtained 
images depicting proton T2 relaxation time (ms) and the corresponding R2 
Sample Code 
T2 Time 
(ms) 
Error (±) r2 (mM-1 s-1) 
MAG G1 2.642 0.01 22.68 
MAG G2 2.634 0.009 22.75 
MAG G3 1.791 0.007 33.47 
MAG G4 4.84 0.02 12.37 
0.05 M Ammonium Iron 
Citrate 
44.28 0.02 0.44 
Water 2122 0.01 - 
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relaxation are given in Figure 5.18. In Figure 5.18 (a), the T2 relaxation time for 
water is so high, that the image appears as if there is no sample present. 
Likewise the R2 relaxation value is so low that there is no discernible difference 
between the water sample and background. 
 
 
Figure 5.18. Images collected from the 2.35 T MRI scanner showing T2 
relaxation times (in ms) and R2 relaxation for (a) water blank, (b) 0.025 
M Ammonium Iron Citrate (precursor), (c) MAG G1, (d) MAG G2, (e) 
MAG G3, and (f) MAG G4. 
 
On the contrary, The T2 relaxation times for samples MAG G1-4 are much 
shorter, and correspond to the values shown in Table 5.10. The non-circular 
image seen in Figure 5.18 (f) generated by sample MAG G4 is cause by an air 
bubble present in the sample vial during analysis, rather than the MR properties 
of the sample itself. The colour of the obtained images for MAG G4 are 
significantly different to those of MAG G1-3 - ascribed to its longer T2 relaxation 
time, and smaller R2, compared to the other three samples. This is consistent 
with the data obtained using the Halbach 0.5 T system. 
 
The r2 relaxivity values can be calculated using the T2 times and the theoretical 
concentration of Fe in the samples, and are summarised in Table 5.10. The 
Chapter 5. MRI Contrast Agents 
210 
 
relaxivity of all the synthesised samples of Fe3O4 are lower than the commercial 
contrast agents Feridex IV®, which has a relaxivity of 98.3 mM-1 s-1 (Wang, 
2011), and Resovist®, which has an r2 value of 151 mM-1 s-1 (Wang, 2011). This 
is most likely to be due to effects of particle coagulation, thereby eliminating the 
benefits seen at the nanoscale. This is a common problem when synthesising 
nanoparticles, especially Fe3O4, and so surfactants or capping agents need to be 
introduced. 
 
The addition of PVP to the synthesis reaction has little effect on relaxivity, and a 
similar value to the uncapped sample is derived, 22.75 mM-1 s-1. This may be 
because PVP is not having a very effective stabilising influence on the Fe3O4 
particles; or that the PVP is indeed preventing particle aggregation to some 
degree, but also reducing the surface interactions of the particles. 
 
Sample MAG G4, with sodium alginate as a capping agent, has a much longer T2 
time than the other samples, and consequently a lower relaxivity of 12.37 mM-1 
s-1. This could be a result of the capping agent interacting with the surfaces of 
the Fe3O4 particles and hindering the superparamagnetic properties. 
 
Lastly, sample MAG G3 shows the most promise as a contrast agent, with a T2 
time of 1.79 ms and corresponding r2 of 33.47 mM-1 s-1 ± a relaxivity 
comparable to some of the commercial contrast agents highlighted in Section 
5.1.5. In sample HEM C3, which was discussed in Section 5.3.1, a detrimental 
effect on r2 relaxivity was observed with the incorporation of dextran as a 
capping agent ± this was attributed to possible thermal decomposition of the 
surfactant. Interestingly, this effect is not seen in the case of MAG G3 in 
comparison to MAG G1, the uncoated sample, despite reaction temperatures ca. 
400 °C. Instead, dextran improves the r2. This difference in results could be due 
to the phase change of water into the supercritical re
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synthesis compared to water being subcritical during synthesis of HEM C3. At the 
supercritical state, water is less dense and in turn, the residence time of 
particles/dextran in the reactor is shorter. This means dextran is exposed to the 
high temperatures in the reactor for less time during synthesis of MAG G3 and 
may not be enough time for thermal decomposition to occur. 
 
While the r2 value for MAG G3 is promising, but lower than some commercial 
contrast agents, it is derived from a theoretical concentration of Fe which 
assumes 100% conversion during the synthesis reaction. Therefore, it is possible 
that the actual concentration of Fe in the sample is lower, thus yielding a higher 
relaxivity still. If the ratio of Fe3O4 and dextran were optimised to ensure there is 
no particle aggregation at all, it is likely that the relaxivity could be enhanced 
further. 
 
As MAG G3 gave this promising T2 result, it was characterised further. The 
sample was dried to a powder and analysed using XRD to ascertain its crystal 
structure. XRD was also performed on sample MAG G1, for comparison. The XRD 
patterns of both samples are given in Figure 5.19, with the reference peak 
positions of cubic phase Fe3O4 also shown. All the peaks corresponding to the 
reference phase are present in both samples, confirming that cubic phase Fe3O4 
is the predominant crystal structure for both MAG G1 and G3. Nevertheless, 
there are differences between the two samples; the pattern for MAG G3 contains 
a lot more noise than that of MAG G1. This may be due to the amorphous 
dextran content in MAG G3, which is not present in MAG G1. 
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Figure 5.19. XRD patterns obtained for samples MAG G1 and MAG G3. At 
the bottom are the expected peak positions for cubic Fe3O4 (ICCD PDF 
88-315). 
 
The images of MAG G1 collected using TEM analysis are shown in Figure 5.20. It 
can be seen that the particles are spherical in morphology with their diameters 
measuring between 9 and 30 nm. TEM images collected at a higher 
magnification (Figure 5.20 (b)) highlight the crystalline nature of the particles. 
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Figure 5.20. (a) and (b) are TEM images of MAG G1, uncoated Fe3O4. 
 
A TEM image collected for sample MAG G3 is given in Figure 5.21. It was seen 
that particle morphology and size did not deviate significantly from those seen in 
MAG G1. Yet the principle difference observed between the two samples was the 
apparent presence of an amorphous coating around the Fe3O4 particles in MAG 
G3 ± ascribed to dextran. It can be seen that while the dextran sufficiently 
covers the entirety of the nanoparticles, it does appear that there is still some 
degree of particle aggregation which the dextran has not completely prevented. 
Here, the capping agent is enveloping the small clusters of particles, rather than 
coating the individual particles as desired. This is an issue which can be 
addressed by either changing (increasing) the concentration ratio of dextran to 
iron precursor used, or altering the method of how the dextran is introduced to 
coat the particles. This provides scope for future work. 
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Figure 5.21. TEM image of MAG G3, Fe3O4 nanoparticles coated in 
dextran. 
 
  Gadolinium Hydroxide, Gd(OH)3 5.3.3
 
The first set of Gd(OH)3 samples synthesised with the water heater set 
point at 385 °C all gave rise to transparent, colourless samples. When tested 
with a laser pointer, no beam path could be seen ± indicating no particles were 
present. As such, it was concluded that the reaction temperature was not high 
enough to produce particles and the samples were not characterised further. 
 
The second set of samples manufactured with the water heater set point at 
450 °C yielded the samples shown in Figure 5.22. Sample GAD E1 was 
translucent with a white haze, and when tested with a laser pointer, showed a 
positive beam path. GAD E3 and E4 were a more opaque white, while GAD E2 
appeared to contain a slight yellow tinge. The particles in all four samples 
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sedimented over time, meaning particle sizing by DLS technique was not 
possible. A day or so after synthesis, the particles in GAD E1 dissolved; this may 
be due to the HNO3 which is produced as a by-product. Still, before this 
occurred, a sample of the particles were dried and analysed by XRD. 
 
 
 
Figure 5.22. Photo of the Second Set of Gd(OH)3 Samples. 
 
The four samples of Gd(OH)3 produced in the second experimental set were 
analysed using the Halbach 0.5 T scanner, along with the precursor, and the 
obtained T2 times are shown in Table 5.11. Their r2 relaxivities were calculated 
using the measured T2 times and Equation 2 which was listed in Section 5.1.3. 
These are also displayed in Table 5.11. It can be seen the T2 time for the 
precursor, gadolinium acetate hydrate, is the lowest value obtained for this 
sample set, at 1.69 ms. Hence the calculated r2 relaxivity of 11.82 mM-1 s-1 is the 
highest for all in this sample set. This is unsurprising, as the Gd3+ ion has been 
reported as having the highest degree of paramagnetism of all metal ions (Dutta 
et al., 2008). Nevertheless, the cytotoxicity issues associated with Gd3+ ions 
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which were previously described in Section 5.1.4 mean it cannot be used as a 
free ion for clinical MRI applications. 
 
Table 5.11 also shows that a relatively low T2 time and high r2 value is produced 
from GAD E1, uncapped Gd(OH)3 ± 7.32 ms and 8.17 mM-1 s-1 respectively. 
However, it was observed that the white particles which were produced in this 
VDPSOHEHJDQWRµGLVDSSHDU¶DIWHU a day of so. This is likely to be due to chemical 
decomposition caused by HNO3 which is produced as a by-product. 
Consequently, it is probable that particle breakdown occurred before and during 
analysis. This means the Gd(OH)3 particles were being dissolved to yield Gd
3+ 
ions and give rise to the efficient signal decay in MRI scans. While a good T2 and 
r2 result, this sample presents the same problem of cytotoxicity as the precursor 
and cannot be considered as a potentially viable contrast agent. 
 
Table 5.11. Summary of the measured T2 relaxation times for the 
Gd(OH)3 samples, precursor and water blank. The r2 values, calculated 
using Equation 2, are also given. 
 
 
Sample Code 
T2 Time 
(ms) 
Error (±) r2 (mM-1 s-1) 
GAD E1 7.32 0.01 8.17 
GAD E2 17.2 0.02 3.46 
GAD E3 9.952 0.01 6.00 
GAD E4 16.26 0.02 3.66 
0.025 M Gadolinium 
Acetate Hydrate 
1.69 0.001 11.82 
Water 2122 0.01 - 
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Unlike sample GAD E1, samples GAD E2-4 did not exhibit visible signs of particle 
decomposition after synthesis. The T2 and r2 values for GAD E2 and GAD E4 are 
very similar, with GAD E2 possessing a relaxivity of 3.46 mM-1 s-1 and GAD E4 of 
3.66 mM-1 s-1. These values, a fair degree lower than GAD E1 and the precursor, 
suggests that PVP and sodium alginate are having an effect in coating particles 
and preventing particle decomposition. Still, the extent of this positive effect 
cannot be concluded from this data, as the T2 and r2 data may also be affected 
by the capping agents themselves either enhancing or pacifying the 
paramagnetic behaviour of the Gd(OH)3 particles. 
 
Sample GAD E3, with dextran as the capping agent, shows a promising T2 time 
of 9.952 ms, which translates to an r2 of 6.00 mM-1 s-1. Like the other GAD 
samples though, it cannot be determined from this data if the signal decay can 
be entirely attributed to the synthesised particles, or if it due (even in part) to 
the presence of Gd3+ ions present in the samples. To eliminate this possibility 
during analysis in future work, samples should be washed prior to analysis. 
 
The relaxivity of GAD E3, and those of GAD E2 and GAD E4, are quite 
comparable to that of the commercial contrast agent Omniscan®, which has an 
r2 of 3.4 mM-1 s-1. As well as the possible presence of Gd3+ ions in the samples 
which has been discussed, it should also be noted that the Gd-based complexes 
in Omniscan® contain tightly bound ligands to prevent leaching of toxic ions. 
These could be partially diminishing the paramagnetic properties of Gd3+ ions 
and decreasing the r2 value. Nevertheless, the r2 values of the Gd(OH)3 samples 
described in the Chapter show promising r2 data which provides scope for 
further future investigation. 
 
To confirm the nanomaterial species being produced in this set of experiments, 
XRD analysis was performed on sample GAD E1. The acquired pattern is shown 
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in Figure 5.23, with the peak positions for hexagonal Gd(OH)3 also given. It can 
be seen that all the expected peaks are indeed exhibited by the samples, 
denoting that this is principle and sole crystalline phase in GAD E1. In addition, 
the peaks are sharp and narrow, which suggests a high level of crystallinity and 
probably large crystallites (See Chapter 2 for reasoning). With the exception of 
different organic capping agents being introduced, the experimental parameters 
for synthesis of GAD E2-4 did not change, so it is gathered that Gd(OH)3 is 
synthesised in the other three samples. 
 
 
 
Figure 5.23. XRD Pattern obtained for GAD E1, with the expected peak 
positions of hexagonal Gd(OH)3 (ICCD PDF 83-2037) shown below. 
 
  Cobalt Oxide, Co3O4 5.3.4
 
The synthesised sample of Co3O4 was opaque and black in colour, where 
the particles remained in dispersion over time, i.e. the particles did not 
sediment. The MRI properties of the sample, and its precursor, were tested using 
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the Halbach 0.5 T kit. The T2 times and respective r2 values are given in Table 
5.12. The measured T2 time of Co3O4 was 578.1 ms and significantly longer than 
those of Fe2O3 and Fe3O4 described in Sections 5.3.1 and 5.3.2 respectively. This 
gave rise to a low r2 value of 0.30 mM-1 s-1; consequently, the sample of Co3O4 
was not tested on the 2.35 T MRI scanner. 
 
Table 5.12. Summary of the measured T2 relaxation times for the sample 
of Co3O4, its precursor, and water blank. The r2 values, calculated using 
Equation 2, are also given. 
 
This sample of Co3O4 was found to possess antiferromagnetic properties (Moro et 
al., 2013); though T2-weighted contrast agents are usually superparamagnetic, 
and T1-weighted agents have paramagnetic properties (Conn, 2009). This 
explains the low r2 values. This sample of Co3O4 was produced for analysis of its 
other properties which are described elsewhere (Moro et al., 2013) and so, 
despite the poor MR properties, TEM and XRD analysis was conducted on the 
sample. A darkfield TEM image of the particles is given in Figure 5.24, which 
shows the cubic morphology of the particles. Using Digital Micrograph software 
from Gatan, the edge lengths of 300 particles were measured and a mean length 
of 7.03 nm was calculated. Using this data, the particle size distribution graph 
displayed in Figure 5.25 was generated, showing the majority of nanoparticles 
have an edge length between 2 and 10 nm. 
 
Sample Code 
T2 Time 
(ms) 
Error (±) r2 (mM-1 s-1) 
Co3O4 578.1 0.2 0.30 
0.05 M Cobalt Acetate 
Tetrahydrate 
101.95 0.02 0.19 
Water 2122 0.01 - 
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Figure 5.24. Darkfield TEM image of sample Co3O4 showing particles with 
cubic morphology. 
 
 
Figure 5.25. Graph showing the particle size distribution of Co3O4 
particles. 
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Figure 5.26 shows the XRD pattern of the sample, which matches the expected 
pattern for cubic phase spinel cobalt oxide (ICCD PDF 9-418). No other peaks 
were detected, indicating the purity of the sample. Xfit software was used to 
calculate an average crystallite size of 12.3 nm, a value slightly larger than that 
calculated from TEM analysis; this may be due to the amorphous nature of 
smaller particles which are observed by TEM but not detected by XRD. BraggĻs 
equation was used to calculate the d-spacing of each plane then checked and 
verified with Celref software. Table 5.13 shows the calculated d-spacing and the 
hkl plane for each peak. Considering the highest intensity peak at 2Ǉ = 36.8031, 
corresponding to the plane (311), the calculated d-spacing is 2.44Å (0.244 nm). 
This value is confirmed by the high magnification TEM image shown in Figure 
5.27. Furthermore, Celref software was used to refine the unit cell parameters of 
the sample and yielded a lattice constant a = 8.0937 ± 0.004Å. This figure is 
close to, but slightly larger than the theoretical cell unit size of 8.084 Å. The 
expansion of lattice parameters in nanoparticles has been previously reported 
and ascribed to the high surface to volume ratio which leads to a ³stretched´unit 
cell because of surface tension attraction between nanoparticles (Wei et al., 
2007). 
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Figure 5.26. The XRD pattern obtained for sample Co3O4. Peaks 
correspond with the expected pattern of cubic Co3O4 (ICCD PDF 009-
0418), which are shown below. 
 
Table 5.13. The d-spacing for each plane in the Co3O4 crystal, and the 
respective peak position, as calculated from the XRD pattern. 
 
Peak Position, 2Ǉ (°) (hkl) Plane d-spacing, dhkl (Å) 
18.904 (111) 4.69 
31.223 (220) 2.87 
36.803 (311) 2.44 
38.535 (222) 2.34 
44.785 (400) 2.02 
55.698 (422) 1.65 
59.343 (511) 1.56 
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Figure 5.27. High magnification HRTEM image of Co3O4 nanoparticles 
illustrating the interplanar spacing. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0.24nm
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5.4  Conclusions 
 
In this Chapter, the synthesis of Fe2O3, Fe3O4, Gd(OH)3 and Co3O4 were 
described. With the exception of Co3O4, synthesis was attempted using different 
reactor temperatures. For Fe3O4 and Gd(OH)3, it was found that particles were 
not produced at 350 °C but were at 400 °C; this indicates supercritical 
conditions are required for particle formation. In addition, three different capping 
agents (PVP 10, dextran and sodium alginate) were added to coat particles 
during synthesis, as well as uncoated particles being made for comparison. 
 
In the case of Fe2O3, the samples were manufactured at three different reaction 
temperatures; DLS data showed a general trend of increasing particle size with 
increasing synthesis temperature. Another general trend showed that smaller 
particles exhibited higher r2 relaxivities. At the lower two reaction temperatures, 
the highest relaxivities were produced by particles coated with dextran (HEM A3 
had an r2 of 8.98 mM-1s-1, which HEM B3 was calculated as 8.24 mM-1s-1) ± 
consistent with previous reports in the literature that dextran improves 
relaxivity. At the highest reaction temperature, the largest r2 value was 
attributed to the sample of uncoated particles (HEM C1) rather than those coated 
with dextran (HEM C3); this may be a result of thermal decomposition of dextran 
caused by the reactor temperature. These r2 values for Fe2O3 particles are 
higher than some commercial contrast agents, such as Omniscan at 3.4 mM-1s-1, 
but lower than most. 
 
The synthesised samples of Fe3O4 which contained particles were analysed using 
a 0.5 T MRI scanner to acquire T2 relaxation times. A 2.35 T scanner was then 
used to acquire MR images showing relaxation. The obtained data showed that 
MAG G3, Fe3O4 with dextran as a capping agent, had the lowest T2 time and 
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consequently, the highest r2 relaxivity of 33.47 mM-1 s-1. This complies with 
results from the literature. The r2 value is also comparable to some commercial 
contrast agents, such as Clariscan which has a relaxivity of 35.3 mM-1s-1. Unlike 
the sample of hematite, use of dextran at a high reaction temperature was not 
detrimental to the r2 value; it is plausible that thermal decomposition is not a 
problem in this case due to the supercritical nature of water meaning lower 
solvent density and lower residence times. Obtained TEM images and XRD 
patterns showed that dextran did not affect crystal phase or primary particle 
size, but did form a partial coating around particles. The ratio between particles 
and capping agent can be optimised in future work to ensure ideal particle 
coating, which will then prevent particle coagulation and may enhance relaxivity. 
PVP 10 did not appear to affect relaxivity, as the r2 value was similar to that of 
uncoated particles, while sodium alginate had a detrimental effect on particle 
relaxivity. This may be due to sodium alginate enveloping particles and 
diminshing their superparamagnetic properties. 
 
The relaxivity values calculated in this Chapter were based on theoretical Fe 
concentrations and assumed 100% reaction conversion; the actual 
concentrations of Fe could be experimentally measured to give more accurate r2 
values. These may actually be higher than those presented here. 
 
Of the four samples of Gd(OH)3 synthesised, the uncoated particles were not 
chemically stable and became digested by the acidic by-product after a few days. 
However, the obtained XRD data of the isolated particles confirmed the principle 
crystal phase to be hexagonal Gd(OH)3. Gd
3+ ions are known to be highly 
paramagnetic and so the precursor and uncoated particles displayed high r2 
relaxivities. However, the cytotoxic nature of the cation means it cannot be used 
as a contrast agent. Sample GAD E3, Gd(OH)3 coated with dextran exhibited a 
promising T2 relaxation time; further studies should focus on analysis of washed 
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samples to eliminate the possibility of Gd3+ ions (which could be present in the 
unwashed sample) contributing to relaxation. Meanwhile, samples containing 
PVP 10 and sodium alginate gave the lowest r2, but these were still values 
comparable to those previously reported for Gd-based materials. So, these 
maintain potential as contrast agent materials for further investigation. These 
materials could be characterised using T1-weighted scans as well, in order to 
gather information about their effects on spin-lattice relaxation. 
 
Lastly, the Nozzle reactor was used to synthesise Co3O4 for a separate study, but 
was also analysed for possible application in MRI. From the acquired TEM and 
XRD data, particles are crystalline with cubic morphology. TEM analysis yielded a 
mean edge length of 7.03 nm while XRD analysis presented an average 
crystallite size of 12.3 nm; this discrepancy could be due to smaller amorphous 
particles which are not detected by XRD. Analysis of Co3O4 on the 0.5 T MRI 
scanner showed poor T2 relaxation times; the particles were then found to be 
antiferromagnetic which explained this data. 
 
To summarise, dextran was generally shown to be the most effective capping 
agent in terms of improving r2 relaxivity of samples. Conversely, sodium 
alginate had a detrimental effect on relaxivity. Hematite, Fe2O3; magnetite, 
Fe3O4; and gadolinium hydroxide, Gd(OH)3 produced using the Nozzle reactor 
have been shown to exhibit properties for MRI which are comparable to 
commercial contrast agents. As such, these materials have the potential for 
further research and development which can serve to enhance their r2 
relaxivities further.  
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Chapter 6 
 
6 Conclusions and Future Work 
 
6.1 Conclusions 
 
The work described in this Thesis follows on from that of previous 
researchers using the Nozzle reactor, including Li (Li, 2008), Hobbs (Hobbs et 
al., 2009) and Aksomaityte (Aksomaityte et al., 2013, Lester et al., 2012). Since 
the reactor geometry was invented in 2005 (Lester and Azzopardi, 2005), the 
wide range of materials which could potentially be synthesised using it, has only 
been touched upon. Furthermore, the industries and applications which could (or 
already do) benefit from the implementation of nanomaterials is vast. In this 
Thesis, the objective was to investigate the synthesis of, and subsequently 
characterise, nanomaterials which could be applied into biological or biomedical 
fields. 
 
Firstly, Chapter 1 showed that the Nozzle reactor could be used to reproducibly 
synthesise HA with either platelet, rod or tube morphology. Data obtained from 
this investigation suggested that NH4OH plays several roles during HA synthesis, 
from directing precursors towards the formation of HA over other CaP minerals, 
to promoting the formation particular morphologies. In particular, it was found 
that in the presence of NH4OH, rods were produced LQVWHDGRIVKHHWVDWÛ&
DQG WXEHV LQVWHDG RI URGV DW Û&. While more data needs to be gathered 
before a formation mechanism can be concluded, it appears that the 
mechanisms for the three morphologies are linked. Cell proliferation and bone 
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nodule assays performed using HA from the Nozzle reactor indicated that the 
nanoparticles did not have cytotoxic effects and appeared to promote bone 
nodule formation. 
 
Chapter 1 also detailed experiments to introduce zinc and simvastatin into the 
structure of HA. It was found that the morphology of synthesised particles did 
not change by adding other compounds into the reaction. However, it was 
unclear from the obtained data whether simvastatin was successfully 
incorporated into the structure. By adding a zinc salt into the synthesis method, 
parascholzite (CaZn2(PO4)2.2H2O) was formed. This could have potential 
applications in bone based materials where zinc may provide antimicrobial 
properties (6WDQLüHWDO). 
 
In Chapter 4, synthesis of CdS yielded bright yellow particles of diameters 20 to 
50 nm - consistent with what was others had observed previously. The 
fluorometry data collected for the CdS sample were inconclusive within the scope 
of this Thesis. The methodology for CdS synthesis was adapted to produce ZnS 
nanoparticles ± a material which had not been previously produced by a 
continuous hydrothermal route. For both CdS and ZnS, a minimum reaction 
temperature of 400 °C was required to yield particles. The ZnS sample was 
shown to contain a mixture of hexagonal and cubic phases of ZnS, with primary 
particle sizes <15nm; these had aggregated into clusters with diameters of 50 to 
100 nm. Under the same experimental conditions, but using thiourea as a 
sulphur source, ZnS was not produced ± showing that thiocarbohydrazide and 
thiourea cannot be used interchangeably. 
 
Also in Chapter 4, the synthesis of ZnS with 3 different capping agents was 
reported. Structural and photoluminescent properties of these products were 
compared to unmodified ZnS. It was found that the addition of 3-MPA to the 
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synthesis method yielded particles with an average crystallite size of 3.1 nm, 
with a PL emission peak in the violet or blue light range (450 nm). This was 
compared to a peak at 558 nm, in the green light range, for Uncapped ZnS 
nanoparticles. This emission data for ZnS:3-MPA is in a wavelength range 
comparable to previous reports for cadmium-based QDs (Saraswathi Amma et 
al., 2008), thus there is the potential to develop ZnS as a heavy-metal free QD 
alternative. Furthermore, the zeta potential data highlighted a change in the IEP 
of particles in response to capping with 3-MPA; uncapped particles had an IEP at 
pH 7.8 while ZnS:3MPA 5/5 had an IEP at pH 4.1 and a stable zeta potential at 
pH 7. 
 
Coating particles with PVP had little observed effect on structural properties of 
particles. In addition, the zeta potential data was inconclusive. However, the PL 
data showed a shift in the optimum emission wavelength compared to uncoated 
particles, with the peak reached at 572 nm, corresponding to yellow light. 
Meanwhile, the obtained data showed that the addition of NaOH to synthesis did 
not have any discernible effect on the structural or PL characteristics. It is 
inferred that differences in emission peak wavelength between the four samples 
are linked to differences in particle band gap energies. 
 
In Chapter5, the synthesis of Fe2O3, Fe3O4, Gd(OH)3 and Co3O4 were described. 
With the exception of Co3O4, synthesis was attempted using different reactor 
temperatures. For Fe3O4 and Gd(OH)3, it was found that particles were not 
produced at temperatures below 400 °C, indicating supercritical conditions are 
required for particle formation. Three different capping agents (PVP 10, dextran 
and sodium alginate) were added to coat Fe2O3, Fe3O4 and Gd(OH)3 particles 
during synthesis, as well as uncoated particles being made for comparison. 
 
Chapter 6. Conclusions and Further Work 
230 
 
Samples of Fe2O3 were synthesised at three different reaction temperatures; a 
general trend of increasing particle size with increasing temperature was 
observed. Moreover, smaller particles typically exhibited higher r2 relaxivities. 
The highest relaxivity seen for the Fe2O3 sample set was ascribed to particles 
coated in dextran and synthesised at the lowest reaction temperature of 
~150 °C. Still, all of the uncoated particles produced at the three different 
temperatures appeared to be quite amorphous when analysed using XRD. 
 
Likewise for Fe3O4, particles coated with dextran displayed the highest relaxivity. 
It was shown that the dextran coating did not affect primary particle size or 
crystallinity, but did partially coat individual particles. 
 
Without the use of capping agents, Gd(OH)3 produced in the scope of this Thesis 
was chemically unstable and dissolved. As Gd3+ ions are known to be highly 
paramagnetic, the uncapped sample exhibited high relaxivity. Particles coated 
with dextran also showed high relaxivity. However, samples were not washed 
prior to analysis, so the effect of Gd3+ ions - which may be present in the sample 
- on relaxivity is unknown. 
 
For all samples, sodium alginate had a detrimental effect on r2 relaxivity. It is 
thought that the alginate may have a dampening effect on the 
superparamagnetic properties of the iron oxide particles. Hematite, Fe2O3; 
magnetite, Fe3O4; and gadolinium hydroxide, Gd(OH)3 produced using the Nozzle 
reactor have been shown to exhibit properties for MRI which are comparable to 
commercial contrast agents. As such, these materials have the potential for 
further research and development which can serve to enhance their r2 
relaxivities even more.  
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Synthesis of Co3O4 was also reported in Chapter 5, but the particles were found 
to be antiferromagnetic so did not display good relaxivity data. Still, this material 
may find use in other applications (Moro et al., 2013). 
 
6.2 Future Work 
 
Following on from the work on HA reported in Chapter 1, further attempts 
to incorporate drugs into the structure of HA can be made. Here, it is important 
to use compounds with high thermal stability. The work in this Thesis developed 
issues due to the low concentration of statin used, so this should be increased in 
future work. As well as FTIR or ToF-SIMS, thermal analysis such as TGA could 
provide additional data to ascertain the presence of organic compounds in 
samples. 
 
Subsequent to the addition of Zn(NO3)2.6H2O to HA synthesis which resulted in 
the novel synthesis of parascholzite, the ratio of Ca:Zn can be investigated 
further, to determine if other calcium-zinc phosphates can be produced using the 
Nozzle reactor. 
 
The work described in Chapters 4 and 5 began to look at the use of stabilisers or 
capping agents to coat nanoparticles and prevent their aggregation. Meanwhile, 
the difficulty in choosing suitable surfactants for each particle, which are also 
compatible with the synthesis reaction system, was highlighted in Chapter 1. 
Nevertheless, the work in this Thesis described the positive effects of using 3-
MPA as a surfactant for ZnS, and dextran for iron oxide nanoparticles (Fe2O3 and 
Fe3O4). There is scope for determining the optimum concentration ratios between 
these particles and surfactants. By improving the coating of these nanoparticles, 
their properties could be enhanced even further. 
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Also in Chapter 5, the relaxivities of samples was calculated based upon 
theoretical concentrations of Fe or Gd. Elemental analysis, such as atomic 
adsorption (AA) or inductively coupled plasma (ICP) could provide experimental 
concentrations for more accurate relaxivity values. 
 
The functional properties of HA, ZnS, Fe2O3, Fe3O4 and Gd(OH)3 were tested in 
this Thesis. However, other such tests could be performed to acquire more 
information on how these nanomaterials would perform if applied to commercial 
products. For example, more in depth cell assays or using other cell lines would 
yield additional cytotoxicity data for HA; tests could be carried out to determine 
the electroluminescent properties of ZnS; and T1-weighted scans could be used 
on Fe2O3, Fe3O4 and Gd(OH)3, in order to gather information about their effects 
on spin-lattice relaxation. 
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8 Appendix 
 
 
 
Figure A1. SEM images of (a) ZnS:NaOH 9/1, (b) ZnS:NaOH 8/2, (c) 
ZnS:NaOH 7/3, (d) ZnS:NaOH 6/4. 
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Figure A2. SEM images of (a) ZnS:3MPA 9/1, (b) ZnS:3MPA 8/2, (c) 
ZnS:3MPA 7/3, (d) ZnS:3MPA 6/4. 
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Figure A3. SEM images of (a) ZnS:PVP 9/1, (b) ZnS:PVP 8/2, (c) 
ZnS:PVP 7/3, (d) ZnS:PVP 6/4. 
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Table A1. Zeta Potential data for Uncapped ZnS. 
 
pH 
$YHUDJHǅSRWHQWLDO
(mV) 
Standard 
Deviation 
2.59 20.1 1.362 
4.48 21.12 1.126 
6.72 3.668 0.991 
8.12 -0.843 0.274 
9.52 -1.407 0.46 
10.38 -34.6 1.589 
11.69 -55.1 5.704 
 
 
 
Table A2. Zeta Potential data for ZnS:3MPA 5/5. 
 
pH 
$YHUDJHǅSRWHQWLDO
(mV) 
Standard 
Deviation 
2.09 19.92 1.184 
3.62 13.5 0.731 
4.31 -3.992 0.767 
5.92 -23.86 1.036 
6.44 -26.74 2.348 
9.33 -22.34 1.074 
10.97 -52.28 1.875 
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Table A3. Zeta Potential data for ZnS:PVP 5/5. 
 
pH 
$YHUDJHǅSRWHQWLDO
(mV) 
Standard 
Deviation 
3.05 0.443 0.423 
3.53 -5.926 1.318 
4.98 -6.492 1.37 
7 -11.34 0.811 
8.24 -18.34 0.879 
10.14 -22.1 0.675 
11.03 -18.06 3.469 
 
 
 
Table A4. Zeta Potential data for ZnS:NaOH 5/5. 
 
pH 
$YHUDJHǅ
potential (mV) 
Standard 
Deviation 
3.16 9.622 0.518 
5.04 10.598 0.635 
7.1 8.52 0.835 
8.21 8.244 0.859 
9.35 -21.34 1.378 
10.96 -38.48 1.813 
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Figure A4. D7KHH[FLWDWLRQVSHFWUDǊHP QPDQGEHPLVVLRQ
specWUD ǊH[ QP IRU=Q6393VDPSOHVSURGXFHGXVLQJ different 
precursor flow ratios. The spectra of the precursors and water blank 
were obtained as a control. 
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Figure A5. D7KHH[FLWDWLRQVSHFWUDǊHP QPDQGEHPLVVLRQ
spHFWUDǊH[ QPIRU=Q61D2+ samples produced using different 
precursor flow ratios. The spectra of the precursors and water blank 
were obtained as a control. 
 
 
